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Abstract
Introduction
Despite the growing emphasis on the collection, monitoring and reporting of
outcomes of surgical care within the UK, few data exist for such purposes. Equally,
few data are available on disease occurrence and surgical practice in England. In this
thesis, the hypothesis that Hospital Episode Statistics (HES) data can be used for such
purposes is tested.
Methods
The objectives of this thesis were twofold. Firstly, to review the literature to establish
to what extent lIES data has been used to study incidence, surgical treatments and
their outcomes. Secondly, to evaluate - using a number of individual lIES-derived
case studies, to what extent the lIES database can be utilised to answer clinical
questions concerning incidence, practice and outcome of urological surgery.
Strengths and weaknesses of the lIES database were subsequently sought on which to
generate recommendations concerning the future clinical use of the database.
Results
The review highlighted the completeness of the database identifying very low under-
ascertainment when compared to local audit data although did identify that use of
Finished Consultant Episodes (FCE'S) resulted in over-estimation of disease
incidence.
lIES-derived case studies suggested, first, the incidence of hypospadias was
considerably higher than previously reported and furthermore, did appear to be on the
increase. Second, boys continue to undergo clinically inappropriate foreskin surgery.
Third, the shift away from surgery for men with symptomatic BPlI has not resulted in
more men experiencing an episode of acute urinary retention. Fourth, high-volume
cancer centres appear to achieve improved outcomes following cystectomy by
reducing the risk of "failure-to-rescue" following an adverse event.
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Recommendations on the future clinical use of HES data drawn from the HES-derived
case studies were first, if incidence is to be calculated using HES data, there must be
no or minimal ambiguity regarding diagnostic or procedural coding. Second, a
number of diagnostic and procedural codes can be "operationalised" to define an
event provided coding practice is not identified in advance. Third, the incidence of a
condition can be identified using HES data provided all patients or at least the
majority of patients undergo hospital treatment for that condition. Fourth, for HES
data to comment on clinical appropriateness of treatment, the prevalence of the
condition requiring treatment must be known. Fifth, if HES data is to be used to
analyse trends in disease incidence over time, there must be no changes in coding
practice over the study period. Sixth, HES data should not be used in isolation to
report long-term oncological outcomes. Seventh, HES data is suitable to investigate
the determinants of short-term surgical outcome such as mortality.
Conclusion
Evaluation of the use of HES data to answer specific questions concerning the
incidence, practice and outcome of urological surgery suggests HES is a useful source
of data provided caveats concerning the strengths and weaknesses of the database are
considered at the time of data analysis.
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1.2 Background
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1.1 Introduction and Objectives of thesis
This thesis describes work I undertook during a 24-month period as a research fellow
attached to the clinical effectiveness unit at the Royal College of Surgeons of
England. The thesis is divided into four sections, each sub-divided into chapters
describing different aspects of this work.
The objectives of this thesis were twofold. Firstly, to review the literature to establish
to what extent Hospital Episode Statistics (HES) data has been used to study
incidence, surgical treatments and their outcomes. Secondly, to evaluate to what
extent the HES database can be utilised to answer clinical questions concerning
incidence of urological disease as well as practice and outcome of urological surgery.
Section one consists of two chapters. The first chapter is a general introduction to the
thesis while the second chapter contains a summary, for non-urological readers, of
Hypospadias, Phimosis, BPH and Bladder Cancer as well as the surgical procedures
employed to treat such conditions.
Section two consists of two chapters. The first chapter presents a general overview of
the HES database while the second chapter presents a review of the published
literature to establish, first, to what extent the HES database of the Department of
Health in England has been used to report on the incidence of surgical disease and
second, to what extent the HES database has been utilised to report on the
determinants of outcome following surgical activity.
Section three of this thesis included five case studies specifically chosen to evaluate
the use of the HES database as a source of data for the urologist to answer clinically
relevant and important questions concerning incidence of urological disease, surgical
treatments and their outcomes.
The first two case studies within this section considered two paediatric urological
procedures, namely Hypospadias repair and circumcision. The first case study used
HES data concerning surgical treatment of hypospadias, to report trends in the
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incidence of the congenital anomaly and subsequently compared incidence based on
treatment to that reported by the national congenital anomaly register.
The second case study used HES data to identify the incidence of circumcision in
England. Given that the prevalence of phimosis - almost the only true medical
indication for medical circumcision in the paediatric population, is so well
documented, HES data was used in this case study to evaluate the clinical
appropriateness of surgical treatment for the condition.
The third case study utilised HES data to comment on trends in the incidence of acute
urinary retention - a known complication of Benign Prostatic Hyperplasia (BPH), to
investigate the impact of change in the management of BPH.
The fourth case study used HES data to investigate whether delay in radical urological
cancer surgery resulted in poorer long-term oncological outcomes in patients with
invasive bladder cancer.
The final case study used HES data to investigate how higher volume cancer hospitals
achieve improved short-term peri-operative outcomes, again following radical
urological cancer surgery.
Section four of this thesis comprises a general discussion in which the use of the HES
database to answer clinical questions concerning the incidence of urological disease
and the determinants of outcome following urological surgery are evaluated. In this
last section, the strengths and weaknesses of the HES database are discussed in the
context of the review and the individual case studies. These findings are subsequently
compared with those gained from studies that have investigated the use of databases
other than HES for similar purposes.
Drawing on the findings of this thesis, specific conditions are identified that need to
be met before the HES database may be used as a source of information for the
urologist. These conditions are subsequently summarised in a number of
recommendations. The types of clinical questions that the HES database may be most
suited to answer are then discussed.
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Finally, the aim of this thesis was to evaluate to what extent the HES database can be
utilised to answer clinical questions concerning the incidence of urological disease as
well as practice and outcome of urological surgery
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1.2 Background
Quality within the context of health care provision has recently been defined in the
Lord Darzi review - High Quality Care for All: NHS Next Stage Review Final Report
[www.dh.gov.uklenlPublicationsandstatisticslPublicationslPublicationsPolicyAndGui
danceIDH_085825]. This review, commissioned by the Department of Health in
England, stated that quality should be defined and so evaluated according to three
aspects of care, namely, patient safety, patient experience and finally, effectiveness of
care.
Defming what quality is, represents the first key step in improving healthcare
provision as once quality can be defined, data on can be collected, systematically
measured and subsequently published [Lakhani et al, 2005].
The framework or system through which organisations such as the National Health
Service (NHS) achieve and continuously improve the quality of their care is
collectively referred to as clinical governance [www.dh.gov.uk].Clinical governance
activities have always been an important aspect of clinical medicine, however,
increasing emphasis has been placed on such activities in the United Kingdom
following recommendations drawn from the Bristol inquiry - an independent public
inquiry into paediatric cardiac mortality rates at the Bristol Royal Infirmary
[www.Bristol-inquiry.org.uk]. Currently, all doctors working with the NHS are
contractually obliged to participate in clinical governance activity while the General
Medical Council (GMC) lists such activity as an essential aspect of "Good Medical
Practice", a code of conduct published by the organisation.
It is well recognised that data concerning all three aspects of quality of health care
provision are lacking in the UK, despite quality improvement being the key tenet of
clinical governance [Aylin et al, 2001] and the widely held belief that it is only
through the process of data collection and data reporting that the quality of care within
the NHS is likely to improve [Lakhani et al, 2005].
It is to be expected that few data are available concerning patient experience as this
aspect of quality has been neglected in the past, only being highlighted in the recent
23
Darzi report. However, it is disappointing that there remains a lack of data concerning
the two other aspects of health care quality, namely clinical effectiveness and patient
safety in the UK.
At the same time, patients and government alike have been increasingly demanding
transparency with regard to quality of care. A recent NHS chief executives report
commented on the "constraints of current measures of quality and productivity and on
the need for better measures of output and outcome" [DOH, 2004]. This view was
reinforced by a recent review of government outcome and productivity which
acknowledged a "lack of measures of output and outcome within the NHS" [Atkinson
et al, 2004]. Such reviews are important, as government is keen not only to ensure
improving standards within the NHS, but also to identify the gains achieved by
increasing public spending within the service. Patients on the other hand are
increasingly demanding data concerning quality of care so as to enable informed
decision making when deciding on their own medical treatment.
The monitoring of surgical outcomes in an attempt to report effectiveness of care and
patient safety, requires complete, timely and accurate data that will in turn help
identify factors that contribute to variations in quality [Nuttall et al, 2007]. As
mentioned earlier however, this data is lacking on a large scale in the UK
[www.ncl.ac.uklqip. Gill et al, 2003]. For this reason, information on the quality of
surgical care is predominantly generated by relatively small ad hoc studies. Such
studies, traditionally carried out by the individual surgical specialty associations, have
often suffered from limited funding, lack of essential resource and support [Fine et al,
2003]. Recently, a small number oflarge-scale national audits were initiated and
sponsored by the Healthcare Commission to address mainly NHS priorities
[Healthcare commission, 2004]. However, these audits are expensive and labour-
intensive projects and therefore understandably, only a limited number of surgical
problems and interventions can ever be investigated in this way [Measuring and Using
outcomes of Surgery: www.rcseng.ac.uk].
The Bristol Royal Infirmary inquiry [www.Bristol-inquiry.org.uk] report made 198
recommendations that concerned many aspects of clinical care applicable to all
clinician's not only cardio-thoracic surgeons. Key recommendations from the inquiry
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included the need for periodic revalidation, the need for the development of national
standards of care, the increased transparency of sentinel event reporting as well as the
creation of regulatory bodies to regulate healthcare standards and institutions. The
report also stated that patients and the public alike should be able to obtain
information as to the relative performance of trusts and the services and consultant
units within such trusts. This last issue essentially called for increasing transparency
concerning the collection and reporting of surgical outcomes.
While the Bristol inquiry was ongoing, cardiac surgeons in the UK had foreseen the
increasing requirement for the collection and reporting of national audit data [Keogh
et al, 2004]. As a direct result of this insight, the Society for Cardiothoracic Surgery in
Great Britain (SCTS) developed a highly detailed national database - the Central
Cardiac Audit Database (CCAD) for the collection of national surgical outcomes
[Fine et aI, 2003]. The Society made it compulsory that all surgeons performing
cardiothoracic surgery in the UK provide their own detailed audit data to the CCAD.
Collection of such data has allowed the SCTS to monitor quality of surgical care
within the UK using risk adjusted models that in turn have been published to inform
the government and patients alike [Bridgewater et al, 2005]. Furthermore,
Bridgewater and colleagues [2007] have demonstrated that data collection and
subsequent publication of cardiac surgery mortality data in the UK has itself resulted
in a decreased mortality following such surgery, a trend not associated with fewer
high risk patients being operated upon.
While such a policy on data collection is highly admirable and highly desirable, it is
not practical or cost-effective to collect such detailed audit data on all surgical
procedures completed within the NHS. It is therefore important to consider
alternative approaches to provide data of adequate quality at relatively low cost across
the breadth of surgery.
In the US, a growing number of studies on the quality of surgical care are published
based on administrative data [Romano et al, 2002]. Most studies use such
administrative data to report effectiveness of surgical care. An administrative database
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that is often used in the US is the Medicare database. This database encompasses the
Medicare claims of 97% of individuals aged 65 or older. The HES database,
containing information about all admissions in NHS Trusts, is an English equivalent
of the US Medicare database.
In contrast to its American counterpart, the HES database has historically been used
relatively infrequently to report on effectiveness of care in the UK - although of late
this trend is increasingly being reversed. There are several reasons why the HES
database has not tended to be used to report on this aspect of quality of care. First,
there are concerns about the accuracy of the HES data, although there is limited
evidence to underpin this. For example, a recent systematic review including studies
comparing HES records with case notes in the UK only retrieved studies that
examined the period before the introduction of the lCD-to in 1995 [Campbell et al,
2001]. Most of these studies used methods of variable quality, were performed in a
limited number of centres, and included a small number of patients.
Second, the HES database is less detailed than the databases used in the US, because
the latter are generated as a component of a prospective payment system. Despite
this, there is clear evidence that coding of additional or secondary procedures, as well
as coding of pre-existing comorbid disease within the HES database is increasing. In
1993, although it was possible for an additional six secondary diagnoses, other then
the primary diagnosis to be recorded with in the database, as a result of a policy of
only documenting a secondary diagnosis in 'special circumstances " only a small
number of HES records actually had a documented secondary diagnosis pertaining to
a complication occurring during admission or comorbid pathology (2 million)
[www.hesonline.nhs.uk]. However, having changed coding policy to document and
code for all additional diagnoses, as well as increasing the number of secondary
diagnoses capable of being recorded within the database - 14 diagnosis fields were
introduced in 2002, by 2004, more than 20 million secondary diagnosis codes were
listed within the 13 million patient records included in the database that year.
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Third, comparisons (among providers or between different types of treatment) based
on HES data may be misleading as the HES database contains only limited
information on disease severity and comorbidity.
Despite the above concerns, the HES database would appear to have considerable
potential for the investigation of surgical outcomes and quality of surgical care with
specific regard to patient safety and effectiveness of care, in the UK. It is population-
based, highly representative of its population, and given that it routinely collected by
the UK government and has been since 1989, it represents a cheap source of data
spanning more than 15 years. Furthermore, it is readily available and relatively low
cost. As such, the HES database would appear to represent a much under-utilised
epidemiological resource.
The advantages of HES database listed above, also make the database potentially
useful, not only for investigating quality of surgical care, but also for the evaluation of
disease occurrence within the UK. Again the US counterpart to the HES database -
Medicare, has been utilised extensively for this purpose [Baron et aI, 2000].
Identification of disease occurrence may be of great importance for 'healthcare needs
assessment', evaluation of public policy, detection of change in health practices and
the effects of these changes, as well as the evaluation of the natural history of disease.
[Farmer et al, 1998, Teutsch et al, 1994].
However, alike surgical outcome reporting, few data exist on disease occurrence
within the UK while those studies and systems designed to do so are again highly
labour-intensive and therefore expensive [Dolk et al, 2004].
1.2.1 Origin of this Thesis
The Clinical Effectiveness Unit (CEU) of the London School of Hygiene and Tropical
Medicine and The Royal College of Surgeons of England has been developing a
programme of work to study the "epidemiology of the quality of surgical care". Its
aim is to provide quantitative information on processes and outcomes of surgical care
as well as their determinants.
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Part of this ongoing research programme is the evaluation of alternative data sources
to answer specific clinical questions. While the randomised controlled trial (RCT) is
generally regarded as the gold standard research methodology for answering clinically
significant research questions, there are many situations where the RCT is not feasible
or ethical to conduct [Joffe et al, 1994, Leyland et al, 1991]. Data from RCT's are
often limited to the specific question being asked while the strict criteria for RCT
entry often raises concerns regarding the applicability of RCT results to everyday
practice. It is in this context that alternative data sources such the HES database may
have great potential.
With these issues in mind, the purpose of this thesis was to evaluate to what extent the
HES database may be used to answer specific pre-determined clinical questions.
These questions were broadly divided into those that evaluate the use of the HES
database as a source of data to report on the incidence of urological disease, and those
that evaluate the use of the HES database as a source of data to report on patient
safety and effectiveness of surgical care - two of the three tenets of quality.
Within this thesis, these clinically important, pre-determined questions take the form
of case studies. Itmust be stressed that at the heart of our methodology lies the fact
that all questions be pre-determined prior to data review. It is through these case
studies that the HES database is evaluated as a source of data for clinical use.
The focus of this thesis concerns urological disease and urological surgery, however,
conclusions generated within this thesis concerning the clinical use ofHES data to
answer clinically important research questions are likely to be relevant for all surgical
care.
1.2.2 Case Studies
Section three of this thesis included five case studies specifically chosen to enable the
evaluation of the HES database as a source data to ask clinically important questions.
Such evaluation is the subject of section four of this thesis.
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The first of these case studies addresses the clinical question - is the incidence of
hypospadias, a congenital anomaly affecting the male urethra, on the increase?
This is a clinically important question as there is evidence to suggest the incidence of
hypospadias may be rising as a result of increasing environmental exposure to
environmental pollutants [Paulozzi et aI, 1997]. However, in England, due to concerns
regarding the accuracy and validity of pre-existing congenital anomaly systems, as
highlighted in a recent validity study [www.eurocat.ulster.ac.uk].itis not possible to
verify if such a trend is occurring. This case study therefore attempts to compare
incidence based on treatment, captured in HES with that reported in the congenital
anomalies register.
The second case study included within this thesis addresses the clinical question - are
too many boys undergoing paediatric circumcision for phimosis of the foreskin in
England?
A number of well-conducted studies have reported on the incidence of pathological
phimosis in England [Rickwood et a11989, Dewan et aI, 1996]. In this case study, the
use of lIES data to complement pre-existing data on disease incidence was evaluated
to identify ifboys continue to undergo clinically unnecessary surgery. In such a way,
HES was used to evaluate the clinical appropriateness of treatment.
The third case study included within this thesis concerns the incidence of acute
urinary retention - a known complication of Benign Prostatic Hyperplasia (BPH)
progression. Clinical management of BPH has changed significantly over the last
decade due to advances in pharmaceuticals [Kirby et al, 2000]. This in turn has
resulted in far fewer men undergoing surgery for the disease. However, little is known
about the impact of such a change on disease progression. Acute urinary retention is
one consequence of BPH disease progression [Barry et aI, 200 I]. The third case study
within this thesis asks the question - what is the impact of a shift away from surgery
towards medical therapies for the treatment of men Benign Prostatic Hyperplasia on
the incidence of acute primary urinary retention?
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The fourth case study asks the question - does delay in the time from diagnosis of
advanced bladder cancer to the time of definitive cancer treatment impact on the long-
term oncological outcome of such cancer treatment?
A number of clinical studies have reported that delays of more than 3 months between
diagnosis and definitive treatment can infer a worse outcome following subsequent
radical surgery for bladder cancer patients [Chang et al, 2003, Mahmud et al, 2006].
This study evaluates if the HES database, with its inherent lack of data concerning
oncological variables, can be used to demonstrate similar findings. If HES data were
unable to establish a trend of worse outcome in relation to preoperative delay" it
would subsequently cast doubt on the use of HES data to report on long-term
outcomes cancer treatment without the need for linkage with other data sources such
as pathological databases.
Evaluating the use of the HES database to answer questions concerning the impact of
administrative variables such as operative delay is of increasing importance.
Government is generating an increasing number of targets concerning cancer
treatment, the impact of which we are currently unable to evaluate through local audit.
Furthermore, with the increasing centralisation of cancer services within the UK, as
advocated by government for radical pelvic cancer surgery for example, the impact of
administrative variables such as pre-operative delay will be increasing importance as
patients will have to travel longer distances to receive treatment.
The fifth and final case study reported on within this thesis asks the question - how do
higher volume hospitals achieve improved outcomes following radical cystectomy for
bladder cancer?
Considerable data are available reporting the association between volume and
outcome, not only for urological surgery but also for a number of other non-urological
surgeries [Birkmeyer et al, 2002, Goodnet et al, 2003]. However, as yet, there are few
data investigating how such a correlation is achieved. In this fifth and fmal case study
included within the thesis, the HES database is evaluated for its ability to uncover the
cause and effect of such a volume and outcome relation.
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In summary, with the growing emphasis on clinical governance throughout the
medical profession, there is an increasing demand for the monitoring of clinical
outcomes so as to maintain and improve the quality of care within the UK. Despite
this, there is a lack of data available on patient outcomes within the UK. At the same
time, there is also a lack of data concerning the volume of disease within the UK that
needs clinical care. This thesis explores the use of the HES database, an example ofa
routinely collected data source, collected for the purpose of administration, to answer
specifically designed clinical questions concerning the incidence of disease within the
UK as well as provide quantitative information on the processes and outcomes of
surgical care.
1.4 Practical Considerations
For the purpose of this project, the Clinical Effectiveness Unit (CEU) established a
collaboration with the HES Section of the Department of Health. The Director
(Professor Jan HP van der Meulen) and the Clinical Director (Mr Mark Emberton) of
the CEU appointed a research fellow (Mr Paul Cathcart), who had completed basic
surgical training, who would be responsible for the day-to-day management and
coordination of the project for two years. The entire study was funded by the
Research Fellowship Scheme of The Royal College of Surgeons of England.
The Clinical Effectiveness Unit at The Royal College of Surgeons of England is an
academic collaboration between the Health Services Research Unit of the London
School ofllygiene and Tropical Medicine of the University of London and The Royal
College of Surgeons of England. It is the remit of the CEU to study "the
epidemiology of the quality of surgical care". The CEU was established in 1996,
replacing the Surgical Audit and Epidemiology Unit.
The vast majority of work within this thesis has been undertaken by me. However, in
the course of conducting this work, I have worked within a team consisting on my
supervisors, Mr Mark Emberton and Professor Jan van der Meulen, in which all three
of us contributed ideas to this work. I performed all analyses presented in this work,
although statistical and methodological guidance was provided by Professor Jan van
dcr Meulen. All literature searches and background research was conducted by me,
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and the entire text has been written by me under the guidance of my supervisors. This
thesis represents original work, although some aspects of this work have been based
on methods used by other workers and where this is the case, appropriate references
have been made.
Chapter 2
Summary of the urological diseases and urological surgeries on which the case
studies included within this thesis are based
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2.1 Objectives
The objectives of this chapter were to describe in brief the urological diseases and
urological surgeries on which the case studies included within this thesis are based.
2.2 Description of the Diagnosis and Treatments for Hypospadias
2.2.1 Diagnosis of Hypospadias
The first case study within this thesis concerns hypospadias. This is the medical term
applied to a congenital penile anomaly in which an abnormal ventral opening of the
urethral meatus is identified. This defect is often associated with two further fmdings,
namely, a ventral curvature of the penis known as chordee and a hooded foreskin that
is in turn deficient on the ventral aspect of the penis [Thomas et al, 2002, Gallentine et
al,2001].
Many theories have been suggested in an attempt to explain the aetiology of
hypospadis. These include deficiencies in hormonal stimulation of the penis, genetic
disorders and vascular anomalies. A genetic link has been suggested by the finding
that the condition appears more common in monozygotic twins as well as the
offspring of fathers who have hypospadias themselves [Thomas et al, 2002, Vrijheid
et al, 2003, Gatti et al, 2001].
Hypospadias is associated with another congenital anomaly, namely undescended
testes in which the testicle fails to descent from the posterior abdominal wall into the
scrotum during later stages of pregnancy. Furthermore, this association appears to be
more apparent in those with severe or more proximal hypospadias.
Hypospadias has been traditionally described according to the site of the abnormal
meatus. As such, hypospadias is described as distal - where the meatus lies either on
the glans or the coronal sulcus, mid-shaft or peno-scrotal- where the meatus opens
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onto the proximal penis or the perineum. Distal forms are by far the commonest
[Thomas et aI, 2002, Vrijheid et al, 2003].
2.2.2 Treatment for Hypospadias
Surgery is indicated in the majority of boys with hypospadias - excluding those with
mild glanular hypospadias, as the deformity will often interfere with voiding or
subsequent sexual function in latter life. Currently, surgery tends to be performed on
boys between 6 and 12 months of age.
There are a number of different hypospadias repairs, the most common of which are
the MAGPI and Snodgrass repairs [Manzonni et al, 2004].
Meatal Advancement and GlanuloGlasty or MAGPI is a single stage procedure for
milder more distal forms of hypospadias while the Snodgrass procedure, again a
single stage procedure, is reserved for more proximal forms.
The results of hypospadias surgery depend on the original defect as well as the type of
surgical procedure employed. A number of complications of hypospadias are
commonly recognised that include bleeding, infection and subsequent urinary fistula
formation. Complications are relatively common (15%) following hypospadias
surgery with complication rates being considerably higher when boys undergo surgery
for more proximal forms. Complications will often result in the child requiring
addition hypospadias procedures.
2.3 Description of circumcision and the diseases treated by the procedure
2.3.1 Circumcision
The second case study within this thesis evaluates the use of HES data to identify if
boys undergo unnecessary surgery give the incidence of phimosis - the almost
exclusive disease that circumcision is indicated for, is so well documented.
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Circumcision is a relatively simple urological procedure in which the foreskin of the
penis is removed. The skin of the penis is then sutured or stitched to a layer of mucosa
or skin immediately adjacent to the coronal sulcus of the glans. The procedure, if
performed in the paediatric population will almost always be performed under general
anaesthetic.
A number of complications can occur following circumcision [Williams et aI, 1993,
Kaplan et aI, 1983]. Early complications include haemorrhage and urinary retention ..
The most common complication is thought to be postoperative infection which tends
to occur between 5 and 10 days following surgery. More serious complications such
as amputation of the glans and urethral fistula are exceeding rare.
2.3.2 Phimosis
Phimosis, or more accurately, pathological phimosis, is characterised by cicatrisation
- narrowing of the preputial orifice, together with the histological appearance of
Balanitis Xerotic a Obliterans (BXO) on microscopic pathological analysis [Thomas et
al, 2002]. This contrasts with, physiological phimosis, also referred to as
developmental non-retractability of the foreskin, which describes the normal penile
development in which preputial adhesions, located between the glans penis and the
foreskin, prevent the retraction of the foreskin in young boys.
Pathological phimosis with associated histological changes of BXO is an absolute
indication for circumcision where as physiological phimosis, a perfectly normal
phenomena, affects all boys at the time of birth and persists to varying degrees during
childhood, and therefore should not be regarded as abnormal and as such does not
require circumcision [Rickwood et aI, 1989].
Presentation of pathological phimosis usually takes the form of secondary, non-
retractability of the foreskin following an initial period of retract ability, a feature that
separates it from developmental non-retractability and rarely occurs in boys less than
five years of age.
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The incidence of phimosis has been investigated and reported in some detail by both
Shankar and Rickwood. Both found the incidence of phimosis within similar English
populations was about 0.6%. Given that few other medical conditions are indicated
for circumcision, if HES data suggested that more than 0.6% of the English
population were undergoing circumcision, the HES database would have identified
that too many boys were undergoing the procedure within the NHS.
2.3.3 Additional medical conditions that may be treated by circumcision
In addition to pathological phimosis, circumcision may also be indicated for recurrent
balanoposthitis, paraphimosis and megaprepuce, all three of which are relatively rare
indications for circumcision.
Recurrent balanoposthitis - is the term used to describe recurrent infections of the
foreskin, as well as being rare, must occur on more than three separate occasions
before a paediatric surgeon will consider foreskin surgery and furthermore, even when
surgery is considered, the majority of boys undergo foreskin saving procedures such
as preputioplasty as opposed to full circumcision.
Paraphimosis - a condition that occurs when the foreskin is incapable to being
reduced following initial forceful retraction, is again rare in boys below 15 years of
age and does occur, often simply needs reduction rather than circumcision.
Finally, megaprepuce - a congenital abnormality characterised by a large prepucial
sac, is extremely rare, only being described within the medical literature relatively
recently and as such is unlikely to count for a high percentage of the boys undergoing
circumcision on a national basis.
2.4 Description of the Diagnosis and Treatments for Benign Prostatic
Hyperplasia (BPH)
The third and fourth case studies within this thesis both concern Benign Prostatic
Ilypcrplasia, often referred to simply as BPH.
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2.4.1 Diagnosis of BPH
BPH is a chronic disease affecting the prostate, the aetiology of which is poorly
understood. However, although the disease is likely to be the result of many different
interactions [We in et al, 2007, Kirby et al, 2000], the majority of theories note the
importance of androgens such as testosterone in prostatic development and
enlargement.
Histologically, BPH results from the formation of nodules within the prostate brought
about by an increase in the number cells within the gland. These nodules lead to the
disruption of the normal architecture of the prostate together with enlargement of the
gland as a whole. It is this disruption of the prostatic architecture that leads to the
symptoms experienced by men with the disease.
Symptoms resulting from BPH - commonly referred to as Lower Urinary Tract
Symptoms or LUTS for short, can be classified as either voiding symptoms such as
poor flow and hesitancy, or storage symptoms such as frequency and urgency.
Voiding symptoms are thought to relate to mechanical obstruction to the flow of urine
caused by the prostate enlarging and encroaching on the urethral lumen. Storage
symptoms on the other hand are thought to result from secondary changes within the
bladder brought about by chronic obstruction of the bladder by the prostate, which
results in the bladder muscle - the detrusor muscle, becoming hyperactive.
In an attempt to characterise and measure the symptoms of BPH, the American
Urological Association (AUA) developed a self-administered questionnaire that was
designed and validated not only to identify the need for treatment in men with LUTS
secondary to BPH, but also to evaluate men once treatment had been
commenced/performed [Barry et al, 1992]. This questionnaire forms the basis of
assessment for men with BPH.
2.4.2 Treatments for BPH
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Prior to the development of medical therapies for the treatment of BPH in the early
1990's, men would either undergo prostate surgery or be monitored with a watchful
waiting policy [Wilson et al, 2004, Wasson et al, 2000].
At the current time, treatment options for men with LUTS suggestive of BPH will
often depend on the AUA symptom score [Barry et al, 1992].
Men with mild symptoms will be recommended watchful waiting while men with
moderate or severe symptoms will be offered medical therapy as first line treatment
followed by surgery if their symptoms don't improve.
Medical therapy essentially involves the use of two different classifications of drugs,
alpha-receptor antagonists and 5-alpha-reductase inhibitors.
Alpha-receptor antagonists act by initiating smooth muscle relaxation within the
prostate and bladder neck that in tum reduces the impairment of urinary flow caused
by BPH. 5-alpha-reductase inhibitors on the other hand result in a reduction in
prostate size by blocking the conversion of testosterone to dihydrotestosterone - an
androgen essential for prostatic growth.
Surgical options for men with LUTS suggestive of BPH include Transurethral
Resection of the Prostate (TURP) and open simple prostatectomy.
TURP involves removal of prostatic tissue from within the prostatic urethra with the
use of electrical cautery. A camera and lens system is used to enable visualisation of
the prostatic urethra allowing the surgeon to remove prostatic tissue using a wire loop
that cuts into the prostate removing boat-shaped chips of tissue.
Open simple prostatectomy is an open procedure by definition whereby a lower
abdominal incision is fashioned to approach the prostate. Today, it is only performed
in men with very large prostate glands in whom TURP would be unsafe.
By the early 1990's, 95% of men undergoing prostate surgery underwent TURP as
apposed to open prostatectomy [Xia et aI, 1999]. The outcome of this procedure has
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been studies in detail and as such has become known as the gold standard surgical
treatment for men with LUTS suggestive of BPH against which all other treatments
should be considered [Wasson et a11995, Thomas et al, 2005].
2.S Description of the diagnosis and treatment of invasive bladder cancer
2.S.1 Diagnosis and staging of bladder cancer
Bladder cancer is estimated to be the fifth most commonly diagnosed non-cutaneous
solid malignancy in Europe and the US and the second most commonly diagnosed
genitourinary malignancy after prostate carcinoma [Boring et al, 1995, Cancer
Research Statistics, 2000]. Bladder cancer is three times more common in men than
women and more common in Caucasians as opposed to non-Caucasians.
In the western world, 90% of bladder cancers originate from the transitional cells that
line the urinary tract and as a result are called Transitional Cell Carcinoma's (TCC).
Alternative bladder cancers include adenocarcinoma's, Squamous Cell Carcinoma's
(SCC) and small cell carcinoma's.
Haematuria -blood within the urine, is the cardinal sign of bladder cancer. Classically
patients describe painless intermittent haematuria. 1 in 4 patients presenting with
macroscopic haematuria - blood within the urine that the patient can visibly see, will
subsequently be found to harbour a urogenital malignancy.
All patients with haematuria are required to undergo a full history and abdominal
examination that should include a digital rectal examination to evaluate the prostate.
All patients should provide urine for analysis (both microscopy and culture together
with cytological interpretation), undergo imaging of the urinary tract e.g. renal tract
ultrasound, and finally undergo flexible cystoscopy - endoscopy of the bladder.
The definitive diagnosis of a bladder cancer is made on histological analysis of a
biopsy taken from the identified bladder lesion. If the bladder lesion is small to
moderate in size, the whole lesion can be removed endoscopically. This procedure,
performed with the patient under general anaesthetic, is known as a Transurethral
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Resection of Bladder Tumour (TURBT), and is performed using a resectoscope. This
piece of equipment is exactly the same as that used to perform a TURP for BPH.
Bladder tumours are "staged" according to the depth of tumour invasion into the
bladder wall. Currently, bladder tumours are staged via the TNM (Tumour, Nodes,
Metastases) classification system. This system allows precise and simultaneous
description of primary tumour extent (T) along with the status of the lymph nodes (N)
and the presence or extent of metastatic disease. Staging varies from Ta, meaning the
tumour is limited to the inner lining or mucosa of the bladder, to T4 meaning the
tumour has invaded into an adjacent organ beyond the bladder itself. All patients with
stage T2 disease - tumour invasion into bladder muscle wall, and above are
considered to have muscle invasive bladder cancer.
At the time of diagnosis, 70-75% of patients will have Ta-Tl bladder cancers, i.e.
cancers that are limited to the lining of the bladder. These tumours are sometimes
referred to as 'superficial' bladder cancers. The remaining 25-30% have muscle
invasive bladder cancer.
As one might expect, bladder cancers that have invaded into the bladder wall and
beyond, have a significantly worse prognosis than those limited to the lining of the
bladder wall.
2.5.2 Treatment of bladder cancer
Patients found to have superficial disease can easily be treated by TURBT. However,
patients with muscle invasive disease require additional treatment. Without such
treatment, mean life-expectancy is approximately 2 years, much worse than
superficial disease where very few patients die of their disease.
Curative treatment for patients with muscle invasive disease involves either removing
the bladder surgically, known as a radical cystectomy, or radical radiotherapy, both of
which may be combined with chemotherapy. To date, few studies have compared the
effectiveness of surgery versus radiotherapy for muscle invasive bladder cancer.
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However, a recent meta-analysis of 4 randomised controlled trials suggested a
survival advantage in favour of surgery, especially for younger patients.
Radical cystectomy is performed via a mid-line abdominal incision. In the male, the
bladder is removed en-bloc with the prostate and occasionally the urethra. In addition,
pelvic lymph nodes are removed. In the women, an anterior pelvic clearance is
performed whereby a hysterectomy, salpingo-ophrectomy and upper third
vaginectomy is performed, in addition to removing the bladder.
Following removal of the bladder, urine output can be directed via a cutaneous
diversion (ileal conduit) to a stoma bag for collection. Alternatively, an orthotopic or
ectopic bladder can be reconstructed using the patients' bowel.
2.5.3 Determinants of outcome following radical cystectomy
There is no doubt that reviewing results of early radical cystectomy series i.e. prior to
1980, operative mortality rates were reported as high as 15-40% [Hollenbeck et al,
2007]. With improvements in operative surgical technique and post-operative care,
peri-operative mortality has fallen significantly over the last 20-30 years to between 2
and4%.
Stage of disease and lymph node status has also been found to correlate strongly with
long-term outcomes namely disease specific and overall survival. Disease-specific 5-
year survival can be expected to be as high as 90% in patients with pT2NO disease.
This compares with 77% for patients with pT3aNO and 62% for those with pT3bNO.
Furthermore, it has been shown that in patients with organ confined disease and more
than one lymph node positive for malignant disease, 5-year specific survival falls to
54% compared to 86% in patients with organ-confined disease without lymph node
involvement.
Recently, a number of studies have been reported that, at least for short-term
outcomes, a surgeons or individual hospitals annual work load with regard the number
of surgeries performed, impacts on patient outcome. As yet however, there is no data
that explains why such an association may exist.
41
Section 2
The Hospital Episode Statistics (HES) database and review of the literature
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Chapter 3
The Hospital Episode Statistics (HES) database
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3.1lntroduction
The Hospital Episode Statistics (HES) database was first established in 1989.lts
inception was the result of a report authored and chaired chiefly by Dame Edith
Komer that concerned the predecessor of the HES database, namely the Hospital
Activity Analysis (HAA). This database, established in 1970, only collected a 10%
sample of all records concerning hospital admission to a National Health Service
(NHS) hospital. On the other hand, the introduction of the HES database was
designed not to contain data on a representative sample of hospital admissions, but to
contain data on all hospital admissions. The database covers all NHS trusts in
England, including acute hospitals, primary care trusts and mental health trusts. More
recently, the database has included records relating to care commissioned by the NHS,
but provided by independent treatment centres in England.
Data are collected and made available in data-year files running according to the
financial year, i.e. from 1SI April to 31st March and as such, so far data files are
available from 1989-1990 to 2004-2005. From 2003 onwards, as well as collecting
records on hospital admissions, data relating to outpatient attendance were also
included in the database, which added a further 40 million records to the pre-existing
15 million already collected concerning admission.
Currently over 15 million records are collected each year containing data on 13
million admissions to NilS hospitals in England [www.hesonline.nhs.uk]. These
records include private patient admissions in NHS hospitals but not those admissions
to distinct private hospitals.
Since 1989, there have been a number of changes to the processes by which HES data
is collected analysed and subsequently made available. These changes have
inevitably been brought about by changes in the structure of the NHS as a whole.
Initially liES data was collected on a sub-national level by individual Regional Health
Authorities (RHA). Ilowever, from 1996 onwards, these bodies were disbanded and
the NilS-Wide Clearing Service (NWCS) was set up to facilitate the transmitting of
data files from a regional to a national level. This work will subsequently be taken
over by the National Programme for IT's Secondary Uses Service in 2006.
44
3.2 What is the purpose of the database?
The database was initially established for use in policy development, for illustrating
variations in health status and delivery with time and between geographic areas,
medical research, in assessing performance, and determining the distribution of
taxpayers' money on healthcare. However, recently there has been a change in
emphasis with greater resources being devoting clinical data. The current aims of the
database are first, to provide a high quality service, responsive to the needs of the
users of liES data including the government and medical researchers. Second, to
continue adapting such that HES reflects changes in healthcare delivery. Third, to
continue developing new analytical methodologies within the database. Fourth, to
offer high quality, informed advice on how best to utilise HES.
3.3 What is liES an example of!
The data contained within the liES database is an example of 'routine data'. Routine
data is data that is collected irrespective of the procedure or outcome. Other examples
of routine data include deaths, births and stillborns, cancer registry data and statutory
notifications of infectious diseases. Alternatively, data may be collected with a
specific purpose in mind. Most audit and research data may be thought of as
representing this form of data. This form of data is normally collected after a specific
research question has been identified with the data collected relating specifically to
the specific research question. Protocols would normally be generated prior to any
data collection as well as data proforma's. Examples of this form of data include the
National Tonsillectomy audit [Lowe et al, 2004] and the National Prostatectomy audit
[Emberton et al, 1995].
Other 'routine data' sources alike lIES tend to arise from the administration of
healthcare delivery and as such the main producers of such data tend to be national
governments and insurance providers. Advantages of using routine data such as HES
is that routine data are relatively cheap - given that they have already been created,
they tend to be large which in turn reduces sampling error when analysing association
and span significant time period s which in tum allows time-trend analysis.
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3.4 Structure of the HES database
The HES database collects data in the form of Finished Consultant Episodes or
FCE's. A FCE is defmed as a completed period of care that a patient has received
under a single named consultant. FCE's were initially introduced to measure resource
use within the NHS. An FCE is initiated or commenced when either a patient is
admitted to hospital or if a patient's care is taken over by another named consultant
while remaining in hospital. In contrast, an FCE is terminated either when a patient's
period of care is completed and the patient is discharged from hospital, or when a
patient care is transferred to another named consultant. In this way, a single FCE does
not always correspond to a single admission, nor does each separate FCE correspond
to a different patient. As a result, each FCE is numbered according to its sequential
occurrence during a patients' hospital admission, this is subsequently referred to as
the EPIORDER. Data concerning the EPIORDER of each FCE is collected and
documented within each FCE.
A spell is defined as a patients' entire stay in hospital. A spell is terminated in anyone
of three ways. First, the patient dies during the hospital admission second, the patient
is discharged from hospital or third, the patient is transferred to another hospital. As
such, a spell may consist of several different episodes of care or FCE's. However, as
mentioned above, lIES data is not, in its raw form, packaged or collected in spells.
Instead, the data needs to be manipulated and analysed by linking episodes of care
(FCE's) so as to view data of admission or spell level.
Counting FCE's as well as spells is not the same as counting individual patients. A
patient that is unwell may have multiple FCE's relating to more than one spell during
a particular year and as such, ifFCE's or spells were considered and counted as
separate individuals, this would lead to patients being counted more than once, so-
called double counting. In such a way, use ofFCE's or spells as numerators to
calculate incidence of disease is likely to lead to over-estimation of disease incidence.
In an attempt to make lIES data more useful for clinical research, the Department of
Ilealth in England introduced from 1997 onwards, patient specific identification
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numbers called HESID numbers. Within each FeE, there is from 1997 onwards, a
data field in which each patient's HESID is documented. This number is unique to
each patient and is generated from a patients NHS number. When a new FeE is
generated, a search is done using a HESID matching algorithm to determine if the
patient has a previous HES database history i.e. a search to detect activity records that
relate to the same patient. This matching algorithm involved two steps. The first step
involves attempts to match records using the variables SEX, DOB (Date Of Birth) and
Hospital Number. If this step fails to identify a matching FeE, attempts are made to
match according to SEX, DOB, Postcode and Local Patient Identifier within Provider
- a local patient identifier number. If the FeE is matched to a previously existing
record, the record assumes the HESID already established for that patient, if no pre-
existing record is identified, that a new HESID identifier is generated.
Once lIESID was introduced, patients could be identified across multiple database
years and as such allowed for the identification of patient as opposed to episode level
data.
Data is collected within lIES according to liES datayears. Each datayear starts on the
1SI April and ends on the 31SI March - a period that equates to the financial year. As a
result, studies that utilise liES data, especially those that report on trends over time,
will often report trends between these dates.
3.5 How liES data is collected
Ilealthcare providers such as the NHS trusts collect administrative and clinical
information locally. Data are collected from medical records following the discharge
of the patient from hospital. The process of data collection is summarised below.
1. Documentation in the medical record of all diagnoses made and
procedures under taken by the doctor.
2. Transfer of the medical record to the coding office following patient
discharge from a clinical area by hospital management.
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3. Dates of inpatient spell and FCE identified using NHS data definitions
by the coder.
4. Identification of relevant diagnoses and procedures from the medical
record by the coder.
5. Coding of primary diagnoses and procedures from the medical record
by the coder.
6. Returns sent to NHS-Wide Clearing Service (NWCS) by hospital
management.
7. Data aggregated and analysed by the department of Health.
As mentioned above, data returns are submitted at regular intervals throughout the
year to the NHS-Wide Clearing Service (NWCS). However, as of December 2006,
the NWCS is due to be taken over by the Secondary Users Service (SUS) as part of
the National Programme for IT. Currently the NWCS then forwards the data to the
Health care commissioners but also copies the data to a separate database. At pre-
arranged times throughout the year, the NWCS takes an extract of their collected data
and sends it to Hospital Episode Statistics database. HES then verifies, cleans and
validates the extract, derives new items and then makes the data available within the
so-called liES Data Warehouse. Initial verification is the process by which the HES
database reviews each record to ensure that it contains a minimum amount of data.
Minimum data requirements for each record include data regarding hospital provider,
type of hospital admission as well as date of admission and date of termination of
each episode such that the record can be incorporated within a specific HES datayear.
The process of data cleaning or autocleaning on the other hand involves not only
identifying that data is present within each data field but that all coded data as well as
recorded admission and termination of episode dates are valid i.e. they are in the
correct format for the database. In addition, autoc1eaning involves the reclassifying or
overwriting of invalid codes and dates with "unknown" indicators. HES also checks
for anomalies within the data, e.g. reviewing the recorded sex within HES for those
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who have given birth. lIES will either correct the code if there is sufficient evidence
that the code can accurately be corrected or overwrites the code again as "unknown"
if this is not possible. On occasion, lIES may identify that a particular NHS provider
consistently uses an incorrect provider code. If this is the case, then the particular
code is changed within lIES providing the provider is in agreement.
Finally, validation refers to the process by which individual records are tested against
a set of rules with the aim of identifying errors that may remain following the
autocleaning process. Following this a report is generated that summarises the quality
of the submission from the data provider. This report contains a target data quality
threshold that acts as a benchmark against which dat providers can assess their
performance.
The lIES service is run on behalf of the Department of Health of England by
Northgate Information Solutions.
3.6 Data collected within the liES database
As alluded to above, data concerning an episode of care is recorded in a data record
called an FCE that in tum is divided up into a number of data fields. These data fields
include basic demographic and administrative data, details regarding a patients
method of admission to hospital, clinical data referring to the admission including
operative and diagnostic details and details of hospital discharge. In addition, the
specified consultant that the patient is primarily assigned to will be documented
according to a specific number that in tum is derived from the practitioners general
medical council number. Many of these items are generated automatically by the
Patient Administration Systems (PAS) that are present within all NHS hospitals in
England although the liES database does generate specific data such as the patients
age, identified from PAS detailed date of birth.
The liES database stores clinical data in the form of alphanumeric codes. Prior to
Apri11995, diagnoses were recorded with lIES according to the ninth revision of the
International Classification of Diseases coding system (ICD-9), thereafter, the tenth
revision of the International Classification of Diseases coding system was used (ICD-
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10) [WHO, 1994]. This coding system was generated by the World Health
Organisation (WHO) and is maintained and published by this organisation. The ICD-
10 classification of diseases is the latest in a series of disease classifications that were
formalised in 1893 as the Bertillon Classification or International List of Causes of
Death.
Within the database, from 2002 onwards, there are 14 diagnoses fields, each of which
has space for a single ICD-I0 diagnosis code. These data fields are labelled DIAG _1-
14, meaning diagnosis field 1-14. These diagnosis fields are further labelled primary
diagnosis _ i.e. the main complaint that the patient experienced for that particular
episode of care, secondary diagnosis, tertiary diagnosis etc. Thus it is possible to
report up to 14 different medical conditions that the patient may currently have or
have previously experienced. Prior to 2002, there were only 7 diagnosis fields
(labelled DIAG_I-7). Diagnosis codes commence with a letter and thereafter are
followed by two or three digits. For example:
N47
R33
Phimosis
Urinary Retention
Q54
N40
Hypospadias
Benign Prostatic Hyperplasia
Over the last decade there has been a shift towards identifying additional secondary
diagnoses within the HES database. This is supported by a recent study by the
Department of llealth that identified that twice as many secondary diagnoses were
recorded for the liES datayear 2003-2004 (20 million) compared to 1993-1994.
Operations are recorded within the HES data according to the 4th revision of the
Offices of Populations Censuses and Surveys operative procedure coding system
(OPCS-4) [OPCS, 4threvision, 1987]. The OPCS-4 coding system has evolved from a
series of classifications initially published by the Medical Research Council (MRC) in
1944. Several updates have been performed to the latest 4th revision, in 1987, 1988
and 1989. The classification is maintained and published by the NHS information
Authority. Up until the liES datayear 2002-2003, there were 4 operative fields within
the liES database, each of which has space for a single OPCS-4 operative code. These
data fields are labelled OPER_I-4, meaning operation field 1-4. However, from 2002-
2003 onwards, in a similar manner to diagnosis coding, the number of operative fields
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increased to 12 (OPER_I-12). These operative fields are labelled primary
procedure/intervention, secondary procedure/intervention onwards. Although the
primary procedure may not be the main procedure performed during that episode of
care, it should be the 'most resource intense'. This in effect makes the primary
procedure the main procedure performed in the majority of patients. In addition, each
operative field is associated with another data field labelled the date of primary or
secondary etc operative procedure. These 'date of operative procedure' fields tend to
be recorded in chronological order and as such, occasionally if patients have a minor
procedure e.g. a prostate biopsy, and then undergo radical prostatectomy, the prostate
biopsy can be recorded as the primary operative procedure with the prostatectomy
being recorded as a secondary procedure. This highlights the need to evaluate all
operative field codes when searching for surgical procedures that a particular patient
may have undergone.
The OPCS-4 coding system consists ofa tabular list of23 anatomically based
chapters relating to a body system. Each chapter, concerning a particular body system,
is allocated an alphabetic character that forms the first digit of the code, for example
M denotes urinary tract. Subsequent numbers included within the operative procedure
code record the particular procedure performed on that body system. For example:
N303 Circumcision
1\1731 Repair of Ilypospadias
M65
M34
Transurethral Resection of the Prostate
Cystectomy
3.7 Coding accuracy
The quality of data - be it routinely collected or primary data, will be dependant on
how complete the data are as well as how accurate the data are. While one of the key
strengths of the lIES database is its size and completeness, there are concerns with
regard the accuracy of lIES data and this will always be the case providing validation
of lIES data continues to be performed on a national as opposed to a local level.
These concerns inevitably relate to the accuracy of coding, especially diagnosis and
operative procedure coding, within the database. In response to these concerns,
especially given that use of routine data such as HES was increasingly being utilised
by both UK government policy makers as well as medical researchers, Campbell and
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colleagues [2001] recently performed a systematic review of both diagnostic and
operative discharge coding accuracy within routine UK hospital statistics. This
review identified 21 studies, published between 1996 and 1998, that had investigated
the accuracy of coding within routinely collected hospital episode data. Accuracy was
defined as the proportion of hospital episode records that have the same code as that
assigned by an independent review of the discharge summary or medical record. The
review found that median coding accuracy rates for diagnoses ranged from between
82 and 91% depending on whether the data originated from England and Wales or
Scotland and between 70 and 97% for operative procedures. The authors concluded
that coding accuracy on average is high in the UK, especially for operations and
procedures.
There is also evidence that coding accuracy within the HES database is improving
further. For example, Hansell and colleagues - reporting on patients undergoing
varicose vein operations in a single region of England, identified, after comparing
HES data records with diagnoses and operative procedures identified following
medical note review that the accuracy of coding within HES had increased between
1989 and 1995 with 98% accuracy being found for the last year of the study.
While it has been argued that the accuracy of coding within UK routine data sources
was inferior to that of the US, UK routine data such as HES is more likely to be free
of 'code creep' than their US counterparts. Code creep - the deliberate and systematic
shift in a hospitals reported case-mix, achieved by using additional diagnostic codes,
so as to improve financial reimbursement, although previously demonstrated to exist
in routine medical databases such as Medicare in the US, is less likely to be a
confounding factor within HES as reimbursement is not linked in same way to hspital
reimbursement as it is in the US [Lezzoni et al, 1997]].
Linkage with death records/rom the Office of National Statistics (ONS)
Where a patient dies in hospital, this is clearly documented within the database. From
this it is possible to report in-hospital mortality. One important issue identified from
the Bristol inquiry into outcomes of paediatric cardiac surgery at the cities hospital
was that there were no procedures in place at the time to ensure systematic follow-up
of patients following surgery. In particular, there was no data on 30-day mortality
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after surgery. This was especially important as all statistical analysis done for the
Bristol inquiry was based on 30-day mortality outcomes as opposed to in-hospital
mortality. In response, Murray and colleagues [Murray et al, 2002] developed a
methodology by which HES data records could be linked to death records taken from
the Office of National Statistics (ONS) mortality statistics. In such a way, 30-day
mortality could be reported.
The validation study by Murray et al of HES record linkage to national mortality
statistics was performed and published in June 2000. Their methodology was based
of that used in Scotland for many years to link the Scottish equivalent ofHES data-
the Scottish morbidity records, to Scottish national mortality records.
Linkage of records is essentially based on a technique of probability matching which
translates the level of agreement and disagreement between each item of identifying
information contained within 2 records. Identifying information would include data
such as Date of Birth, Sex and Postcode as these variables are present both within the
mortality records held by the Office for National Statistics as well as the HES
database.
Murray and colleagues concluded in their HES/ONS linkage exercise that linkage was
highly feasible. In specific regard to the Bristol inquiry, the authors concluded that
simply reporting in-hospital mortality as opposed to 30-day mortality resulted in 8.4%
of 30-day deaths not recorded. They further concluded that it should become routine
practice within the Health Service in England and Wales to link HES data records
with Office for National Statistics mortality records [www.bristol-inquiry.org.uk].
Further work by Aylin and colleagues [Aylin et al, 2001], again investigating the
value of liES data linked to mortality records reached a similar consensus.
In response, the Department of Health in England has agreed to link such records and
as such data within the liES warehouse is now indeed matched with death records
taken from the Office of National Statistics (ONS) mortality statistics as a matter of
course [www.doh.gov.uk/hes].
3.8 The Emerging uses of liES data
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The Introduction of Payment by Results
In 2002, the Department of Health in England announced a new system of financial
remuneration for NHS hospitals which was named Payment by Results (PbR)
[Department of Health: Reforming NHS financial flow, 2002].
Traditionally, hospitals developed contracts with their local primary care trusts-
organisations legally established whose purpose it is to develop health services for a
particular community, in which they would receive an agreed financial sum to provide
a certain amount of clinical activity. Block contracts were often developed whereby
the hospital in question would agree to provide a particular service for an agreed
period of time, often without specifying the volume of activity that such a service
provision would require. For example, a hospital might agree to perform aU hip
replacements deemed clinically necessary for a certain period of time.
In contrast to block contracts, under PbR, hospitals are paid essentially on a case per
case basis. This policy is facilitated by treatments and procedures being assigned to a
"Healthcare Resource Grouping" [Farrar et al, 2009]. HRG's represent health care
activities that are clinically similar and require similar levels of resources. Prices for
activities in each HRG's are then set by the DOH and detailed in a national tariff. In
2005, PbR was brought in to cover nearly all medical and surgical specialities in
England.
Since the introduction of the PbR policy, HES data has taken on vital importance as
the policy is essentially administered by the HES database with hospitals only gaining
financial reward for the clinical activity identified to have been undertaken at their
institution according to their HES data returns.
The impact of PbR on the quality of HES data is yet to be known, however it is
suggested that the quality oflIES data may potentially improve as hospitals realise
that if data submitted to the NIlS-Wide Clearing Service (NWCS) is not accurate,
they will loose out financially [www.abdn.ac.uklheru]. In addition, there is the
possibility that liES data will sufTer from "code creep" whereby multiple codes are
increasingly used to gain maximum financial gain for the hospital, the effect of which
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is to distort disease burden which in tum can influence the ability of researchers to
accurately account for co-morbidity confounding [Lezzonni et al).
The increasing use of HES data to generate Hospital Standardised Mortality Ratio's
and Dr Foster Intelligence
Hospital Standardised Mortality Ratio's (HSMR) were devised by Professor Jarman
and the Dr Foster Unit at the Imperial College of Science and Technology in London
[Jarman et al, 2005]. It has been suggested that HSMRs can represent a measure of
quality within healthcare provision. HSMRs act to identify if the death rate at a
hospital is higher or lower than expected [Aylin et al, 2009].
HSMR's are unable to identify specific failings in healthcare but may be used to
identify areas where more investigation is required. RSMR's are calculated by
dividing the observed number of deaths within a hospital by the expected number of
deaths multiplied conventionally by 100 i.e if the mortality is higher in the population
being studied than expected, the HSMR will be greater than 100. The expected
number of events or deaths is calculated by evaluating data on all patients undergoing
the procedure or admission across the country, i.e. a comparison with the national
average. Adjustment can subsequently be made for age, gender, method of admission
and socio-economic deprivation.
The Dr Foster Unit is an independent organisation which collects and analyses
information on healthcare services in the UK. The unit is headed by Professor Jarman
and Dr Aylin. The Dr Foster Unit has developed a number of so-called quality
indicators, one of which is HSMR's [www.drfosterintelligence.co.uk]. RES data is
used by Dr Foster to generate many of their quality indicators including HSMR's.
Dr Foster has access to lIES data which it uses to publish its HSMR's which are
documented within its yearly Dr Foster Hospital Guide. RES data is used by Dr
Foster to identify the number of observed events for each hospital which it then
divides by the expected number of events generated by its analysis of average
outcomes across the UK, again derived from its analysis of HES data.
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Dr Foster analysis and publication of HSMR's has been used to benchmark practice in
the UK and has identified marked failings in the quality of health care provided by
several hospitals in England. One high profile case involved the Mid Staffordshire
hospital trust which Dr Foster identified as having significantly higher mortality ratios
than expected for a 3-year period between 2003 and 2006
[www.drfosterintelligence.co.uk]. The Healthcare Commission was alerted and a
report conducted into the quality of care provided at the hospital demonstrating the
value of lIES data to monitor the quality of care across NHS hospitals.
3.9 Accessing liES data and Confidentiality issues
Access to liES data can be achieved in one of two ways [Hansell et al, 2001]. First, an
application can be made to the HES database to acquire a HES data extract for a
specific period of time. A HES extract specification form must be completed which
details the data years required e.g. 1989/90 to 200112002, the filter details e.g. identify
all FCE's in which surgical repair of hypospadias was performed (OPER_I-4=M731)
as well as the fields to be extracted. These fields would normally include date of
admission (AOMIDATE), method of admission (AOMIMETH), method of discharge
(DISMETlI), date of birth (DOB), episode duration (EPIDUR), date of episode end
(EPIEND), episode order (EPIORDER), sex (SEX) as well as many others (see
appendix I).
Alternatively, lIES data extracts can be accessed via the online HES Interrogation
System. Using a software computer system called Business Objects, the HES database
can be accessed directly by the researchers institution allowing the researcher to build
a liES data extract query which can subsequently be downloaded via secure internet
connection to the researchers base computer from the HES database.
Business Objects essentially acts to translate a query in Standard Business Terms
into SQL which is then submitted directly to the HES database.
To gain either access to HES online via the online HES Interrogation System or to
gain a liES extract via application, the HES applicant or prospective HES user must
sign the liES protocol that states that the user as well as the users institution satisfies
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the necessary system security requirements as well as stating that the user has paid the
stated fee (£2,842 annual charge for 2003-2004) as well as the licence fee. In
addition, approval of the Security and Confidentiality Advisory Group is required
before any data is accessed. Finally, if online access is sought, the user must attend a
specific training course to be taught how to use the Business Objects software
computer package.
Accessing HES data/or this thesis
liES data analysed within this thesis was acquired in two separate ways. First, an
application was made to the HES database by completing a HES Extract Pack
application form. This form stated that I- Paul Cathcart, was the Data Custodian.
The liES Extract Specification Form (appendix one) requested a data extract for the
liES datayears 1995/1996 through to 2003/2004. Filter details included all FeE's in
which it was identified that a circumcision (OPCS-4 code -N33) had been performed
(OPER_I-0PER_ 4). We requested all subsequent episodes of care over a period of2
years following the initial surgery. This was requested so that we could identify any
complications arising from surgery that were sufficiently severe to warrant hospital
readmission. Amongst others, requested data fields included all diagnoses (DIAG _1
to DIAG_14), all operations (OPER_1 to OPER_ 4), admission date (ADMIDATE),
treatment speciality (MAINSPEF) and date of birth (DOB) such that patient age could
be calculated.
To collect a liES data extract concerning Hypospadias surgery, transurethral
prostatectomy and acute urinary retention, a query was generated using the Business
Objects software programme which was submitted to the online HES Interrogation
System. The 3 separate queries (appendix two, three and four) were submitted to the
online lIES Interrogation System for the HES datayears 1989/1990 through to
2003/2004. As each liES datayear is managed as a separate Universe _ logical
groping of classes within Business Objects corresponding to an individual datayear
within the lIES database, a separate query submission was constructed and submitted
so as to download a lIES data extract for each HES datayear. As a consequence, to
extract lIES data for each procedure between 1989/1990 through to 2003/2004, 15
identical queries were required to be submitted to the online system.
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Due in part because the online submission and query-generation process was a
detailed process, and because all users of the HES database should undergoing
training with regard HES database confidentiality, I - Paul Cathcart, attended The
Information Centre for Health and Social Cares (The IC) authorised training course.
As part of this 4 day course, held and organised by Northgate systems HQ in
Hartfordshire, I received training in the use of Business Objects. In addition I was
required to sign the HES Protocol, stating that Iwould comply by the HES defmed
security requirements.
Finally, the HES data extract used to investigate the impact of delay prior to radical
cystectomy as well as the investigation of how higher volume hospitals achieve
improved outcome following radical cystectomy, was again acquired by submitting a
application to the liES database for all records relating to hospital admissions in
which urological cancer procedures took place. However, this HES abstract, relating
to patients undergoing surgery in England between 1995/1996 and 200112002 and
including all records concerning admissions in the year before and after surgery, was
originally applied for by my predecessor - Mr Martin Nuttall, and as such he is the
named Data Custodian. Ilis application is illustrated in appendix. However, although
he has previously analysed this HES data abstract, it was not for the purpose
described in this thesis. Furthermore, although he acquired this dataset, Iperformed a
further lIES data extract request concerning all recorded deaths for those patients
identified to have undergone radical cystectomy between 1995/1996 and 200112002
and subsequently linked all index records - FCE in which surgery took place, with all
death records obtained from the Office of National Statistics (ONS) via the HES
database.
3.10 Costs of utilising HES data over other national audit data
The increasing demand for improvement in the quality of care within the NHS has
resulted in the increasing need to collect and report data on clinical outcomes -
especially surgical outcomes which represent measures of clinical effectiveness.
I Iowever, the creation and upkeep of clinical databases is considered expensive which
why it is argued that lIES data may be able to provide a cost effective alternative.
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This argument is reinforced by a recent review of costs of individual clinical
databases by Raftery and colleagues [Raftery et al, 2005]. This review identified that
use of HES data could save between £9 and £60 pounds per patient record collected
depending on which clinical database HES was compared to. The review estimated
that the cost of each individual HES record was £1 compared to £10 pounds to each
record within the UK cardiac surgical register and £60 for each patient record created
within the Scottish Hip fracture audit database. Clearly ifHES could be used instead
of generating individual clinical datasets, the cost of monitoring and improving the
quality of care in the NHS could be substantially reduced.
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Chapter 4
Use of lIES data to study incidence, surgical treatments and their outcomes: A
review of the literature
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4.1 Introduction
An essential component of the NHS modernisation agenda is the need for quality
improvement of surgical services [Cancer Services: Improving outcomes]. For
improvement to occur within all three recognised domains of quality, namely -
effectiveness of care, patient safety and patient experience, better collection and
monitoring of data concerning existing services is required [High Quality Care for
All: NHS Next Stage Review Final Report. www.dh.gov.uklenIPublicationsandstatistics]. As such,
complete, timely and accurate data is required.
In response the Care Quality Commission, formerly the HealthCare Commission and
before that the Commission for Health Improvement (CHI) has commissioned several
large national audits such as the National Tonsillectomy Audit [Lowe et al, 2004] to
collect data on the effectiveness of patient care - one of the three aspects of health care
quality. However, such audits have proved to be expensive, labour-intensive and time
consuming [Measuring and Using outcomes of Surgery: www.rcseng.ac.uk].
Furthermore, they will only ever be able to investigate and report on a narrow select
number of surgical procedures and interventions.
In the US, a similar desire for accurate surgical outcomes data to reflect effectiveness
of surgical care has led researchers to look towards administrative data such as the
Medicare database. A number of researchers have utilised such data to evaluate
outcomes of surgical activity on a large population-based scale to considerable
success. The advantages of administrative data are that they are relatively cheap to
utilise as they already exist and therefore data does not need be collected, they tend to
be large which enables studies utilising such data to be amply powered as well as
reducing the chance of sampling error while data will often span a number of years
which will enable trends over time to be elucidated [Lauderdale et al, 1993, Bright et
al, 1989]. Limitations of such data are likely to stem from concerns over their
accuracy, as clinicians have not been involved in the collection process.
Alike outcomes data, data concerning disease occurrence within society are also
known to be lacking. Those data that are available are often based on small sample-
based studies, the results of which have been extrapolated to the general population to
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give disease burden estimates. Such methodology has many limitations and as a
result, the validity of such data has been brought into question. An alternative
approach is to conduct population-based studies where all cases of a particular disease
within the population are identified. However, such studies have tended to be
expensive and labour-intensive. As a consequence, only a limited number have been
performed. lIES data may be considered a source of population-based data and as
such potentially has the capacity to be used to identify disease incidence in England.
In this thesis, the lIES database is evaluated as a source of data to answer specific
clinical questions regarding first, the incidence of urological disease and second, the
processes and outcomes of urological surgery. However, before these analyses are
commenced, this chapter reviews the literature to identify to what extent the HES
database has previously been used for both these purposes.
In addition, when available, data concerning the accuracy ofHES to report on both
disease incidence and outcomes of surgical activity, when compared to local
information systems such as clinician audit data, was also sought. Finally, the purpose
of using liES data to perform the study was also evaluated.
4.2 Methods
The following electronic databases were searched: Medline (1st January 1966-1 st
January 2006), Embase (1980-2003), the Health Management Information
Consortium and the Cochrane library. The searches were performed using both key
words and MeSH headings (see Appendix 6). The reference lists of all articles of all
identified articles were hand searched for other relevant studies and electronic
searches were performed using the names of key authors who were known to have
published widely in this field.
Inclusion criteria to identify studies utilising the Hospital Episode Statistics database
to report on the incidence of surgical conditions
Studies were included if they utilised HES data to report incidence on the one hand
and surgical conditions on the other. Studies were excluded if the majority of the data
report on was not liES data. For example, a number of studies by Goldacre and
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colleagues, published on behalf of the Oxford Record Linkage (ORL) study group
have not been included in this review as although they do use HES data to report on
incidence of surgically treatable disease, for the most part, the data utilised in these
studies pre-dates the existence ofHES data. For example, Goldacre and colleagues
have reported incidence of cancer after cholecystectomy using HES data extracts for
the Oxford NilS region, however, only data from 1989 onwards was HES data, while
the majority of data reported on in this study - 1963-1989, was generated from
Hospital Inpatient Enquiry records which were the predecessors of RES data records.
Inclusion criteria to identify studies utilising the Hospital Episode Statistics database
to report on outcomes of surgery
Studies were included if they utilised RES data to report health related outcome on
the one hand and surgical procedures on the other. Studies were excluded if the
majority of the data reported on was not HES data. For example, a study by Filipovic
and colleagues, reporting mortality after Abdominal Aortic Aneurysm (AAA) repair
has not been included in this review as although HES data is used to report on
outcome of AAA repair between 1989 and 1999 inEnglish hospitals, for the most
part, the data utilised in the study (1979-1989) predates the existence of the HES
database.
In addition, studies were also excluded from the review if they report outcome ofa
surgical condition rather than specifically reporting outcome of surgery, even if that
surgical condition would almost inevitably ultimately require surgery. For example, a
study by Goldacre and colleagues, reporting 30-day, 90-day and 180-day mortality
following fractured neck of femur, is excluded from this review as, although it
identifies outcome of patients who almost always require surgery, a small proportion
of the patients included in the study would not have undergone surgery and as such, it
does not strictly report on the outcome of a surgical procedure.
Two reviewers assessed the retrieved articles for inclusion and exclusion criteria. The
same reviewers extracted data from included articles. Any disagreement in study
inclusion or data extraction was resolved by a third reviewer.
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Data extraction from studies reporting on the incidence 0/ surgical conditions
Data extracted from each study was divided into three sections. The first section
included data on study characteristics and included first author name, year of
publication, surgical procedure or surgical condition being reported on as well as the
time period over which the data was collected. The second section, referred to as the
methodological section, included data extracted on whether 'patient level' or 'hospital
admission/episode level' statistics were analysed, whether trends over time were
reported on and whether liES data was compared with a local information system. If
comparison was made with a local data system, the accuracy of HES data to report
incidence was recorded. Accuracy was designated as high, intermediate or low. An
accuracy category was assigned by each of the two reviewers. Any disagreement was,
again resolved by a third reviewer. The third section included data concerning the
purpose of the study. Studies were considered either to have been performed for
health needs assessment, understanding of disease aetiology or assessment of new
technology introduction. The studies were grouped in chronological order by date of
publication and summarised in tabular form.
Data extraction/rom studies reporting on outcomes a/surgery
Data extracted from each study was divided into four sections. First, data were
extracted from each study on authors name, year of publication, surgical procedure,
outcome reported on, whether the study reported descriptive outcomes of a particular
procedure - categorised as a descriptive study, or if the study identified the
determinants of outcome of a procedure - categorised as an analytical study.
Second, data were extracted on whether adjustment was made for confounding factors
when analysing the determinants of surgical outcome such as patient age, patient co-
morbidity and disease status. Each study included in the review was assigned a score
that corresponded to the degree of adjustment accounted within the study when
reporting on outcomes of surgery. A score of 0 indicated no adjustment, a score of 1
indicated adjustment for demographic variables only while a score of 2 indicated
adjustment for demographic variables together with co-morbidities. A score of 3
indicated adjustment for demographic variables, co-morbidities and disease severity.
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Third, data was collected on whether the HES reported outcomes were compared with
those identified from local information systems. If comparison was made with a local
data system, the accuracy of HES data to report health related outcomes of surgery
was recorded. Accuracy was designated as high, intermediate or low. An accuracy
category was assigned by each of the two reviewers. The studies were grouped in
chronological order by date of publication and summarised in tabular form.
Fourth, data was extracted on the purpose of the study. Studies were considered either
to have been performed for benchmarking of surgical standards in England, patient
safety, healthcare-needs assessment or finally for the evaluation of the accuracy of the
HES database to report surgical outcomes. The studies were grouped in chronological
order by date of publication and summarised in tabular form.
Patient level versus admission/episode level of care
Studies that utilise lIES data to report either incidence of disease or outcome of
surgery may report their results either on an individual patient level, on an admission
level or on an episode level. This is because HES data is collected in units of
completed consultant care called "FCE's", as opposed to collecting data on an
individual patient basis (see introduction to the HES database). In this review, we
investigate to what extent individual studies attempt to account for FCE's when
reporting either incidence of surgical disease or outcome of surgical activity.
4.3 Results
4.3.1 Incidence of surgical conditions
Included studies
Overall, 20 articles were included in the review (see table 4.1). 6 studies were
identified as having utilised HES data to report the incidence of orthopaedic
conditions, 7 on general surgical conditions, 2 on oral surgical conditions, 1 a vascular
condition, 1 a urological condition and finally 1 article reported on the incidence of a
gynaecological condition. 2 further studies reported incidence of multiple surgical
conditions, irrespective of surgical speciality.
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Coding
12 studies utilised the UK Tabular List of the Classification of Surgical Operations
and Procedures Version 4 of the UK Offices of Populations, Censuses and Surveys
(OPCS-4) to report incidence of surgical procedures while 8 utilised the International
Classification of Diseases coding system to identify incidence of disease diagnoses.
Time periods & locality reported on
The earliest article to utilise liES data to report incidence of a surgical condition was
published in 1996, after which the annual number of publications utilising liES data
remained steady at approximately 2 (0-3) articles per year up unti12006, the last year
included in this review. The majority of studies (11120) utilise HES data to report
trends over time in the incidence of surgical conditions.
The majority of studies (17/20) included liES data before 1997 (the year in which
IIESid numbers were introduced) while only 2 reported incidence estimates
exclusively using data after this date. Regional liES data records were utilised by 7
studies as opposed to utilising national HES data files.
Unit of reported incidence
The majority of studies (14) utilised age-standardized rates as their unit of incidence,
while 4 studies reported annual rates only and I study reported a cumulative incidence
rate. In this study, the incidence of paediatric femoral fracture was calculated by
dividing the number of finished first consultant episodes for all children aged up to 16
years of age by the mid-year population estimate for the number of children living in
the area for which liES data was collected (denominator, West Midlands).
In addition, I study reported standardized operation ratio's by dividing the number of
surgical procedures performed in a specific primary care trust region of England by
the population estimate for that region and then dividing this fraction by that
identified for other English primary care trusts. In this way, variation in surgical
activity for specific surgical conditions across healthcare boundaries was reported on
which inturn suggested inequalities of access to surgical services across England.
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Accuracy of HES data
Only 2 studies compared HES data findings with other data systems. In the first study,
Ferris and colleagues interviewed vascular surgeons practicing in hospitals located
within the Wessex Regional Health Authority to identify if the number of carotid
endarterectomies identified to have performed within the region between 1991 and
1996 according to HES was correct. The study concluded that there was minimal
underascertainrnent by HES as the surgeons confirmed the approximate number of
operations. The second study, by Gupta and colleagues, compared the incidence of
pneumothorax identified within HES with the General Practice Research Database
(GPRD). This study reported an incidence of pneumothorax of24.0 per 100,000 per
year generated from the GPRD compared to 16.7 for the HES database. However,
although these figures appear slightly different, it was acknowledged that the HES
database would only identify those patients that required hospital admission whereas
the GPRD would have identified milder cases that may have been managed in the
primary care setting only. On average, accuracy ofHES data to identify incidence was
assessed as moderate or high.
Numerator used to calculate Incidence
10 of the 20 articles included in the review report incidence using the FCE as the
numerator value when calculating the incidence of the particular surgical condition
while 6 studies identified the first episode of an admission spell (see introduction to
the lIES database) as the numerator while 4 studies utilised a combination of date of
birth, postcode, discharge destination in combination with the episode order to
identify individual patient level numerator values. McColl and colleagues identified
that using a combination of episode order as well as date of birth and length of stay,
the use of FCE's as opposed to patient level data, overestimated incidence by 17%.
Furthermore, the study suggested that when this methodology was applied across
regions, the degree of overestimation varied from 1% to 56%. Ferris and colleagues,
utilising a similar methodology, reported that over ascertainment by using FCE's as
opposed to patient level data overestimated incidence by 11.3% (30 duplicates out of
266). Pollock and colleagues, again reporting on variation between use ofFCE's to
report incidence compared to patient level data, identified using linkage methodology
using a combination of postcode, date of episode start, and patient identifiers
postcode, date of birth and sex, that FCE's over estimated incidence by between 5%
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and 8%. They report this difference as a ratio 1.05-1.08. No study identified within
this review however, reported use of HESid to identify patient level data.
Purpose of studies included in review
The vast majority of studies (19/20) identified within this review were commissioned
for Health needs assessment purposes as opposed to the identification of aetiology or
the assessment of technology introduction. 3 studies identified inequality in surgical
services, both for the availability of orthopaedic and bariatric as well as oral surgery
services, while 2 studies utilised HES data to champion centralisation of specific
surgical services. 3 studies reported on or hypothesised about disease aetiology. The
first study compared the incidence of salivary duct calculi across the different regions
of England with the hardness of tap water in these regions in an attempt to investigate
the hypothesis that hard water leads to an increasing incidence of the disease. The
second study, utilised liES data to identify that the incidence of pancreatitis in
England was rising and then in turn linked this finding with data from the General
Household Survey that suggested alcohol consumption in England was rising. The
last study, reported incidence and cause of paediatric femoral fractures utilising HES
data to suggest maltreatment was less frequent a cause than previously thought.
6 studies reported on how the introduction of new medical technologies have
impacted on the incidence of surgical conditions. For example, Kang and colleagues
reported that the use of surgery for cholelithiasis i.e. cholecystectomy and bilary duct
exploration has fallen while the use of new therapeutic techniques for treating gall-
stones (e.g. ERep) has increased. This trend at the same time had coincided with an
increase in the admission rate for cholelithiasis suggesting that either the incidence of
the disease was rising or that endoscopic procedures were less efficacious than
surgery. Another example of how HES has been used to report the impact of new
technology is demonstrated by Oliver and colleagues in their paper entitled, ''the
epidemiology of diffusion". In this study, the incidence of radical prostatectomy for
the treatment of localised prostate cancer can be seen to have increased 20 fold in
England since 1991, a trend that mirrored the increasing incidence of localised
prostate cancer that resulted from the introduction of widespread Prostate Specific
Antigen (PSA) testing during this time.
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Methodological Limitations
All but 1 study included in this review reported limitations associated with the use of
HES data. These limitations included, lack of data on patients undergoing surgery in
the private sector, the use ofFCE's as opposed to patient level data, questions over
lIES data completeness as well as issues over accuracy of coding of both diagnoses
and operative procedures. Arguments to counter these limitations included, the
finding that less than 5% of patients in England have private health insurance, that
95% of admissions identified in the HES database have a single episode recorded, that
studies conducted by the Department of Health suggest coverage of HES to be
consistently high - for example, 98% completeness in 1989-90 and 102%
completeness (because of extra submissions from a single RHA) in 1991, and that a
number of studies have consistently reported the accuracy of lCD-l 0 and OPSC-4
coding within the lIES database was high (between 75% and 97% accurate).
4.3.2 Outcomes of surgery
Included studies
Overall, 21 articles were included in the review (see table 4.2).5 reporting on
outcomes following general surgical procedures, 4 reporting vascular procedures, 4
cardiac procedures, 4 urological, 1 gynaecological, 1 orthopaedic and ear nose and
throat surgeries and 1 reporting on multiple surgeries of different specialities.
9 studies were descriptive in nature, reporting national outcomes of upper and lower
bowel surgery, aortic aneurysm repair, coronary artery bypass surgery, paediatric
cardiac surgery, radical nephrectomy and radical cystectomy, while 12 were analytical
papers reporting on the determinants of outcome for oesphagectomy,
cholecystectomy, laparoscopic appendectomy, radical prostatectomy, carotid
endarterectomy, radical cystectomy as well as paediatric cardiac surgery (3) and
tonsillectomy.
Time Period
3 articles were published before 2004 (2001, 2001 and 2003), the rest thereafter with
the majority (18) being published in 2005 (2007 - 5 papers, 2008 - 4 papers) a trend
that demonstrates the increasing use of, and interest in, HES data to report surgical
outcomes in England.
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Outcomes
15 of the 21 articles used in-hospital mortality as their primary outcome measure,S of
which further define the outcome to in-hospital mortality within 30 days of admission.
Only 1 of the 21 articles identified in the review explicitly report in their studies
methodology section that FCE's were linked such that outcomes may be reported on a
patient level. 3 studies report using the FCE as the reporting unit, while the remaining
5 articles do not mention if analyses are based on an episode, admission or patient
basis. However, 1 study was designed such that FCE's were the unit of interest rather
than individual patients and as such FCE's were not used as a proxy for individual
patients.
Several other outcome measures were analysed. Clark and colleagues scanned all
operative fields within the HES database to identify all patients undergoing
tonsillectomy who had the additional operative OPSC-4 code "F36.5" which
specifically describes "surgical arrest of post-tonsillectomy bleeding". Using this
single code, this article suggested that adults were at higher risk of post-operative
bleeding than children. Harley and colleagues developed a much more elaborate and
comprehensive method by which the HES database could be used to identify outcome
of surgery. In this study, 7 performance measures or outcomes were identified. The
first measure or outcome was the percentage ofFCE's with a coded complication.
Complications were identified by scanning all diagnostic fields of patients undergoing
gynaecological procedures for ICD-9 codes 996-999 and ICD-IO codes TSO-T88
indicating "complications of surgical and medical care not elsewhere classified". In
addition, outcome was evaluated by reporting the mean length of a spell, the
percentage ofFCE's with more than one operation, the percentage ofFCE's where a
spell was longer than an episode, the percentage ofFCE's for dilatation and curretage,
the percentage of FCE' s for sterilization in patients under 25 years of age and finally
the percentage of FCE' s for hysterectomy on women under 30 years of age.
Adjustment
S of the 12 analytical papers adjusted for confounding in their analyses of
determinants of surgical outcome. Aylin and colleagues, reporting on the outcome of
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paediatric cardiac surgery between 1991 and 2002 - a study designed to evaluate the
impact of the Bristol inquiry, adjusted for the different cardiac procedures performed
by each of the 11 paediatric cardiac centre included in their analyses. Given that
different cardiac procedures have different risks of in-hospital death, this clearly
important when analysing outcome from each centre. Furthermore, although the
authors did not adjust within their analyses for age, they did perform separate analyses
for patients above and below 1 year of age, the effect of which was age adjustment.
Furthermore, although specific co-morbidity was not separately adjusted for, given
that patients included were under 1 year of age, their co-morbidity status would have
been inferred by the particular surgical procedure they underwent as it would be
unlikely they had an additional medical problem other than their primary cardiac one.
The second article by Aylin and colleagues included in this review again reports on
outcome of paediatric cardiac surgery. However in this study, the authors adjusted for
patient age at the time of operation, the proportion of patients with Downs syndrome
(i.e. to some degree adjustment is made for co-morbidity), the proportion of transfers
from other units as well as the proportion of patients admitted as an emergency.
The article by Spiegelhalter and colleagues, again using HES data to investigate the
determinants of outcome of paediatric cardiac surgery, also attempted to adjust for
patient related factors when performing their analyses, on this occasion including type
of cardiac procedure when investigating the impact of centre volume on outcome.
A final article by Aylin and colleagues, on this occasion evaluating the accuracy of
liES data to predict death following surgery compared to national clinical databases,
also attempted to make adjust for confounding in their analyses. On this occasion,
secondary diagnostic fields were utilised to create comorbidity variables which were
then categories according to the Charlson Index of comordities.
Comparison with other data sources and accuracy of HES
6 studies in total compared HES data with alternative data sources. Both Aylin and
Spiegelhalter compared liES with the UK Cardiac Surgical Register (CSR). Aylin and
colleagues report that lIES identified 99% of in-hospital deaths compared to CSR data
although if deaths outside hospital were included it identified a slightly lower
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percentage at 92%. Furthermore, despite this slight underascertainrnent, the authors
found that HES was able to identify that Bristol was an outlier with regard in-hospital
30-day mortality in those under 1 year undergoing open cardiac surgery and as such,
would have identified that the Bristol Royal Infirmary required investigation for its
excess mortality rate. Spiegelhalter, again comparing HES with the CSR, found both
identified that higher volume centres had better outcomes with regard in-hospitaI30-
day mortality and again found both HES and the CSR could have been used to
identify the excess cardiac mortality in Bristol.
Westby and colleagues in their 2007 BMJ paper compared the HES database with the
Central Cardiac Audit Database (CCAD). The primary outcome measure of the study
was the comparison of the data sources with specific respect to capture of 30 day
mortality after paediatric heart surgery in those children under 1 year of age. The
study found that lIES data omitted between 5% and 38% of infants operated on in
each centre. It also identified a median 40% shortfall in the number of deaths
occurring following surgery. The study went on to state that 30-day mortality
according to lIES data was 4% compared to 8% as identified by the CCAD. The study
concluded that lIES data was unsatisfactory for the reporting of individual units
outcomes following paediatric cardiac surgery.
In a similar vein, Pandey and colleagues utilised HES data to report hospital
standardised mortality ratios (SMR) and compared those gained from HES data with
those calculated from a single centres internal clinical database. The study found that
liES data identified 115 of 223 aortic procedures undertaken at the unit. Furthermore,
the study calculated that the SMR calculated for the institution using HES data was
160 compared to 67 when their own internal clinical database was used. The study
concluded that liES data may be misleading.
In contrast, 2 more recent studies have suggested HES data has moderate to high
accuracy when compared to local clinical data sources. In the first, Garout and
colleagues compared caseload and mortality following colorectal cancer surgeries
identified using liES with that recorded in the Association of Coloproctology of Great
Britain and Ireland (ACPGBI) colorectal cancer database. The study identified that
lIES identified 12% more procedures than the clinical database with overall
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reasonable agreement for national caseload as well as mortality reporting. Itwas
noted that individual hospital reporting however was poor.
In the last study that compared HES data with clinical audit data, Aylin et al
compared the ability of HES data to predict death following surgery with that derived
from national clinical databases including the National Cardiac surgical database, the
national vascular database and the colorectal cancer study database. The study
identified that HES data could be used to predict risk of death with similar
discrimination to that of clinical databases (ROC curve score 0.77 versus 0.78 for
CABG procedures, 0.80 versus 0.78 for colorectal excision surgeries).
Purpose of studies included in review
10 of the 21 studies identified within this review were commissioned for the purpose
of evaluating and reporting national outcomes of surgery, the effect of which is the
utilisation ofHES data to benchmark surgical practice in England. 7 of the 21 studies
were commissioned to report on healthcare needs assessment in England, the majority
of which reported that outcomes of several different surgeries are improved if
performed in higher volume centres, the overall message being that services should be
centralised.
4 of the 21 studies included within this review were commissioned for the purpose of
assessing the accuracy of lIES data when compared to local or national audit data.
Information concerning these studies is the subject of the prior section.
2 of the 21 papers identified within this review were commissioned to evaluate the use
of the HES database to report on issues of patient safety - one of the 3 aspects of
quality, in England. In the first, by Raleigh and colleagues, investigated ifHES data
could be utilised, with the use of ICD-I 0 diagnosis codes, to identify a number of
patient safety indicators. The study concluded that lIES data does have the potential
for monitoring safety events. The second study reporting on use of HES for patient
safety purposes found that HES could be used to identify geographic areas where
there was excess mortality following aortic surgery suggesting HES cold be used not
only to benchmark outcomes but also identify outliers.
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Methodological limitations
All but I study included in this review reported limitations associated with the use of
HES data. Aylin and colleagues report that HES has problems with data quality but
state that the "crucial issue is not whether the data are correct, since they manifestly
contain errors, but whether such errors are likely to be great enough to mask the
underlying pattern in the data". It happened that the extent of the Bristol mortality was
such that HES was able to identify it as an outlier. In such a way, the ability ofHES to
identify outliers will depend the how much of an outlier they are. Michaels and
colleagues also raise the issue of coding irregularities as a limitation of HES. To
address this, the authors aggregated codes for different procedures, sub-divided
patients according to whether they underwent elective or emergency surgery and
excluded younger patients, as they were likely to have different disease parameters.
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4.4 Discussion
Summary
This review demonstrates HES data has been utilised to report incidence of surgical
disease over time. In addition, the review identified that of those studies that have
utilised HES data to report incidence of surgical disease, the majority used the
Finished Consultant Episode (FCE's) as the numerator while only 20% of studies
attempted to identify patient level data. In tum, use ofFCE's was identified to over-
estimate incidence of surgical conditions by as much as 17%. No studies to date were
found to have utilised lIESid to identify patient level data when evaluating incidence
of surgical disease. Age-standardized incidence rates were the most commonly used
unit of incidence although cumulative incidence and age-standardized ratios were
described. Furthermore, although few validation studies had been performed,
comparing liES incidence estimates with those generated from local information
systems, those that have, suggest liES data accuracy was either moderate or high.
Finally, the majority of studies identified in this review to report incidence of surgical
conditions were performed with the purpose of informing health needs assessment.
This review also identified that HES data has been used to describe and investigate
the determinants of outcome of surgical activity. Although in-hospital mortality was
found to be the most commonly studied surgical outcome, authors appear to have
developed alternative outcome measures by screening diagnostic and operative fields
for codes suggesting adverse events or second surgical procedures. Studies utilising
liES data to report outcomes of surgical activity have also utilised demographic,
admission, diagnostic and procedural information to adjust, at least in part, for case-
mix when analysing outcomes of surgery. The review identified that HES data are
increasingly being used to report national outcomes that in tum allows benchmarking
of effectiveness of surgery in England - one aspect of quality. In addition, studies are
being to be commissioned to look at how liES data may be used to identify patient
safety as well as benchmark practice, both of which are likely to lead to improvement
in quality of surgical services in the UK. Finally, there appears to be an ongoing
debate concerning the accuracy of HES data to report outcomes of surgery with some
arguing its use is appropriate whereas others have strongly suggested HES data can
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lead to inappropriate conclusions. However, more recent studies have suggested the
accuracy of HES data to predict outcome of surgery is similar to clinical datasets.
Methodological limitations of the review
This review, alike all reviews, suffers from the limitation of publication bias. This is
nowhere more appreciable than when analysing the reported accuracy of HES data for
studies that utilise liES data to report their conclusions are likely to report high levels
of ascertainment and as such a high level of accuracy when comparing their data with
local data systems, as if this were not so, the paper is unlikely to have been published.
By the same token, studies that utilised HES data to report incidence of surgical
disease, which subsequently found their data to be inaccurate, are unlikely to have
been accepted for publication. A further limitation of this review again concerns our
ability to make strong conclusions with regard the accuracy ofHES data. We found
only 8 out of a possible 41 studies that compared their HES data with local data
systems and those that did reported conflicted fmdings. As such, our ability to make
strong conclusions on the accuracy of HES data to report incidence of surgical
conditions is hampered.
Clinical Implications
The findings of this review suggest that the HES database can, and is, able to be used
to report the incidence and changing incidence of surgical conditions in England.
However, our finding that, despite the availability ofHES data, only 2 papers on
average are published each year using HES data for this purpose, suggests that the
database is currently an under-utilised resource.
However, our review does suggest that straightforward use of the database, for
example, by means ofFCE's as the numerator unit of incidence, leads to biased
estimates of incidence. A finding that is in keeping with other studies that have
reported on the utilization of routinely collected administrative data in monitoring
incidence of disease. As such, our study implies HES data should not be used
indiscriminately to report incidence, rather that data be analysed using data-sensitive
methodological solutions.
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Although the review found that use ofHES data to report individual surgeons
outcomes can be misleading, the finding that HES data appears to be as accurate as
clinical datasets to predict outcome of surgery suggests that HES data can been used
to describe and investigate the determinants of outcome of surgical activity.
This review also found that outcomes measures, other than in-hospital mortality, may
be developed within the confines of the HES database, either by developing novel
strategies to search and identify diagnostic and operative coding or by aggregating
diagnosis and operative codes that in tum would enable the database to be more
useful. This is especially so when using the HES database to analyse outcomes of a
surgical procedure where in-hospital death is a rare event. In such cases, the
development of alternative, more commonly occurring outcomes, such as post-
operative bleeding for example, would allow for more appropriate data interpretation
and as such allows the database to be more useful both for research purposes as well
as the continued monitoring of the quality of delivered healthcare.
One commonly quoted limitation of the use of administrative data to report on
outcomes of surgical care is that adjustment for case-mix is essential when
interpreting and analysing outcome. This has lead to resistance by clinicians to use
liES data and other administrative data sources alike. This review identifies that,
although adjustment will never be complete within the HES database, appropriate
statistical methods can be utilised whereby adjustment for case-mix can at least be
partly accounted for. Furthermore, while authors to date have adjusted for particular
surgical procedures as well as specific medical diagnoses, this review suggests that
this methodology could be further extended such that a co-morbidity score, generated
from diagnostic and operative codes identified within the diagnostic and procedure
fields of each patients HES record, could be developed which in turn could be used to
adjust more fully for case-mix when analysing and comparing outcomes of surgery.
Lastly, our finding that those studies that have reported on the accuracy ofHES data
to report outcomes of surgery do report conflicting results does suggest future
research should include further work to establish the accuracy ofHES data.
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Conclusions
The HES database has been used to identify both trends in the incidence of surgical
diseases as well as surgical outcomes reporting. The review highlights that care needs
to be taken when analysing HES data for purpose of incidence reporting as incidence
estimates are sensitive to data handling. On the other hand, the HES database would
appear to offer exciting opportunities for the reporting of disease incidence together
with the investigation of health-related surgical outcomes provided appropriate
statistical analysis and methods are applied.
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Section 3
Case Studies
Use of the Hospital Episode Statistics database to answer questions concerning
the incidence of urological disease
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Chapter 5
Is the incidence of hypospadias rising in England?
Use of liES to comment on trends in the incidence of hypospadias based on
treatment of the condition compared to registry data on incidence of congenital
anomalies
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5.1 Introduction
Hypospadias, incomplete development of the male urethra, is one of the most
common congenital malformations, the aetiology of which remains unknown
[Thomas et al, 2002].
A number of studies have investigated the incidence of this anomaly, with reported
estimates ranging from 0.37 to 41 per 10,000 infants [Chambers et al, 1999, Nelson et
aI2005]. While the incidence of hypospadias appears to be geographically influenced,
considerable variability in incidence has been reported for individual countries. This
inconsistency in reported incidence is thought to be due to variation in case
ascertainment as well as differences in the inclusion and exclusion criteria employed
by different authors.
The importance of accurate surveillance data for this anomaly has been highlighted by
several recent studies that have suggested the incidence of hypospadias may be rising.
Paulozzi and coworkers were amongst the first to report on such a trend. In their
study, using data from two separate US birth surveillance registries, the incidence of
hypospadias was found to have increased from 2 per 1000 in 1970 to nearly 4 per
1000 in 1990. Since then, this trend has been reciprocated in several countries
including Scandinavia where the incidence of hypospadias has reportedly increased
from about 7 per 1000 to over 15 per 1000 since the 1970's [Aho et ai, 2000].
Much debate has been had over why the incidence of hypospadias may be increasing.
Some have argued that the rate of change in the incidence ofhypopadias points
towards an environmental, as opposed to a genetic aetiology [Vrijheid et aI, 2003,
Gallentine et al, 200 I]. A number of environmental compounds, including various
drugs, tobacco, alcohol and pesticides, have all been found to have oestrogen-like
effects. Furthermore, laboratory studies using animal have suggested that these
compounds are able to disrupt endocrine and reproductive systems. As such,
increasing environmental exposure to these chemicals may be responsible for the
reported changes in incidence of hypospadias.
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In England and Wales, epidemiological surveillance of congenital anomalies is the
remit ofthe National Congenital Anomaly System (NCAS) [www.ncas.ac.uk].Using
this data, the incidence of hypospadias in England and Wales would appear to have
increased from 1.5 per 1000 male births in 1964 to 3.6 by 1984.
However, a recent validation study has questioned the accuracy of the NCAS data for
epidemiological surveillance purposes [Dolk et al, 2005]. In this study, completed by
a European Surveillance of Congenital Anomalies working group, only 25% of
eligible cases of hypospadias were identified to have been captured within the NCAS
database while 16% of registered cases were found to have been incorrectly notified
[http://www.eurocat.ulster.ac.uk]. Furthermore, the introduction of new guidelines
concerning the exclusion of 'minor' forms of hypospadias within the NCAS database
was found to have resulted in marked changes in the incidence of reported
hypospadias which further raised concerns with regard the applicability ofNCAS data
to be used for surveillance purposes.
In response, we developed a programme of work to evaluate the feasibility and
validity of using Hospital Episode Statistics data on the frequency of corrective
hypospadias surgery to report on trends over time in the incidence of hypospadias in
England.
5.2 Methods
We considered liES records related to admissions that occurred between 1April 1997
and 31 March 2005. This time period was chosen because a unique patient identifier
was introduced in April 1997, on the basis of which it is possible to link HES records
that belong to the same patient. The HES database is structured in reporting years
running from the 151April to the 31 st March. We report results from 1997/1998 to
2004/2005 (subsequently referred to as 1997 to 2004).
Identification of index record
We used a three-stage selection procedure. First, we identified all HES records with
an ICD-IO code indicating "hypospadias" (Q54) in any of the diagnosis fields.
Second, we filtered these records to identify all records containing an OPCS-4 code
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indicating "repair of hypospadias" (M731) in any of the operative procedure fields.
Finally, so as to identify the index record and so prevent double-counting of patients
undergoing more than one corrective hypospadias procedure, we selectively identified
all records relating to the first hospital admission in which corrective hypospadias
surgery was performed.
Incidence of hypospadias
Incidence estimates of corrective hypospadias surgery were established by two
different analyses.
In the first analysis, a retrospective cohort study was performed using HES data to
calculate an incidence estimate for corrective hypospadias surgery in 1997 - the first
year in which it was possible to link HES records belonging to the same patient.
The year of birth was established for all boys undergoing corrective hypospadias
surgery between 1997 and 2004 using data concerning patient age held within the age
field (labelled STARTAGE) of the index labelled HES record. We then divided the
number of boys, identified as having been born in 1997 (numerator), by the total
number of male births in England for that year (300,689), as estimated by the UK
Office for National Statistics.
Using this methodology, we were able to calculate the proportion of boys, born in
1997, who had undergone corrective hypospadias surgery within 8 years of birth. This
equates to the cumulative incidence of corrective hypspadias surgery over the 8-year
study period.
In the second analysis, the proportion of boys undergoing corrective hypospadias
surgery by their 9th birthday was used as a proxy for the cumulative incidence of
corrective hypospaias surgery. To calculate this cumulative incidence estimate, we
first calculated the annual rate of corrective hypospadias surgery for each year
reported on within the study. This was achieved by dividing the number of boys who
underwent corrective surgery in that year (numerator), by the mid-year estimate of the
number of boys aged between zero and 8 years living in England according to the UK
Office for National Statistics (denominator) [www.statistics.gov.uk]. The proportion
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of boys who would undergo corrective hypospadias surgery by their 9th birthday was
then established by multiplying the annual rate of corrective hypospadias surgery for
boys aged between zero and 8 years by 9. Calculated cumulative incidence estimates
generated in this fashion assumes the observed annual rate of corrective hypospadias
surgery for each reporting year would remain unchanged.
We then compared the cumulative incidence estimates generated by these two
different methodologies.
Trends in incidence of hypospadias
Itwas not possible to comment on temporal trends in corrective hypospadias surgery
using the retrospective cohort study design (analysis one) as every subsequent year
would have one year less follow-up which would bias any results on incidence.
Instead we only utilised data on cumulative incidence estimates generated from our
second analysis when commenting on trends over time in the incidence of corrective
hypospadias surgery. In addition, we assumed all incidence estimates generated were
Poisson-distributed counts. Poisson regression was then used to analyse trends over
time.
All P values were two sided, and those less than 0.05 were judged to indicate a
statistically significant result. Stata software (version 8) was used for all statistical
calculations.
5.3 Results
Age at which surgical correction of hypospadias was performed is presented in Figure
5.1.
Over the 8-year study period, the median age at time of surgical correction of
hypospadias was 2 years and nearly 85% (84.1 %) of boys included in the study had
undergone surgery by four years of age. Median age at time of surgical correction fell
from 2 in 1997 to 1 in 2004 (mean age in 1997 - 2.4 years, versus 1.8 years in 2004).
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Furthermore, the proportion of boys undergoing surgical correction by their fourth
birthday increased from 78.0% in 1997 to 88.4% in 2004.
Incidence of hypospadias
Between 1997 and 2004, 12,458 boys aged less than 9 years were admitted to NHS
hospitals in England and underwent corrective hypospadias surgery. 1,549 boys,
identified as having been born in 1997, underwent hypospadias surgery by the last
year of the study (2004), i.e. within 8 years of birth. This corresponds to a cumulative
incidence estimate of5.15 per 1000 male births.
1,641 boys, aged less than 9 years, were identified to have undergone corrective
hypospadias surgery in 1997. Using this figure, the annual rate of corrective
hypospadias surgery for 1997 was observed to be 0.56 per 1000 boys per year. The
proportion of boys who would undergo corrective hypospadias surgery by their 9th
birthday if this annual rate of corrective hypspadias surgery would remain unchanged
it would therefore be 5.09 per 1000.
Trends in the cumulative incidence of corrective hypospadias surgery
Over the 8-year study period, the proportion of boys undergoing corrective
hypspadias surgery by their 9th birthday, i.e. the cumulative incidence of corrective
hypospadias surgery, increased significantly from 5.09 per 1000 boys in 1997 to 5.51
per 1000 boys in 2004 (Table 5.l, Figure 5.2).
5.4 Discussion
Summary
Incidence estimates of corrective hypospadias surgery generated in this study from
liES data records are more than three times higher than the incidence of hypospadias
reported over a similar period by NCAS - the national congenital anomaly register.
Furthermore, this difference appears compatible with the estimated under-
ascertainment to NCAS. The comparability of cumulative incidence estimates
generated from use of annual rates of surgery with that calculated from the
retrospective cohort study suggests annual rates of surgery could be used to report on
trends over time and as such suggests liES data could be used to monitor the
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incidence of this congenital anomaly over time. Finally, this study provides some
evidence to support the hypothesis that the incidence of hypospadias may be rising.
Methodological limitations
There are a number of limitations associated with the use of administrative data for
epidemiological purposes. First, there are concerns over the accuracy of
administrative data to identify boys undergoing corrective hypospadias surgery.
However, it is unlikely that coding accuracy has been a major source of error in this
study as there is only a single specific OPCS-4 code for corrective hypospadias
surgery as well as a single lCD-IO diagnosis code for diagnosis ofhyposapdias.
Second, boys undergoing more than a single-stage correction hypospadias surgery are
at risk of being double-counted and as such, incidence estimates generated from this
analysis may be artificially high. Again this is unlikely to have been a major source of
error in this study as we specifically only used HES data from April 1997 onwards
after which a unique patient identifier was introduced that enabled the identification
of index records i.e. the admission during which the first corrective hypospadias
surgical procedure was performed.
Third, interpretation of trends in incidence of corrective hypospadias surgery as a
proxy for the incidence of hypospadias assumes first, that all boys with hypospadias
undergo surgical correction and second, that the surgical management of hypospadias
has not changed. Addressing the first issue, while the reporting of corrective
hypospadias surgery for this anomaly will naturally represent an under-estimate of the
true incidence of this condition, providing any increase in the incidence of
hypospadias is not limited to those cases not managed by corrective surgery, and
providing that there has been no systematic change in the use of corrective surgery,
the frequency of surgical correction may be considered a reliable surrogate marker for
its incidence.
As mentioned earlier, the increase in incidence of hypospadias identified is this study
could reflect change in the surgical management of the condition rather than a true
increasing trend in disease incidence. This is unlikely to a major source of bias as
first, there is no evidence to support such a hypothesis and second, there is evidence
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on the contrary from the US that the use of surgery for the correction of hypospadias
has changed little over the last 20 years [Choi et al, 2001].
Furthermore, even if our data reflected change inpractice rather than true incidence, it
still provides valuable information that may be utilised for health assessment purposes
and the planning of treatment provision.
Comparison with other studies reporting incidence oJhypspadias
Our mean cumulative incidence estimate for corrective hypospadias surgery generated
from our retrospective cohort data for 1997 of 5.15 per 1000 boys as well as our mean
cumulative incidence estimate of 5.19 per 1000 boys generated from annual rates oj
surgery over the entire 8-year study period compares well with the fmdings of a
recent US study reporting on the incidence of hypospadias during the 1990's [Nelson
et al, 2005]. This study, based on data from the National Inpatient Sample, utilised
ICD-9 diagnosis codes to identify an overall incidence of 5.7 per 1000 boys between
1988 and 2000. Furthermore, the study reported an increasing trend in the incidence
of congenital penile anomalies - including micropenis and epispadias together with
hypospadias, with incidence rising from 7.0 per 1000 in 1998 to 8.3 per 1000, in
2000, a trend mirrored by our data.
Our mean incidence estimates are more than three times higher than the incidence of
hypospadias reported over a similar period by NCAS (1.8 per 1000 births) while they
are also not dissimilar from that reported in a recent UK study using data from the
Avon region of England in which incidence of hypospadias was reported to be 6.4 per
1000 births (5117,928) [Gallentine et al, 2001].
However, our mean incidence estimates as well as our temporal trend analysis is at
odds with a recent Finnish study reporting on Finish hospital Discharge data between
1970 and 1994 [Aho et al, 2001]. In this study, the mean incidence of hypospadias,
generated by utilisation of ICD-8 codes to identify those boys undergoing corrective
hypospadias surgery by 8 years of age, appeared to be significantly lower than our
estimates of incidence (2.8 per 1000 boys), while incidence appeared to remain stable
over time. While this may reflect geographical differences in exposure to endocrine-
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disrupting chemicals, it may equally reflect difference in management of boys with
mild hypospadias.
Clinical Implications
It is of clear importance that surveillance of congenital anomalies be performed first,
to look for associations between the occurrence of that anomaly and potential
environmental teratogens, second, to support health service planning and third, to
monitor prenatal diagnosis and screening programmes. These objectives apply not
only to hypospadias, but also for all congenital anomalies.
It is already known that ascertainment to the national register for England and Wales
(NCAS) is poor while at the same time, being highly labour intensive and as such
expensive to administer and implement. Furthermore, NCAS ascertainment accuracy
is expected to decrease yet further with the introduction of 'NHS numbers for babies'
- a new electronic babies record that only permits tick box information to be recorded
as opposed to text data.
This study suggests that use of measures such as annual rates of surgery, generated
from routinely collected HES data, to calculate cumulative incidence, may represent a
more representative and certainly more economic alternative to NCAS data for the
surveillance of congenital anomalies in England.
Conclusions
Until the problems of ascertainment to NCAS are addressed, analysis of HES data to
report annual rates of corrective hypspadias surgery appears to represent a useful
resource to monitor the incidence of hypospadias in England.
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Chapter 6
Are too many boys undergoing circumcision for phimosis of the foreskin in
England?
Use of liES data to identify clinical appropriateness of treatment
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6.1 Introduction
Circumcision is a common paediatric surgical procedure. The proportion of boys
circumcised during childhood varies markedly by country, by religion and to some
extent, by socio-economic group [Dewan P et al, 1996]. The proportion of men
circumcised for religious reasons, in either the US or Europe, remains largely
unknown, however, it has been estimated that about 80% of men are circumcised in
the US for medical reasons [America Academy of Paediatrics, 1999], compared to
about 4% in England [Rickwood A et al, 2000] and less than 2% in other parts of
Europe [Frisch M et al, 1995]. There are even indications that the circumcision rate in
the US is still rising [Nelson C et al, 2005].
Clinically appropriate surgery may be considered surgical treatment that is performed
for a specific medical indication. The only undisputed medical indications for
circumcision are pathological phimosis and recurrent balanitis [Rickwood A et al,
1999]. Pathological phimosis, by far the most common medical indication for
circumcision, can be defined as the narrowing of the preputial orifice, leading to an
inability to retract the foreskin, or prepuce over the glans penis [Spilsbury K et al,
2003]. It should be distinguished from physiological phimosis, which is a normal part
of penile development in which preputial adhesions, located between the glans penis
and the foreskin, prevent the retraction of the foreskin in young boys.
The previously reported circumcision rate of 4% in England has led some to argue
that boys in England are undergoing unnecessary surgery which is not clinically
indicated and therefore not clinically appropriate given that first, the incidence of
phimosis has been reported to be only 0.6% [Rickwood A et al, 1989, Shankar K et al,
1999] and second, the majority of boys circumcised in England are less than 5 years
of age, an age at which pathological phimosis is rare [Rickwood A et al, 2000].
Circumcision, alike any surgical procedure, carries the risk of complications. The
reported complication rate following procedure varies greatly from as low as 0.06% to
as high as 55% [Speert H et al, 1953, Patel H, 1966]. This variation is largely the
result of the many different criteria used to define complications.
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This case study utilises HES data to address the clinical question - are too many boys
undergoing paediatric circumcision for phimosis of the foreskin in England?
HES data are used to report paediatric circumcision rate in England between 1997 and
2003. In addition, HES data are used to identify the determinants of outcome
following the procedure.
6.2 Methods
We considered HES records related to admissions that occurred between 1 April 1997
and 31 March 2004. This time period was chosen because a unique patient identifier
was introduced in April 1997 , on the basis of which it is possible to link HES records
that belong to the same patient.
Identification of index record and subsequent readmission
We used a three-stage selection procedure. First, we identified all HES records with
an OPCS-4 code indicating circumcision ("N303") in any of the operative procedure
fields. This was labelled the index record. Second, we linked these index records
with all HES records of subsequent readmissions using the unique patient identifier.
Third, we deleted all HES records that related to circumcision in boys over fourteen
years of age.
Identification of indications
To identify the indication for circumcision, we examined the diagnosis fields of all
index records. A wide range of1CD-10 codes were identified to code the medical
indications for circumcision including phimosis ("N47", "N486"), balanitis ("N481",
"NSI2"), and ritual circumcision ("Z412"). Over the study period, 75,868 boys were
documented to have undergone medical circumcision and 6,122 boys were
documented to have undergone ritual circumcision on the basis of diagnosis coding.
Boys undergoing ritual circumcision were excluded from further analysis.
Identification of complications
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The codes used to identify complications were not defined in advance. Instead, we
examined the diagnosis and operative fields of all hospital admissions for all boys that
were likely to have had a complication of surgery - i.e. index admissions of more than
one day in hospital following circumcision and 30 day readmissions after
circumcision. On the basis of this examination, we were able to identify 19 diagnosis
codes and 22 operative procedure codes (appendix 7) which were used to record
complications following circumcision. These codes were then grouped into
haemorrhagic, infectious and other complications and applied to the index and 30-day
readmission records of all boys included in the study. In addition, we identified
readmissions for revision circumcision (OPCS-4 code "N303" in a subsequent
hospital admission after the index admission) and meatal stricture dilatation (OPCS-4
code "N79") within a 6-month period following circumcision.
For the analysis of the complication rate, we excluded boys undergoing an additional
operative procedure at the time of circumcision as the occurrence of a complication
may have been influenced by the additional procedure. 9,349 (12%) boys were
excluded from analysis of complications on this basis.
Statistical analysis
The HES database is structured in reporting years running from the 1st April to the 31sI
March. We report results from 1997/1998 to 2003/2004 (subsequently referred to as
1997 to 2003). To calculate the circumcision rate in a reporting year, we divided the
number of boys who underwent circumcision in that year by the mid-year estimate of
the number of boys aged between zero and 14 years living in England according to the
UK Office for National Statistics [www.statistics.gov.uk].
The proportion of boys who would undergo circumcision by their 15th birthday, if the
circumcision rate in a specific reporting year would remain unchanged, was
approximated by multiplying the circumcision rate for boys between 0 and 14 years
by 15.
We assumed that the circumcision rate estimates were Poisson-distributed counts, and
Poisson regression was used to analyse trends over time. The complication rate was
described as a percentage. Multivariate logistic regression was used to describe the
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risk of post-operative haemorrhage according to age, indication and surgical
speciality. All p values were two sided, and those less than 0.05 were judged to
indicate a statistically significant result. Stata software (version 8) was used for all
statistical calculations.
6.3 Results
Trends in the rate of circumcision
Between 1 April 1997 and 31 March 2004, 75,868 boys aged less than 15 years were
admitted to NHS hospitals in England and underwent a medically indicated
circumcision. This corresponds to a circumcision rate of 2.3 per 1000 boys per year
over the whole study period.
36% (27,426) of all paediatric circumcisions were performed in boys aged less than 5,
45% (33,922) in boys aged between 5 and 9 years, and 19% (14,520) in boys aged
between 10 and 14 years of age.
Over the 7-year period, the circumcision rate declined by about 20% from 2.6 per
1000 boys per year in 1997 to 2.1 in 2003. Circumcision rates were similar in the
period between 2000 and 2003. The proportion of boys who would undergo
circumcision by their is" birthday if the circumcision rates observed in a reporting
year would remain unchanged fell from 3.9% in 1997 to 3.1% in 2003 (Table 6.1,
Figure 6.1).
The indication for the circumcision was documented in 98% of the boys included in
the study. In boys with a known indication, 90% underwent circumcision for
phimosis, 8% for recurrent balanitis and 2% for other reasons. Over the 7-year study
period, the number of circumcisions performed for phimosis fell by 23% from 11,501
in 1997 to 8,866 in 2003 whereas the number of circumcisions performed for
recurrent balanitis did not change.
The circumcision rate in boys aged less than 5 years declined over the study period by
about 30% from 3.2 to 2.2 per 1000 boys per year. In boys aged between 5 and 9, the
circumcision rate declined by 10% from 3.2 to 2.9 per 1000 boys per year. For boys
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aged between 10 and 14, the circumcision rate increased slightly from 1.3 to 1.4 per
1000 boys per year (Table 6.1). The proportion of paediatric circumcisions performed
by general surgeons, decreased by about 40% from 51% to 31% over the study period.
Complication rates following circumcision
66,519 boys who did not have an additional procedure at the time of their
circumcision were included in the analysis of complications. 1.2% of these boys
experienced a complication. 0.8% of boys developed haemorrhage with about 60% of
these requiring a return to theatre. 1.0% (710) of boys stayed longer than one day in
hospital following circumcision and 0.2% (134) were readmitted within 30 days of the
procedure. 0.5% of boys required a revision circumcision and 0.01% of boys
developed a meatal stricture requiring meatal dilatation within 6 months of the initial
procedure (Table 6.2).
Haemorrhage was the most common complication following circumcision. We
therefore investigated to what extent age, indication and surgical speciality influenced
the post-operative haemorrhage rate. 0.7% of boys aged between 5 and 9 undergoing
circumcision experienced haemorrhage which is about 30% lower than the rate of
haemorrhage in younger and older boys (1.0%). In addition, circumcisions carried out
by general surgeons had slightly lower haemorrhage rates (0.7%) compared to
circumcisions performed by both paediatric (1.1%) and urological surgeons (0.8%).
These observations remained with adjustment for age and indication (Table 6.3).
6.4 Discussion
Summary
According to HES data, between 1997 and 2003, the circumcision rate in England
declined by 20% from 2.6 to 2.1 per 1000 boys per year. This decline was due to a
drop in the frequency of circumcisions for phimosis in the period before 2000. 1.2%
of boys undergoing circumcision were identified within HES as having experienced a
complication following surgery, the majority of which occurred soon after surgery.
Circumcision performed in boys aged between 5 and 9 had lower rates of
haemorrhage than circumcision performed in younger or older boys. Moreover,
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circumcisions done in boys by general surgeons had lower rates of haemorrhage than
those done by paediatric or urological surgeons.
Methodological limitations
There are concerns over the accuracy of administrative data to identify boys
undergoing circumcision. However, it is unlikely that coding accuracy has been a
major source of error in this study as circumcision is a common procedure that is
coded with a single specific OPCS-4 code. Moreover, we found there was a high
degree of consistency between the coding for diagnoses and operative procedure with
98% of the admissions for circumcision containing diagnosis codes of appropriate
medical indications for circumcision.
There are further concerns over the use of administrative data to capture and correctly
code for complications of surgical procedures. Therefore, we specifically did not
identify diagnosis and operative procedure codes relating to complications of
circumcision in advance. Instead, we examined diagnosis and operative coding within
HES records concerning admissions in which a complication was most likely to have
occurred - i.e. index admissions in which the duration of in-hospital stay was longer
than 24 hours and readmissions within 30 days. We then grouped these codes into
different complication categories. By this process, we were able to account for
inconsistencies in coding practice between hospitals. A further concern is that we had
to relay on readmissions to capture complications becoming apparent after discharge.
However, not all complications require readmission and therefore some minor
complications will not have been included in our study.
Comparison with other studies reporting on circumcision rates
There is large geographic variation in circumcision rates around the world which
reflects the different arguments used to justify medical circumcision. In the US, the
majority of circumcisions are performed in newborn boys soon after birth [Wilkes M
et al, 1990, Alanis M et al, 2004]. Arguments used to justify this practice include the
prevention of urinary tract infection [T et al, 1998] in infancy as well as sexually
transmitted disease in later life [Alanis M et al, 2004]. In contrast to the US, the much
lower circumcision rates in Europe and Australia demonstrate that medical
circumcision appears to be reserved for medical conditions affecting the foreskin.
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We estimated that 3.1% of English boys would undergo circumcision by their 15th
birthday, if the circumcision rate found for 2003 would remain unchanged. In the
period between 1989 and 1997, this estimated proportion was found to have fallen
from 6.0% to 3.8%, but the circumcision rate in boys between 10 and 14 years was
found to have remained constant [Rickwood A al al, 2000]. In our study however, we
found that circumcision rates began to increase in this older age group.
Comparison with other studies reporting complications of circumcision
A number of studies have reported complication rates after paediatric
circumcision.[Wiswell T et al, 1989, MetcalfT et al, 1983] These complication rates
vary widely which is for the greater part the result of different study types (e.g.
survey, chart review, administrative data) and defmitions used for complications. For
that reason, we feel that we can only validly compare reported rates of return to
theatre and readmission with our own results. A study of about 136,000 boys, based
on administrative discharge records in the US [Wiswell T et al, 1989], found that
about 0.03% went back to theatre because ofhaemorrhagic complications after
circumcision [T et al, 1998]. The similar figure in our study is 0.5%. An explanation
for this large difference is that the US study only considered neonatal circumcisions
whereas the number of boys younger than Iyear of age in our study was very low
(1.4%). Furthermore, we have to assume that the boys included in our study had
foreskin problems to some degree, whereas in the US study most newborn boys must
have had foreskins that were perfectly healthy. Lastly, the US study only considered
complications during the admission in which the circumcision was performed whereas
we looked at all complications that had occurred up to 30 days.
Other much smaller studies based on medical records have reported on return to
theatre. A study of this type from the US observed that 3 of240 boys 0.3%) returned
to theatre with a haemorrhagic complication [MetcalfT et al, 1983], and a Canadian
study observed this in lout of 100 boys. These figures are slightly higher than return
to theatre rate for haemorrhage of 0.5% that we have found.
To the best of our knowledge, there is only one study reporting readmissions after
circumcision. This prospective study, carried out in 1983 in Southampton (UK)
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[Griffiths D et al, 1985], found that 4 of 140 boys (2.9%) who underwent
circumcision as a day-case required an emergency readmission for haemorrhage (2
boys) and for vomiting (2 boys). Our reported readmission rate ofO.2% is
considerably lower. However, the numbers in the Southampton study are small and
boys were immediately discharged after circumcision, whereas in our study 1.0% of
boys remained in hospital over night.
We found circumcision increasingly being performed by urological and paediatric
surgeons, whereas at the same time we found that circumcisions performed by general
surgeons had the lowest rate ofhaemorrhagic complications. These observations
seem conflicting and contradictory. However, care needs to be taken when
interpreting the complication rates according to surgical speciality as administrative
data did not allow adjustment for disease severity.
Clinical implications
If we assume that circumcision is only performed for foreskin disease in England as
opposed to the US where it is seen as a preventive health measure, HES data suggests
that the circumcision rate in England remains about 5 times higher than the incidence
of phimosis (0.6%) [Skankar K et al, 1999], by far the most common indication for
circumcision. On the basis of these figures, it would appear that over 80% of the boys
reported to have undergone circumcision in England may have been exposed to the
risks of an ablative surgical procedure which is not clinically apprpriate.
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Chapter 7
Has the incidence of primary and recurrent urinary retention changed since a
shift away from surgery for the treatment of this disease?
Use of HES data to evaluate how has the change in management of Benign
Prostatic Hyperplasia has influenced the incidence of acute urinary retention?
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7.1 Introduction
In the early 1990's the only treatment options for men with BPH were watchful
waiting or prostatectomy [Borth C et aI, 2001, Barry M et al, 2001]. The morbidity
and mortality associated with prostatectomy prompted searches for alternative
treatments including medical therapies and minimally invasive procedures. The
expansion of treatment options for men with BPH has coincided with a reduction in
the use of prostatectomy, both in the US and Europe [Borth C et al, 2001, Wilson J et
aI, 2004, Holtgrewe H, 1998, Baine, et al, 1998] as operative intervention is
increasingly being considered only as the final treatment option, both from a doctor's
and a patient's perspective.
However, these alternative treatments may be less effective than prostatectomy. For
example, it has previously been found that prostatectomy lowers the risk of Acute
Urinary Retention (AUR - sudden inability to void urine spontaneously) in men with
BPH by about a factor of8, compared to watchful waiting [Wasson J et al, 1995],
whereas the recently published Medical Therapy Of Prostatic Symptoms (MTOPS)
[McConnell J et al, 2003] study found that medical treatment lowers the risk of AUR
by about a factor 5. Furthermore, the comparison of the risks of AUR with surgical or
medical treatment may be even more unfavourable for medical treatment than these
results suggest In the MTOPS study, AUR was part ofa combined outcome also
including a clinically significant increase in urinary symptoms, incontinence and
urinary tract infections ("overall clinical progression"). Therefore, the reported AUR
incidence is likely to be an underestimate of the true incidence as AUR was not
reported if one of the other outcomes had occurred first.
Treatment of men with BPH who have experienced an episode of AUR has also
changed. For example, it has been reported that the use of medical therapy (alfuzosin)
can improve the short-term success rate of a trial without catheter (TWOC) in men
with AUR from 48% to 62% [McNeill S et al, 2004]. However knowledge regarding
the long-term outcomes after AUR still remains limited.
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In this chapter, HES data to used to describe how the incidence of primary and
recurrent AUR has changed in England between 1998 and 2003. In addition, HES
data are used to identify changes over time both in the use of prostatectomy in men
with AUR and in the frequency of AUR recurrence.
7.2 Methods
We considered liES records related to admissions that occurred between 1 April 1997
and 31 March 2004. This time period was chosen because a unique patient identifier
(HESid) was introduced in April 1997, on the basis of which it is possible to link the
HES records that belong to the same patient.
We used a five-stage selection procedure. First, we identified all HES records with an
ICD-IO code indicating AUR ("R33") in any of the diagnostic fields. Second, we
added all HES records with an OPCS-4 code indicating transurethral resection of the
prostate (TURP) in any of the procedures fields ("M65"). Third, we linked all records
that belonged to the same patients. Fourth, we deleted HES records related to TURP
if there was no diagnostic code indicating AUR in the same record or in a linked
record. Fifth, we deleted records if there was a diagnosis of prostatic cancer ("C61 "),
multiple sclerosis ("G35") or Parkinson's disease ("G20") in one of the diagnostic
fields.
Definitions
We considered AUR to be primary if there was no liES record documenting a
previous AUR in the study period. A preceding period of at least 6 months was used
to determine whether a previous AUR had occurred. This duration was chosen
because we observed that the time to recurrence was less than 6 months in 78% of the
men who had two admissions for AUR.
Furthermore, AUR was classified as spontaneous if the primary diagnosis (i.e. the first
diagnostic field in a HES record) indicated AUR or if the primary diagnosis was BPH
("N40") with a diagnosis of AUR in any of the other diagnostic fields in the same
record. In addition, AUR was only classified as spontaneous if there was no
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preceding admission within the last 5 days unless this preceding admission was for
AUR. In all other circumstances, AUR was classified as precipitated.
Statistical analysis
The HES database is structured in yearly periods running from 1 April to 31 March,
but the reporting period in this paper is shifted 6 months to create a preceding period
of at least 6 months to determine whether an AUR is primary or not (see above).
Results are therefore reported for yearly periods running from 1 October 1997 to 30
September 2003 (subsequently referred to as 1998 - 2003).
To calculate the incidence of AUR in a reporting year, we divided the number of men
admitted with primary AUR in that reporting year by the mid-year estimate of the
number of men aged 45 years and older living in England according to the Office for
National Statistics. The age-specific annual incidence was calculated over the whole
study period by dividing the total number of hospital admissions for primary AUR in
men in specific IO-year age categories by the sum of the mid-year estimates of the
number of men in those age categories.
We assumed that the incidence estimates of men with AUR were Poisson-distributed
counts. Poisson regression was therefore used to test trend over time for the AUR
incidence. Logistic regression was used to do the same for the proportion of AUR
patients treated with surgery.
7.3 Results
Between 1 October 1997 and 30 September 2003, 165,527 men were admitted to an
NHS hospital in England with primary AUR, which relates to an overall incidence of
3.06 per 1000 men per year. AUR was spontaneous in 108,139 (65.3%) of these men
(Table 7.1).
Incidence of AUR fell over the study period from 3.17 in 1998 to 2.96 per 1000 men
per year in 2003. This trend was more pronounced for spontaneous than for
precipitated AUR (Table 7.1, Figure 7.I).
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The incidence of both spontaneous and precipitated primary AUR seemed to increase
exponentially with age, approximately doubling with every 10-year increase (Table
7.1, Figure 7.2).
The percentage of men with primary AUR who underwent surgery within 3 and 6
months declined between 1998 and 2003 for both spontaneous and precipitated AUR
(Table 7.2, Figure 7.4). In 1998,32% of men who had a spontaneous AUR went on
to have surgery by 6 months and this figure fell to 26% in 2003. For men who had a
precipitated AUR, the percentage of men undergoing surgery by 6 months fell from
7.6% to 5.8%.
The prostatectomy rate was also dependent upon the age at which men developed
AUR (table 2). Men were two times more likely to have prostatectomy if they were
between 55 and 84 years compared to men below and above this age range (Table
7.2).
The percentage of men with primary AUR who had a readmission for a recurrent
AUR within 3 and 6 months increased between 1998 and 2003 for both spontaneous
and precipitated AUR (Table 7.2, Figure 7.3). In 1998, 18% of men who had a
spontaneous AUR went on to have a readmission for recurrent AUR by 6 months and
this figure increased to 22% in 2003. For men who had a precipitated AUR, the
percentage of men who went on to have a readmission for recurrent AUR by 6 months
increased from 4.0% to 4.9%.
7.4 Discussion
lIES data demonstrated a slight decline in the incidence of primary AUR between
1998 and 2003 in England. In the same period, the frequency of surgical treatment in
men with primary AUR fell by about 20%, whilst the recurrence rate of AUR
increased by a similar percentage. These trends were observed both in men with
spontaneous AUR as well as those with precipitated AUR.
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Methodological limitations
There are a number of methodological limitations associated with the use of
administrative data [Mckee M, 1993]. First, there are some concerns over the
completeness and accuracy of the diagnostic and procedure coding process. However,
a recent evaluation [www.dh.gov.uk] found that close to 100% of all patients admitted
to an NHS hospital in England are included. It is unlikely that coding difficulties are
a major source of error in our study of the incidence of AUR as it is an acute and
severe condition that is recorded with a single specific ICD-IO code. Furthermore, if
there has been a change in coding practice over the 6-year study period, it would
reflect improvements in the training of clinical coders, which would have resulted in
an increase in the frequency of AUR, as opposed to the decline that we observed.
Second, we considered an AUR to be a first-time event if there was no RES record
documenting a preceding AUR. A limitation of this classification is that some men
may have been classified as having had an episode of primary AUR when they really
had a recurrence if their initial primary event hadn't been previously recorded within
the HES database. This error would have influenced men in the first year of the study
more than subsequent years as for subsequent years more HES database history was
available to capture prior events. As a consequence, the primary AUR incidence is an
overestimate in the earlier years ofthe study period. However, the overestimation is
likely to be small, because - as explained earlier - only 22% of the recurrences occur
more than 6 months after the primary event. For example, the number of admissions
for primary spontaneous AUR in 1998 presented in table 2 is overestimated by less
than 725 admissions (= 22% x 18% x 18,316). Ifwe assume that in 1998 725
admissions were for recurrence and not for a primary AUR, we can recalculate an
incidence of primary AUR of2.01 per 1000 men per year, which is hardly different
from the 2.09 that we report in table 1.
Third, the HES database contains data on hospital admissions. Our overall incidence
would therefore be an underestimate as men with AUR without initial hospitalisation
would not have been captured in our study. This is unlikely to have had a major
effect on our results as almost all men with AUR are believed to be initially
hospitalised in England. Furthermore, our time trends are unlikely to be influenced by
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this limitation as there is no evidence to suggest that there has been a major shift in
management of AUR over the study period.
Finally, HES data is not linked to mortality data, as a result of which we will have
underestimated the AUR recurrence rates. The impact of this limitation is likely to be
small as we only report on recurrence within 6 months.
A UR incidence before 1998
We studied incidence of primary AUR between October 1997 and October 2003.
This study period was chosen because linkage of HES records belonging to the same
patient was possible for patients admitted to hospital after April 1997 , allowing a
distinction between primary and recurrent AUR. However, alternative therapies for
the treatment of BPH were introduced in the early 1990s. As a consequence, it is
possible that the incidence of primary AUR has changed before the start of our study
period.
To address this issue, we calculated the total number of admissions for AUR - without
distinguishing between primary and recurrent AUR - to NHS hospitals in England in
1991, 1998 and 2003 on the basis ofHES figures. We found that the number of
admissions for AUR each year remained similar: 32,835 admissions in 1991,32,223
in 1998, and 33,016 in 2003. These figures suggest that it is unlikely that the
incidence of primary AUR has risen appreciably in the period before 1998. On the
contrary, it is actually more likely that the incidence of primary AUR between 1991
and 1998 has fallen as we found an increase in the percentage of men with recurrent
AUR between 1998 and 2003, and we have to assume that this trend had already
started before 1998. If this assumption is true, a higher percentage of admissions for
AUR were due to a primary occurrence of this condition in 1991 than in 1998 and
2003.
Comparison with other studies
To the best of our knowledge, this is the largest study on the incidence of primary and
recurrent AUR and the first to report on time trends. A number of smaller population-
based studies found incidences of primary AUR that vary around our figure of3.06
per 1000 men per year. Two US studies reported incidences of 4.5 [Meigs J et al,
122
1999] and 6.8 [Jacobsen S et aI, 1997] per 1000 men per year in the first half of the
1990s. A Dutch study reported an incidence of2.2 [Verharnme K et al, 2005] per
1000 men per year in the second half of the 1990s. The higher incidence found in the
US may be explained by selection bias as both US studies only included men who had
responded to a detailed questionnaire. An explanation for the lower incidence found
in the Netherlands may be the strict case definition used in the Dutch study requiring
both evidence of a sudden inability to pass urine and catheterisation which may have
been compounded by data quality problems known to exist in GP databases.
In our study, we found that around 20% of men with a primary spontaneous AUR and
4% with a primary precipitated AUR had a recurrence within 6 months. There is only
limited data on recurrence after AUR, and the recurrence rates that are published are
difficult to compare with the recurrence rates that we observed for a number of
reasons. Most papers present only short-term outcomes after AUR and if they report
on longer-term outcomes they often quote combined outcomes such as emergency
surgery for AUR. Allowing for these difficulties, it can be estimated that about 50%
of men with primary spontaneous AUR will have a successful trial without catheter,
and that about 20% of the men that were successful will have emergency surgery for a
recurrence [McNeill S et al, 2004]. This implies that about 10% of men with a
primary spontaneous AUR will undergo surgery for AUR recurrence (=50% X 20%).
The overall AUR recurrence rate (recurrence treated with surgical as well as
conservative treatment) in men who had a primary spontaneous AUR is therefore
expected to be higher that this figure of 10%, which corresponds rather well with our
observed 6-month recurrence rate of 20%.
Clinical implications
Indirect comparisons have suggested that AUR might occur less frequently in men
who underwent surgical treatment than in those who had medical treatment [Wasson J
et al, 1995, McConnell J et all, 2003]. This suggestion however, is not supported by
the results of our study. Between 1991 and 2003, the frequency of transurethral
resection of the prostate for BPH has decreased from about 40,000 to 24,000
procedures per year in England. Our study demonstrates that despite this 40% decline
in the use of surgical treatment of men with BPH, the incidence of primary AUR has
fallen slightly. This implies that the shift away from surgical treatment for benign
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prostate disease has not resulted in an increase in the occurrence of one of the most
important long-term complications of the disease. One explanation for this observed
finding is that although alternative treatments for BPH, such as medical therapy, are
potentially less effective at preventing AUR, more men with BPH may have been
receiving some form of therapy rather than being assigned to watchful waiting.
Furthermore, the increasing use of medical therapy may in effect be changing the
course of the disease. This explanation is supported by a recent study from the UK
[Logie J et al, 2005] which observed that the time from first treatment of LUTS to an
episode of AUR increased between 1992 and 2000, most likely as a result of
increasing use of medical therapy.
Another clinically relevant observation of our study is that the number of men with
primary AUR who underwent immediate surgical treatment in England fell by about
20% over the six-year period, during which the recurrence rate increased by a similar
percentage. Consequently, this increase in the use of conservative management for
AUR seems to have put more men at risk to have an AUR recurrence. In this context,
an important emerging question is therefore which men with AUR should have early
surgical intervention. A number of risk factors for recurrence have been recognised
[Roehrborn C et al, 2000] (e.g. old age, large prostate size, high post-void urinary
residual volume, low urinary flow rate, age) and these factors might help to identify
men at high risk of AUR recurrence for whom early surgical treatment may be of
particular benefit.
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Chapter 8
Use of HES data to identify if delay in definitive cancer treatment impacts on the
oncological outcome of such cancer treatment?
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8.1 Introduction
Bladder cancer is the second most commonly reported malignancy of the urinary tract
with an estimated 136,000 new cases diagnosed in Europe each year [Parkin D et al,
2005]. About 20% of patients newly diagnosed with bladder cancer will be found to
have muscle-invasive disease [Messing E et al, 1995] for which Radical cystectomy
(RC) remains the treatment of choice [Montie J el al, 1984, Pegano F et al, 1991].
A number of factors have been found to influence survival in patients undergoing RC
[Skinner D et al, 1995]. These include, clinical and pathological stage, lymph node
status and to some extent, the presence of concomitant co-morbid disease and patient
age. There is increasing evidence to suggest that in addition to the above factors, a
prolonged interval between diagnosis of muscle-invasive disease and surgery may
also impact on long-term survival following the procedure.
In this case study, HES data is used to report changes over time in average
preoperative delay before RC in England between 1998 and 2002. In addition, HES
data is used to report the impact of preoperative delay on long-term cancer outcome.
Conclusions drawn from HES data in this case study are then compared with those
reported in the literature.
8.2 Methods
Patient selection procedure
We identified all HES records concerning hospital admission for RC between IApril
1998 and 31 March 2002. This was done by examining a117diagnosis fields of the
HES database for records containing the ICD-l 0 diagnosis code C67 indicating
"malignant neoplasm of the bladder". These records were then further filtered to
identify records containing OPCS-4 procedure codes M341, M342, M343, M344,
M348 and M349 indicating that the patient underwent RC. These records were then
labelled "index records ",
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Capturing Survival
In order to capture survival we linked each "index record" to national mortality
records provided by the Office of National Statistics (ONS). Linkage was based on a
technique of probability matching which translates the level of agreement and
disagreement between each item of identifying information contained within 2
records.
Capturing Preadmissions
To capture data regarding prior hospital admission, we linked, again using probability
matching, each "index record" to all HES records concerning hospital admission in
the year before RC. This final dataset was labelled the 'working dataset'.
Preoperative Delay
For each patient identified as having undergone RC within the 'working dataset', we
extracted information on all diagnostic procedures related to bladder cancer, namely
cystoscopy (M45) and TURBT (M42) that were performed in the year before RC.
Preoperative delay was defined as the time elapsed between the most recent TURBT
or the most recent cystoscopy if a TURBT had not been performed before RC, and the
date ofRC.
Co-morbid disease
For each patient we also extracted information on all medical conditions (coded using
ICD-IO diagnosis codes) documented within HES records relating to hospital
admissions in the year before RC. For each patient, we then generated Charlson co-
morbidity scores [Charlson M et aI, 1987] based on the extracted information using a
translation of the Dartmouth-Manitoba (OM) adaptation [Romano P et al, 1993] of the
Charlson co-morbidity score, as previously reported [Nuttall M et al, 2006].
Hospital Case Load
Hospital case load was defined as the annual average number of RC's performed over
the 4 year study period. Hospital case load is presented as a binary variable,
contrasting hospitals performing ten or fewer RC's per year with those performing
more than ten RC's per year. However, case load was modelled as a continuous
variable when analysing the influence of case load on preoperative delay.
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Exclusions
We excluded patients if we were unable to extract information concerning hospital
admission for either TURBT or cystoscopy in the year preceding RC. In addition, we
excluded patients recorded in the dataset as having undergone RC as an emergency
procedure. Overall, our sample included 3,976 patients.
Statistical Analysis
First, we examined the association between patientlhospital characteristics and
preoperative delay using linear regression. We then examined the association between
preoperative delay and overall survival, calculated from the date of RC to the date of
death or the date of censoring (1 April 2004, median follow-up in censored patients
was 3.7 years). We used Cox proportional hazards models to assess the effect of
preoperative delay on overall survival following RC, while adjusting for age, co-
morbid disease, sex and hospital case load. The assumption of proportional hazards
was assessed for each covariate by examining graphs of scaled Schoenfeld residuals
and by appropriate statistical tests. All p values were two sided, and those less than
0.05 were judged to indicate a statistically significant result. Stata software (version 8)
was used for all statistical calculations.
For our analyses, preoperative delay was initially modelled as a continuous variable.
In a second model, patients were divided according to preoperative delay into 3
clinically relevant groups, less than 8 weeks (n=I,886), between 8 and12 weeks
(n=I,051) and greater than 12 weeks (n=I,039). Those patients with a preoperative
delay of between 8 and 12 weeks and those with a preoperative delay of greater than
12 weeks were contrasted with those patients subjected to a preoperative delay ofless
than 8 weeks. We also repeated our analyses with preoperative delay represented as a
binary variable, contrasting patients who waited greater than 12 weeks (84 days) with
those who waited 12 weeks or less as it has previously been suggested that patients
with a preoperative delay of greater than 12 weeks have a worse survival.
8.3 Results
Patient and Hospital Characteristics
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The study sample included 3,976 patients undergoing RC in 192 hospitals across
England between 1998 and 2002. On average, each hospital performed 11 RC's a year
(range 0.25 to 38.25). Median age at surgery was 68 years (range 29 to 89), 76%
(3,023) were male and 27% (1,083) had co-morbid disease (Table 8.1).
Preoperative Delay
Overall the median preoperative delay was 60 days (Table 8.1, figure 8.1). The delay
was greater than 12 weeks in 26% (1,039) of the cases. However, 95% of patients
underwent RC within 20 weeks of TURBT. Preoperative delay was found to be
greater in men and older patients (Table 8.1 & 8.2). However, although median
preoperative delay was greater in those patients with co-morbid disease, after
adjusting for patient and hospital factors, this difference was no longer statistically
significant (p=O.l13).
In addition, preoperative delay, when analysed as a continuous variable, was found to
be greater in hospitals with lower case loads (p=0.021). However, this association was
no longer apparent when preoperative delay was analysed as a categorical variable
(Table 8.2).
Over the four-year study period, the median preoperative delay increased from 55
days in 1998 to 65 days in 2002. Furthermore, the proportion of patients in whom
surgery was delayed greater than 12 weeks increased from 20% in 1998 to 31% in
2002.
Effect of Preoperative Delay on overall survival
Overall 5-year actuarial survival was estimated at 51%. When analysed as a
continuous variable, or when collapsed into our three categories « 8 weeks, 8-12
weeks, >12 weeks), preoperative delay was not found to be associated with survival,
even after adjusting for year, age, sex, hospital case load and the presence of co-
morbid disease (Table 8.3, Figure8.2). Moreover, when we repeated our analysis with
preoperative delay represented as a binary variable, contrasting patients subjected to a
preoperative delay of more than 12 weeks (84 days) with those having to wait 12
weeks or less, we again found no significant difference in overall survival (Table 8.3).
Cox proportional hazards model assumes that the risk of death is constant over time.
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To test this assumption, we estimated hazard ratios for overall survival at one year and
greater than one year. We again found no significant difference in overall survival
between those waiting more than 12 weeks and those waiting 12 weeks or less (Table
8.3).
8.4 Discussion
Summary
This case study has used HES data to suggest that preoperative delay before RC is
increasing in England. In addition, HES data suggests that delay between diagnosis of
invasive bladder cancer and subsequent radical treatment does not infer a worse
outcome with regard long-term survival.
Comparison with other studies
A number of studies have reported on delay before RC, the majority of which have
observed average preoperative delays similar to our figure of 60 days. Two recent
European studies, one from Germany [May M et al, 204] and one from Sweden
[Leidburg F et al, 2005], have reported average delays of 54 and 49 days respectively
while two further studies, this time from Canada [Mabmud S et al, 2006] and the US,
have reported delays of between 30 and 63 days [Chang S et al, 2003].
Preoperative delay increased over our study period by almost 20% from 55 days in
1998 to 65 days in 2002. While the majority of studies have not commentated on
trends in delay, the Canadian study did note that delay in the Quebec region of
Canada had increased by a factor of two from 23 days in 1990 to 50 days in 2002.
In our study, we found that increasing preoperative delay, analysed both as a
continuous or a categorical variable, did not impact on survival following RC, even
after adjustment for available patient and hospital factors. While there is only limited
data available on this subject, the majority of which originate from retrospective case-
series, the bulk of data suggest delay in radical treatment infers a worse prognosis.
Shanchez-Ortiz and colleagues reported outcome of 290 patients undergoing radical
cystectomy from a single US institution. This group identified that 84% of patients
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experiencing a delay of more that 12 weeks were subsequently found to have
extravesical disease or positive nodal disease - both markers of more advanced
disease, following surgery, compared to only 48% of patients waiting less than 12
weeks. The group went on to report 3-year survival following cystectomy identifying
that survival fell from 62% in those waiting less than 12 weeks to 35% for those
waiting longer than this figure. Chang and colleagues also investigated delay in
cystectomy. This groups findings mirror those of Shanchez-Ortiz. In their study of
303 patients, 81% of patients waiting more 90 days between diagnosis and cystectomy
had extravesical disease compared to 52% of patients waiting for a shorter period.
Mahmud and colleagues, utilising data on 1,592 patients undergoing cystectomy
identified from a Canadian administrative database, found that patients waiting longer
than 12 weeks had a 20% higher risk of dying than those waiting a shorter period.
It would therefore appear that conclusions gained from HES for this particular clinical
question do appear at odds with the majority of data published on this topic. It
certainly seems logical that the longer a patient awaits treatment for a cancer, the
more likely their cancer will progress, therefore reducing the possibility of curative
treatment.
Given that 95% of patients in this study underwent RC within 20 weeks of diagnosis,
one explanation for why we did not find an association between preoperative delay
and survival may be that patients did not experience preoperative delays of sufficient
magnitude to have resulted in worse outcome. However, 20 weeks is certainly a
considerably longer delay than is considered important in other studies - namely 12
weeks. Identifying how long a patient can wait before survival is compromised
remains to be answered. However, our finding that preoperative delay is increasing in
England does raise concern, for if this trend were to continue, patients could begin to
experience preoperative delays that do compromise survival. In view of this
possibility, continued efforts should be made to perform timely surgery once the
decision to proceed to RC has been made.
On the other hand, inherent confounding is the most likely explanation why we did
not find an association between preoperative delay and survival. HES data, alike other
secondary data sources, lacks detailed clinical information such as stage and grade of
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disease. As a consequence, we were unable to identify and adjust for any disparities in
disease severity between the different preoperative delay categories. If patients with
more advanced disease and as such those with a poorer prognosis, were being
prioritised to undergo surgery earlier by urologists working within NHS hospitals in
England, association between preoperative delay and long-term outcome may be lost
in any analyses that were unable to adjust for disease severity. Although there is no
evidence that patients with more advanced disease undergo more expeditious surgery,
it would certainly seem a possibility that they are. As such, the inability to account
for disease severity within HES data does raise concern over the applicability and
accuracy of HES data to report on whether preoperative delay influences long-term
outcome of radical cystectomy. Although this is only one example where analyses of
HES data to report long-term surgical outcome may be influenced by bias and
confounding, it does raise concerns on the general use of HES data to comment on
other determinants of long-term surgical outcome.
Methodological Limitations
Our study does have other potential limitations that must be discussed. Survival was
calculated from the date of RC as opposed to the initial date of diagnosis, as we did
not possess data concerning waiting list mortality. As a result, we were unable to
account for either lead-time or length-time bias [Gates T et al, 2001]. Lead-time bias
occurs when early surgical intervention appears to prolong survival, even when no
such survival advantage exists. However, such bias is unlikely to have had a major
impact on our findings' , as first, we did not fmd that early surgery inferred a survival
advantage and second, lead-time was comparatively short when compared to mean
survival, even in those patients undergoing delayed RC. Length-time bias occurs
when delayed surgical intervention appears to prolong survival as a result of
excluding patients who die while awaiting surgery. Again, this form of bias is unlikely
to have had a major influence on our findings as it is unlikely that many patients,
initially thought sufficiently fit to be scheduled to undergo RC, would have died while
awaiting surgery, even in those patients subjected to preoperative delays of more than
12 weeks.
Conclusion
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HES data suggests that increasing preoperative delay prior to cystectomy does not
impact on long-term outcome. Given that the majority of studies that have reported on
this topic are at odds with this conclusion, this case study raises concerns over the
ability of HES data to reliably report on the determinants of long-term oncological
outcomes following surgery. The underlying reason why HES would appear
inaccurate for the reporting of such outcomes is likely to stem from the inability of
HES data to adjust for disease severity.
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Chapter 9
Use of HES data to identify how higher volume hospitals achieve improved
outcomes following radical pelvic cancer surgery?
Use of HES data to investigate the determinants of short-term surgical outcome
148
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9.1 Introduction
A number of studies have reported that high-volume centres are able to achieve
improved outcomes when compared to lower-volume centres [Nuttall M et al, 2004,
Finlayson E et al, 2003, Konety B et al, 2005]. This volume-outcome relationship has
been demonstrated for a number of cancer surgeries including, pancreatectomy,
gastrectomy, pneumonectomy, esophagogastrectomy, cystectomy [Birkmeyer J et al,
Barbieri C et al, 2007] as well as non-cancerous surgeries [Gammie, 2007]. The
reporting of this volume-outcome relationship for cancer surgery has led to the
restructuring of cancer services both in the US and the UK [NICE Cancer Services -
improving outcomes in urological cancer].
A number of hypotheses have been suggested to explain the volume-outcome
relationship. However there appears little evidence to support them. A recent study
from the US using the Surveillence, Epidemiology, and End Results (SEER)-
Medicare dataset, reporting on 4465 patients undergoing radical cystectomy between
1992 and 1999, suggested that the volume-outcome relationship for radical
cystectomy maybe explained by improved processes of care that in turn reduce the
rate of adverse events after surgery [Hollenbeck B et al, 2007]. However, despite
higher volume centres reporting greater rates of preoperative cardiac testing,
intraoperative arterial monitoring and use of continent diversion, differences in the
processes of care could only explain 23% of the volume-mortality effect.
Furthermore, this finding could not be replicated in patients undergoing other cancer
surgeries [Birkmeyer J et al, 2006] although has been suggested as one possible
explanation why higher volume hospitals are able to achieve improved outcomes
following cardiac surgery [Gammie et al, 2007].
Using data on 1864 patients undergoing gastrectomy for primary gastric cancers, a
recent US study [Smith D et al, 2007] has suggested that high-volume centres may
improve outcome, not by reducing the rate of adverse events following surgery, but by
improving the rate of mortality after an adverse event has occurred. This has led some
authors to suggest that failure-to-rescue (death after an adverse event) underlies the
volume-outcome relationship and as such, represents a better measure of quality of
care than surgical volume alone [Elting L et al, 2007].
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In the present study, HES data is used to investigate to what extent failure-to-rescue
explains the volume-outcome relationship in patients undergoing radical cystectomy
for bladder cancer.
9.2 Methods and patient population
Patient selection procedure
We identified all HES records concerning hospital admission for RC between 1 April
1998 and 31 March 2002. This was done by examining all 7diagnosis fields of the
HES database for records containing the ICD-l 0 diagnosis code C67 indicating
"malignant neoplasm of the bladder". These records were then further filtered to
identify records containing OPCS-4 procedure codes M341, M342, M343, M344,
M348 and M349 indicating that the patient underwent RC. These records were then
labelled "index records ". This data extraction resulted in a sample of 4,900 patients.
Patient Outcomes
Three outcomes, 30-day mortality, adverse event rate and rate offailure-to-rescue
following an adverse event, were evaluated. 30-day mortality was identified by
linkage of each "index record" to national mortality records provided by the Office
of National Statistics (ONS). Linkage was based on a technique of matching each
item of identifying information contained within separate data records.
To identify adverse events following surgery, we searched the diagnosis and operative
fields of all records concerning patients thought likely to have had a complication
after surgery - i.e. records containing data on patients who had either been in hospital
for more than a week after surgery or had required readmission to hospital within 30
days of surgery. Codes used to identify adverse events were specifically not defmed in
advance as this was thought to limit the identification of adverse events. On the basis
of our search, we were able to identify 350 diagnosis codes and 25 operative
procedure codes that were used to record adverse events following radical
cystectomy. These codes were then grouped according to type of adverse event.
myocardial infarction, pulmonary compromise, pelvic collection, pneumonia,
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operative complication, ileus/adhesions, acute renal failure, bacteraemia, wound,
pulmonary embolism, stroke, cardiac arrest, respiratory arrest, gastrointestinal
haemorrhage and complications associated with ileostomy (see appendix eight). These
adverse event categories were then applied to the index records of all patients
included in the study. Failure-to-rescue was defined as death after an adverse event.
Adjustment/or case-mix
For each patient we also extracted information on all medical conditions (coded using
ICD-lO diagnosis codes) documented within HES records relating to hospital
admissions in the year before RC. For each patient, we then generated Charlson co-
morbidity scores based on the extracted information using a translation of the
Dartmouth-Manitoba (OM) adaptation of the Charlson co-morbidity score, as
previously reported [Nuttal et aI, 2006].
Hospital Volume
A National Cancer Guidance Steering group has been commissioned by the UK
government to provide key recommendations on the organisation and delivery of
cancer services [www.nice.org.uk].This group have recently published guidance
suggesting radical surgery for both bladder and prostate cancer be provided by teams
typically serving populations of one million or more and carrying out a cumulative
total of at least 50 such operations each year. Given these recommendations, in this
study Hospital or centre volume was defined as the annual average number of all
pelvic urological surgeries - both radical cystectomy and radical prostatectomy,
performed over the 4-year study period by each individual hospital.
Hospital volume was modelled as a continuous variable when analysing the influence
of volume on failure-to-rescue. However, for the purposes of presentation only,
hospital volume collapsed into a binary variable, contrasting hospitals performing
twenty-four or fewer radical pelvic surgeries per year with those performing more
than this figure.
Statistical analysis
Three multivariate logistic regression models were developed. The first employed 30-
day mortality (yes/no) as the response variable. A second multivariate logistic
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regression model employed risk of adverse event (yes/no) as the response variable.
Similar independent variables were included in the analysis. The third and final
multivariate logistic regression model used failure-to-rescue (yes/no) as the response
variable. Independent variables included in all three models were hospital volume -
modelled as a continuous variable, age, sex, presence of comorbid disease (Charlson
score of 0 versus Charlson score of 1 or more), year of surgery and admission status
(elective versus emergency).
All P values were two sided, and those less than 0.05 were judged to indicate a
statistically significant result. Stata software (version 8) was used for all statistical
calculations.
9.3 Results
Over the four-year study, 4900 patients at 199 hospitals underwent radical cystectomy
for bladder cancer. Men comprised 75.8% of the cohort, 15.3% were older than 75
years of age and 26.8% were found to have a Charlson comorbidity score of 1 or
more. 26.9% (1,319/4900) experienced an adverse event while 4.0% (196/4,900) died
within the 30 days of surgery. 80.1% (157/196) of which died more than 1 week after
surgery.
Adjusting for patient age and sex, presence of comorbid disease, admission status and
year of surgery, hospital volume was found to influence 30-day mortality (OR 0.98,
95% Cl, 0.97-0.99, p=0.02). Hospitals performing more than 25 radical urological
pelvic cancer surgeries a year had a 27% lower risk of death than those performing
less than this figure.
Overall, 26.9% of patients undergoing radical cystectomy experienced an adverse
event following surgery while 8.5% experienced more than one adverse event. Patient
age, admission status and comorbidity status were all found to influence the risk of an
adverse event occurring (Table 9.1). In multivariate analyses, patients over 75 years of
age were more than 30% more likely to experience an adverse event (OR 1.37, 95%
Cl, 1.17-1.60, p=<O.OOI) than those patients younger than 75, while patients
identified with a Charlson comorbidity score of 1 or more were nearly twice as likely
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to experience an adverse event than those without comorbid disease (OR 1.90,95%
Cl 1.66-2.18, p=<O.OOI). Patients undergoing elective, as opposed to emergency
surgery were also at lower risk of an adverse event (OR 0.72,95% Cl 0.56-0.93,
p=O.OI) (Table 9.1).
However, hospital volume was not found to independently predict the risk of an
adverse event occurring following surgery (OR 1.00, 95%CI, 0.99-1.00, p=O.13)
(Table 9.1).
Overall, failure-to-rescue following an adverse event occurred in 10.2% (134/1,319)
of patients. Patient age, comorbidity status, year of surgery and hospital volume were
all found to influence failure-to-rescue rates following an adverse event (Table 9.2).
In multivariate analyses, patients over 75 years of age were more than 80% more
likely to die following an adverse event (OR 1.83,95% Cl, 1.25-2.71, p=0.002) than
those patients younger than 75, while patients with a Charlson comorbidity score of 1
or more were nearly twice as likely to die following an adverse event than those
without comorbid disease (OR 1.99,95% Cl, 1.37-2.89, p=<O.OOI). Failure-to-rescue
rates were found to have fallen from 12.9% in the first year of our study to 6.6% in
the last year of our study (OR=0.84, 95% Cl, 0.71-0.99, p=0.03).
Hospital volume also influenced the rate of failure-to-rescue following an adverse
event (OR 0.98,95% Cl, 0.97-0.99, p=0.026) (Table 9.2). Hospitals performing more
than 25 radical urological pelvic cancer surgeries a year had a 37% lower risk of
failure-to-rescue following an adverse event than those performing less than this
figure. Moreover, the impact of hospital volume on the rate of failure-to-rescue
appeared to be influenced by the number of adverse events the patient experienced.
Patients experiencing more than 1 adverse event in a hospital performing more than
25 radical urological pelvic cancer surgeries a year had a 66% lower risk of failure-to-
rescue than those performing less than this figure, (OR 0.44, 95% Cl, 0.23-0.85,
p=O.OI).
The most common adverse events following radical cystectomy were operative
complications of surgery, for example post-operative haemorrhage or dehiscence of
wound (7.4%), post-operative ileus/ adhesions (6.3%), pelvic collectionlbowelleak
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(6.3%) and myocardial infarction (4.0%) (Table 9.3). The highest failure-to-rescue
rate was seen for myocardial infarction (21.1%), followed by pulmonary compromise
(20.4%) and acute renal failure (18.7%). Treatment at a higher volume centres seemed
to decrease the odds of failure-to-rescue following myocardial infarction, pulmonary
compromise and pelvic collectionlbowelleakage, although these trends did not reach
statistical significance (Table 9.3).
9.4 Discussion
Summary
As previously reported, this study found that increasing hospital volume is associated
with improved 30 day survival following radical cystectomy. However, our study also
demonstrates that higher volume hospitals are able to achieve improved outcomes by
reducing the rate of failure-to-rescue following an adverse event.
Comparison with other studies
In our study, we found that patients undergoing radical cystectomy in centres
performing more than 25 pelvic cancer surgeries a year were 27% less likely to die in
the perioperative period that those treated at centres performing less than this figure.
This finding is similar to that reported in a recent US study that utilized data from
both the national Medicare claims database and the Nationwide Inpatient Sample. In
this study, in-hospital mortality rates was 6.4% for very low volume centres « 2
radical cystectomies a year) compared to only 2.9% for very high volume centres (>
11 radical cystectomies a year) [Birkmeyer J et aI, 2002]. Moreover, our findings are
in keeping with several systematic reviews recently published on this subject (Nuttall
M et al 2004, Konety B et al, 2005).
We report an overall adverse event rate of26.9%. This is not dissimilar to other
studies. A recent paper [Quek M et al, 2006], reporting on 1,359 patients undergoing
RC at a single US institution between 1971 and 2001, found that 32% experienced an
adverse event, the most frequent of which was sepsis. In comparison, two recent
population-based studies, using data from the National Inpatient Sample (Konety B et
aI, 2006] and the National Surgical Quality Improvement Programme (Hollenbeck B
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et al, 2007), have reported post-operative adverse event rates, identified using a
similar methodology to that employed in this study, of28.4% and 30.5% respectively.
We found that while hospital volume did not influence the rate of adverse events, it
did however appear to impact on the rate of failure-to-rescue following an adverse
event. This is similar to that reported for patients undergoing radical gastrectomy.
[Smith D et al, 2007], using data from the Texas Hospital Public Data File, which
found that for patients undergoing surgery at high and low volume centres, the rate of
failure-to-rescue following radical gastrectomy improved from 7.1% for centres
performing between 3 and 15 gastrectomies a year, to 1.9% for those centres
performing more than 15 gastrectomies a year. In our study, the rate failure-to-rescue
fell from 11.5% for centres performing fewer than 25 pelvic surgeries a year to 7.6%
for centres performing more than this figure. Using the same data source, Elting et al,
have investigated the impact of hospital volume on the outcome of radical
cystectomy. In this study, rates ofin-hospital mortality were also found to be
significantly lower for high volume centres (> 10 radical cystectomies a year). In
addition, hospital volume also appeared to influence the rate of failure-to-rescue
following an adverse event, although this trend did not remain statistically significant
in multivariate analyses. Further analysis of their data suggested that, not only were
the majority of deaths after radical cystectomy a result of failure-to-rescue, but also
that a high nurse-to-bed ratio resulted in a 60% reduction in the rate of failure-to-
rescue.
Several other studies, in addition to this study, have sought to identify the
mechanisms underlying the volume-outcome relation. Hollenbeck and collegues,
reporting on 4465 patients identified, using the Surveillance, Epidemiology, and End
Results (SEER) data-set, as having undergone radical cystectomy between 1992 and
1999, found that high and low volume centres differ with regard to many processes of
care, before, during and after surgery. However, the actual differences in the use of
processes of care, such as arterial monitoring, were only found to explain 23% of the
volume-mortality effect. Furthermore, when the same group evaluated this hypothesis
on patients undergoing other cancer surgeries such as lung and gastric resections,
differences in measurable processes of care could not explain the volume-outcome
effect on mortality.
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In our study, we found higher volume centres tended to have lower rates offailure-to-
rescue following adverse events such as myocardial infarction, pulmonary
compromise and bowel leakage. While there is little published data available on the
influence of hospital volume on the management of adverse events occurring after
surgery, Chen and colleagues [Chen J et aI, 1999] have identified, certainly for
myocardial infarction, that patients are more likely to receive more effective medical
management of in high volume centres compared to those patients in lower volume
centres.
Clinical Implications
This study suggests first, that unlike high-risk cancer surgery e.g. oesophagectomy
[Birkmeyer et al, 2002], the majority of deaths after radical pelvic surgery do not
occur intra-operatively, rather from failure-to-rescue after adverse events (>80%) and
second, that lower volume centres may be able to replicate outcomes of higher
volume centres by improving their rates of failure-to-rescue after an adverse event
occurs.
How centres may achieve improve their rates of failure-to-rescue however, does
require further research. It is likely that improved access to interventional cardiology
services as well as increased availability of assisted ventilation within the intensive
care setting plays a role and as such improved availability of these services in lower
volume centres could lead to improved outcome in these centres.
However, financial constraints as well as limited availability of clinical expertise may
mean that these services are themselves centralised and as such, lower volume centres
may not have access to them. In this way, it may be the centralisation of cardiac and
intensive care facilities that limits the capability of low volume centres to provide a
radical pelvic surgery service. On the other hand, if it is the per-operative
management that is important in managing patients undergoing radical pelvic surgery,
it may be that surgeons from lower volume "home" centres could travel, together
with their patients, to more centralised high volume centres to perform the surgery.
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Although the main drivers of patient outcome after radical pelvic surgery are patient
factors such as age and comorbidity, this study does support recommendations, both
in the US and Europe, that radical pelvic surgery continues to be performed in large
high volume centres. However, this study suggests that volume itself should not be
necessarily be used as a proxy for quality as availability of cardiac and intensive care
facilities would appear the most influential factors in patient outcome.
Methodological limitations
These findings should be interpreted with a few caveats. First, outcome of adverse
events following surgery may appear worse if hospitals only identify very severe
complications. In such a way, if clinical coders in low volume centres failed to
recognise more subtle, less severe, adverse events where outcome is likely to be
better, low volume centres would artificially appear to have worse rates of failure-to-
rescue. To investigate this we compared the recording of complications in patients
dying within 30 days of surgery, a cohort of patients expected to have a recorded
adverse event, given they died so soon after surgery. We found a documented adverse
event in 68.3% of patients dying within the first 30 days of surgery having had
surgery in a low volume hospital compared to 67% in our high volume hospital
category, a difference that was not found to be statistically significant (Table 9.4).
This suggests that better outcome of complications identified in higher volume is
unlikely to result in lower volume hospitals only coding more severe adverse events.
Although the majority of studies exploring the volume-outcome relation use
administrative data such as HES data, administrative by its nature is limited in its
ability to adjust for case-mix. While we have attempted to adjust for the presence of
co-morbid disease using an adaptation of the Charlson co-morbidity scores,
administrative data does not contain data on cancer specific parameters and as a result
we were unable to adjust for cancer severity. While it would be optimal to adjust for
these parameters, lack of adjustment is unlikely to have had a major effect on our
findings, as severity of bladder cancer is more likely to influence long-term survival
rather than 30-day mortality.
Further research
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More research is urgently required to understand and investigate why failure-to-rescue
rates vary between the different centres performing radical pelvic surgery, both to
enable lower volume centres to improve by learning and adopting best practices, as
well as enable higher volume centres to improve outcomes still further.
Conclusions
HES data suggest higher volume centres are able to achieve improved outcomes of
radical pelvic surgery by reducing the rate of failure-to-rescue following an adverse
event, most notably for myocardial infarction and pulmonary compromise.
Improvement in outcome of radical pelvic surgery is likely to be achieved by
improving access at an early stage to specialists in cardiac and intensive care
medicine.
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10.1 Objectives
This section is divided into four subsections, the first of which represents a brief
summary of the thesis.
In the second subsection, the strengths and weaknesses of the RES database are
discussed in the context of the case studies included within this thesis. Such strengths
and weaknesses are subsequently compared with those gained from studies that have
investigated the use of databases other than RES.
In subsection three, recommendations are made concerning the use of the RES
database to answer clinical questions concerning incidence of urological disease as
well as practice and outcome of urological surgery based on the strengths and
weaknesses of the database identified in this thesis. Finally, the type of clinical
questions that can and can't be answered using the RES database as a source of data
are speculated upon based on the strengths and weaknesses of the RES database
identified within this thesis.
The fourth and final subsection of this general discussion concerns suggestions for
future work, including the need for further validation studies to assess the accuracy of
RES data as well as the need for collaborative work to link the RES database with
additional national databases.
10.2 Summary of thesis
Section one
Section one was an introduction to, and overview of, this thesis. It set out the
objectives of the thesis and named the urological diseases utilised within this thesis to
evaluate the RES database as a source of data to answer clinically important
questions.
Background information was presented on the growing emphasis of clinical
governance, the increasing demand for measures of clinical quality and outcomes
reporting together with the need for increasing data concerning disease occurrence
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and surgical practice within the NHS. The five individual case studies within this
thesis were subsequently introduced and expanded upon together with an explanation
as to why they were chosen to evaluate the HES database as a source of information.
Chapter two went on to briefly summarise the urological diseases and urological
surgeries on which the case studies included within this thesis are based.
Section Two
Chapter three introduced the HES database and how HES data is collected together
with how HES data records may be linked to Office of National Statistics (ONS)
mortality records. In addition, this chapter set out how the HES data utilised within
this thesis was obtained from the Department of Health in England.
Chapter four presented a review of the published literature to identify to what extent
the HES database has previously been used to answer specific clinical questions
regarding, first, the incidence of urological disease and second, the processes and
outcomes of urological surgery. The review highlighted the completeness of the
database identifying very low under-ascertainment when compared to local audit data
but on the other hand identified that use of Finished Consultant Episodes (FCE'S)
over-estimated disease incidence by up to 56%. The review identified that use of a
combination of date of birth, postcode, discharge destination, and episode order could
dramatically reduce such over-estimation of disease incidence. In addition, the review
identified that although the majority of studies that have reported outcomes of surgery
using HES data have restricted their analyses to reporting of the determinants of in-
hospital mortality, several authors have drilled down into HES data to identify other
indices of quality available within HES. These included, the percentage of FCE's with
a coded complication - identified by searches of HES records to identify diagnostic
and operative coding adverse events, the percentage ofFCE's with a prolonged length
of stay, mean length of spell and the percentage of FCE' s in which patients undergo
more than one operative procedure.
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Section Three
This section included the five case studies on which recommendations concerning
"the use of the HES database to answer clinical questions". included within this
general discussion are based.
Chapter five presented a study developed to evaluate the feasibility of using HES data
to report trends over time in the incidence of hypospadias using frequency of
corrective hypospadias surgery captured within HES as a proxy for the incidence of
the congenital anomaly. Data from this case study was then compared with that
generated from a registry of congenital anomalies - a data source known to have high
under-ascertainment. The study demonstrated that incidence estimates of corrective
hypospadias surgery were more than three times higher than that reported by the
National Congenital Anomaly System (NCAS), with the difference in incidence
estimates being compatible with the previously reported under-ascertainment to
NCAS. Furthermore, the study suggested the incidence of this important congenital
anomaly is increasing in England. This case study therefore provided evidence that
incidence estimates, based on treatment obtained from the HES database, may
represent a more comprehensive source of data than pre-existing congenital anomaly
registries.
Chapter six presented a study developed to evaluate the use of HES data to identify
the clinical appropriateness of treatment with regard use of paediatric circumcision for
the treatment of pathological phimosis - a condition with a well documented
incidence. The study identified that the incidence of circumcision in England
remained 5 times higher than the incidence of phimosis, and as such the study
concluded that over 80% of the boys undergoing the procedure were being exposed to
the risks of an ablative surgical procedure which was not clinically appropriate. This
case study therefore provided evidence that where the incidence of a surgically
treatable disease is reliably known, HES data can be used to identify unnecessary or
clinically inappropriate treatment.
Chapter seven presented a study designed to evaluate the use ofHES data to report
the impact of change in management on urological disease. The example used was
Benign Prostatic Hyperplasia (BPH) as the management of BPH has changed
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dramatically over the last decade with far fewer men undergoing surgery. The
outcome measure used to evaluate the impact of change in disease management was
acute urinary retention as this is a known complication of BPH disease progression
and therefore potentially influenced by a change in the way men with BPH were
managed. The case study suggested that despite a shift away from surgery, there was
no change in the incidence of acute urinary retention over the last decade suggesting
men were not being placed at increased risk of BPH disease progression as a result of
fewer surgical procedures being performed for the disease. On the other hand, the
study did suggest that the adoption of Trial Without Catheter (TWOC) policies in men
who had experienced an episode of urinary retention, advocated by randomised
controlled trials that have demonstrated reasonable success rates after TWOC's for
men with acute urinary retention, have resulted in real-life increases in recurrent
retention of urine. This case study therefore provided evidence that HES data may be
used to monitor the impact of changes in management and treatment of disease.
Chapter eight presented a case study designed to evaluate the use ofHES data to
assess the impact of time from bladder cancer diagnosis to treatment. The case study
found that patients were waiting longer between diagnosis and subsequent treatment,
but on the other hand suggested that delay in treatment did not appear to influence
long-term oncological outcome. This finding was at odds with the majority of
published data that have investigated this particular clinical question. This case study
therefore provided evidence that HES data may not be suitable for the reporting of
determinants of long-term outcomes following surgery.
Chapter nine presented a case study designed to evaluate the use of HES data to
investigate the determinants of peri-operative outcome following radical pelvic cancer
surgery. The study was specifically designed to use the HES database to ask how high
volume cancer centres achieve better short-term outcomes following radical
cystectomy for bladder cancer. This case study demonstrated that high volume cancer
centres have similar complication rates following surgery, but that patients
experiencing a complication of surgery were less likely to die following that
complication than a patient experiencing a similar complication in a lower volume
cancer centre. This case study therefore provided evidence that HES data may be used
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to investigate the determinants of short-term surgical outcome, if not longer-term
outcomes as suggested in the previous case study.
10.3 Strengths and weaknesses of using HES data to answer clinically relevant
questions
The review along with each case study illustrated different strengths and weaknesses
of the HES database when used by the urologist to answer clinical questions. These
must be discussed as they form the basis on which recommendations for the use of the
database may be made.
The literature review that investigated the use of HES to study incidence, surgical
treatments and their outcomes identified a key strength along with several weaknesses
of the database. The review highlighted the completeness of the HES database
demonstrating that HES data, when compared to large local audit data had minimal
under-ascertainment. On the other hand however, the review identified that use of
Finished Consultant Episodes (FCE'S) to report incidence of surgical conditions can
lead to dramatic over-estimation of disease incidence in the order of 1 and 56%.
However, the review did identify that this figure could be greatly reduced using
methods to identify patient level figures as opposed to simply using FCE's. These
methods included use of only first order episodes within admission spells (Le. those
HES records labelled EPIORDER 1), use of date of birth, postcode, discharge
destination, date of episode start, all of which attempt to reduce the double-counting
of episodes.
The review also demonstrated that HES data had few outcome measures available to
evaluate the processes and outcomes of surgery - namely in-hospital mortality. This
certainly represents a weakness of the database to evaluate the outcome of surgery as
for many procedures, death, is an extremely rare outcome event and so is not
particularly helpful for the evaluation of 'quality of care'. However the review did
identify that it is possible to identify alternative outcomes measures. These included
amongst others, searching for specific codes know to be associated with an adverse
event, identifying those with prolonged lengths of stay and reporting the percentage of
spells with more than one operation.
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Another weakness identified from the review of HES is that it is difficult within HES
to adjust for confounding variables when analysing the determinants of outcome of
surgery. On the other hand the review did identify that some have developed methods
by which confounding can at least in part be accounted for. These include, identifying
those admitted as an emergency as opposed to undergoing elective admission and
those with co-existing comorbid disease e.g. identification of those patients with
Downs syndrome undergoing paediatric cardiac surgery.
The first case study utilised the HES database to report on the incidence of corrective
hypospadias surgery. This case study highlighted the first major strength of the
database, namely its comprehensive nature. Itwas due to this comprehensive nature
that incidence estimates generated from HES for hypospadias were more than three
times higher than the incidence of hypospadias reported over a similar period by the
national surveillance registry - NCAS. Furthermore, this difference appeared
compatible with the estimated under-ascertainment to NCAS further demonstrating
the strength of the lIES database to capture disease within society.
On the other hand, despite the incidence estimate for hypospadias being three times
higher than the figure quoted by NCAS, the use of operative codes - as was the case
in this study, as a surrogate for disease itself may represent a weakness of the lIES
database as estimates based on surgical activity may under-estimate incidence of
disease as it presumes all patients with the disease will undergo surgery. Certainly this
was one weakness of the hypospadias case study, for boys with very minor forms of
the congenital disorder may not have undergone surgery, the effect of which would
have been an under-reporting of the true incidence of the condition. Furthermore, if
there had been a trend towards boys undergoing surgery for more minor cases over
time, this could have suggested a rising incidence where this was not the case. This of
course could be true of numerous conditions if surgery for that condition were to be
used as a surrogate marker for the condition itself.
Another weakness identified by the hypospadias case study, although not applicable
to the hypospadias itself, was the finding that medical conditions can be treated by
more than one surgical procedure. The effect of this within the HES database is that
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potentially several operative codes may be required to be grouped together to provide
a single variable which could subsequently be used to calculate the incidence for that
particular medical condition. While this was not the case for hypospadias - corrective
surgery for hypospadias has only one single code - "hypospadias repair" (M731),
this would be the case for many other conditions. Furthermore, as highlighted in our
case study that evaluated the use of the HES database to identify complications
following radical cystectomy, the only method to correctly identify the specific codes
utilised by clinical coders is to review the data itself.
The final weakness of the liES database identified by the hypospadias case study
concerns the identification of the index episode. If a patient could undergo more than
one procedure to treat a surgical condition, it is essential to identify index admissions
to prevent double counting which will in tum result in inflated incidence estimates.
Identifying index admissions is achieved by labelling HES data records with use of
HESid numbers and then trawling the database to identify other records concerning
the same patient undergoing a similar procedure e.g. "hypospasias repair". However,
one weakness of the HES database is that to identify an index admission, sufficient
database history must be available to search for earlier admissions. Clearly patients
undergoing surgery in latter database years will have greater database histories in
which to search for earlier procedures, the result of which is an artificial decrease in
the incidence of the condition over time.
The second case study utilised the HES database to report on the incidence of
circumcision. This case study again demonstrated the comprehensive nature of the
HES database to reflect national practice which in turn could be compared to data
concerning the incidence of a condition. In addition, this case study also clearly
demonstrated the great advantage of HES in that data was available over a significant
time period which in turn could provide information on the changing trends in the
incidence of disease.
However, the case study did raise questions concerning the accuracy of diagnostic
coding within the database. More than 90% of boys undergoing circumcision were
coded as undergoing the procedure for phimosis, more than five times the known
incidence of the condition. While this may reflect unnecessary surgery, it may be
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because boys are incorrectly coded as having phimosis. Incorrect diagnostic coding
may be a result of clinicians making incorrect diagnoses, incorrect labelling of
diagnoses e.g. clinicians noting down phimosis as a diagnosis when the procedure was
really performed for ritual reasons, or the result of clinical coders incorrectly
assigning diagnostic codes. This case study was unable to establish which of these
reasons was more likely.
Apart from reporting incidence of circumcision, this case study also sought to use
HES data to identify the determinants of outcome of the procedure. Complications
occurring as a result of this particular surgery are relatively rare and as a result few
studies have the power to comment on the determinants of outcome of the procedure.
The HES database by its shear size has ample power to identify such factors.
However, one weakness of the HES database is the identification of complications
following a procedure, as there are many different possible procedure diagnostic and
procedure codes available that could potentially be used by clinical coders to record
complications. Clearly, incorrect use of codes within our analysis would have led to
under-reporting of complications.
To address this weakness inherent within the HES database, we specifically did not
identify diagnosis and operative procedure codes relating to complications of
circumcision in advance. Instead, we examined diagnosis and operative coding
within HES records concerning admissions in which a complication was most likely
to have occurred - i.e. index admissions in which the duration of in-hospital stay was
longer than 24 hours and readmissions within 30 days. We then grouped these codes
into different complication categories. By this process, we were able to account for
inconsistencies in coding practice between hospitals.
A further weakness of the HES database is that for a complication to be captured, that
complication must lead to a hospital admission. Complications not requiring
readmission are therefore not accounted for. Superficial skin infection following any
minor open urological procedure such as circumcision is arguably the most common
complication, however HES data identified very few boys with this complication as it
rarely led to hospital admission.
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The third case study in this thesis utilised the HES database to report on the incidence
of acute urinary retention. This study again highlighted, alike the case study
concerning the incidence of hypospadias, the difficulty in identifying the index event.
In this study, an episode of primary urinary retention was sought. However, labelling
an episode the very first event was dependant upon the extent of database history
available over which previous episodes may be sought. In attempt to negate this
weakness, a weakness that could have led to artificial trends in the burden of
urological disease over time, a predefined period of database history, a preceding
period of 6 months within this particular case study, was used to determine if the
event was truly a primary event. This is a key weakness that applies to all analyses of
HES data when a primary event is required to be defined.
This weakness cannot be accounted for in the same manner for all conditions. In this
thesis, the occurrence of a prior episode of retention was reviewed by looking at
patients with multiple years of previous database history. Itwas identified that the
vast majority of prior episodes occurred in the preceding 6 months. However, if one
was trying to identify previous hernia repair surgery for example, to identify those
undergoing primary hernia repair, many years of database history may need to be
sought as hernia repairs would not be expected to fail immediately after primary
surgery.
The fifth case study within this thesis evaluated the use of HES data to report on
whether delay in cystectomy from initial diagnosis impacted on long-term survival.
This study identified one fundamental weakness in the use of HES data to report on
the determinants of outcome of surgery. HES data analysis suggested delay in surgery
had no impact on long-term survival. This finding is at odds with the majority of the
published literature on this topic and goes against what one would expect given that
invasive bladder cancer requiring cystectomy is an aggressive cancer associated with
a poor survival. This case study demonstrated that without linkage of HES data to
other data sources, the HES database should only be used with caution when
evaluating long-term cancer outcomes.
The sixth and final case study within this thesis evaluated the use of the HES database
to drill down and uncover evidence as to how higher volume hospitals are able to
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achieve improved short term outcomes of pelvic cancer surgery, a finding much
reported but poorly understood. Conducting a randomised clinical trial in order to
answer this clinical question would entail considerable costs and may be difficult to
obtain ethical approval for. The comprehensive size, availability and detail concerning
the administration of health care delivery held within the HES database lends itself to
answering this question and those alike. The weakness of the HES database again
concerns the identification and capture of complications or adverse events following
surgery, however, this weakness was addresses in a similar manner as that described
in the circumcision case study.
10.4 Comparison with other studies utilising databases other than HES to
answer clinical relevant questions
A number of authors have reported on the use of administrative data, other than the
HES data, for the purpose of reporting disease incidence. Sund reported on the use of
Finnish administrative discharge data for just this reason. This detailed study, using
hip fracture monitoring as an example application, attempted to identify issues that
require 'rethinking' during the process of utilising secondary data for incidence
reporting. Pitfalls identified included the assumption that for administrative data to
identify 'cases', only hospitalised injuries are observable. The effect of which is case
underascertainment resulting in underestimation of disease incidence if the medial
condition is managed without requiring hospitalisation. Another pitfall identified by
Sund related to multiple hospitalisations relating to the same patient with the
subsequent difficulty in identifying which admissions should be considered
readmissions. Additional pitfalls identified relate to difficulties in case definition,
specifically the need to have detailed and specific clinical knowledge with regard to
the medical condition of interest to enable case definition to be achieved by the use of
complex aggregates of various different diagnosis and operative procedure coding.
In this thesis, we specifically tailored our use of HES data - when evaluating the HES
data to answer questions considering the incidence of urological disease, to evaluate
only those surgical conditions that required surgical intervention. Given that for an
operation to be performed, the patient is required to be admitted to hospital,
underascertainment caused by managing the condition without hospitalisation is not
an issue. However, it is recognised that when reporting on the incidence of acute
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urinary retention, a proportion of men may have been managed without
hospitalisation. Furthermore, identification of index admissions from readmissions
was a specific area that we addressed in this thesis. For example, when identifying the
incidence of acute urinary retention in chapter nine, an episode of acute urinary
retention was labelled a primary retention episode as opposed to a recurrent retention
episode when there was no liES record documenting a previous episode of acute
urinary retention in a preceding period of at least 6 months.
Finally, given the breadth of clinical knowledge at the CEU, as well as the process of
case definition - cases were not identified in advance, diagnosis and operative
procedure coding were instead reviewed to identify coding practice before
aggregating a number of codes to generate and define' cases' , meant that the pitfalls
associated with case definition, highlighted by Sund, were minimised within this
thesis.
In addition to Finnish administrative discharge data, the US Medicare database has
been utilised extensively to answer questions concerning incidence of disease in the
US. Fisher and colleagues report on the pitfalls of epidemiological research using
Medicare data, again using hip fracture as the example application. Fisher raises
concerns over the use of Medicare data for such a purpose as substantial differences
were identified between the characteristics of those in the Medicare population and
those of the general population as documented by the US census. Fisher found that
Medicare coverage varies substantially across age, gender and race groups. Although
some of these differences were thought to be trivial, others were not. The study
concluded that conclusions on incidence drawn from Medicare data, while they may
be accurate for the Medicare population, should not necessarily be generalised to the
elderly US population as a whole.
It has been reported that between 95 and 96% of the US elderly population are
enrolled in Medicare [Lauderdale et aI, 1993]. Systematic differences in enrolment
across age, gender and race explain why Medicare does not reflect the general US
population. However, if one considers the UK population, NHS coverage is thought to
be significantly higher than 96%. However, there is some evidence, including data
utilised from the HES database itself, to suggest there is some degree of inequality in
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surgical services across the UK. It is therefore possible that such inequality, for
example the availability or access to urological services, may have resulted in some
degree of under ascertainment and as such under estimation of disease incidence
within this thesis.
Another limitation or pitfall associated with the use of administrative data, raised by
Baron and colleagues in their review of medical databases for epidemiological
research is the "rule-out" diagnosis. For example a patient is admitted for chest pain,
the clinician investigates the patient for a possible diagnosis of Myocardial Infarction
(MI). However, subsequent tests disprove the diagnosis ofMI. However, when it
comes to medical coding, although a diagnosis of MI was eventually disproved, a
diagnosis ofMI may still be coded with the administrative database, especially ifno
other diagnosis is subsequently made for the particular patient by the clinician.
In this thesis, for the main part, we utilised surgical procedures as the numerator
which do not tend to be susceptible to "rule-out" bias. However, for acute urinary
retention, even the passing of a catheter along with a diagnosis of retention does not
confirm retention and as such, analysis of retention incidence is at risk of "rule-out"
bias.
Lezzoni in an article entitled "assessing quality using administrative data" raises two
further potential pitfalls. Limitation of the number of diagnosis and operative
procedure fields can lead to underestimation of incidence. For example, in a complex
admission in which a patient experiences many medical problems, the occurrence of
urinary retention during admission may not be included in the admission record as
there was insufficient space for the diagnosis code amongst the more severe medical
conditions. This pitfall has been demonstrated by a recent study of Medicare data that
identified chronic conditions were less likely to be coded when patients died during
their admission as all the coding slots were consumed by acute diagnoses. This pitfall
could influence the ability of administrative data to report incidence, not only in the
Medicare database but also the HES database and is why both the Medicare and the
HES database have expanded the number of diagnosis and operative fields available
to clinical coders.
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Lezzoni raises another issue with regard diagnosis coding, on this occasion
specifically regarding the timing of events. Coding of diagnoses occurs after
discharge. Differentiating the timing of each diagnosis is key to risk adjustment. For
example, chronic renal failure and diabetes are obviously pre-existing conditions.
However, pneumonia may be a pre-existing condition or an acute problem. In such a
case, differentiating between acute and co-morbid conditions may be difficult. While
this issue is more important when risk stratifying outcomes of surgery, it may
influence estimation of disease incidence. In this thesis, we attempted to overcome
this issue by utilising the HESID number to identify any previous episodes of care in
which the particular diagnosis or operation of interest may be documented so as to
identify index admissions - namely the first database documented record in which a
particular operation of diagnosis occurred.
A number of authors have reported on the use of administrative data, other than the
HES data, for the purpose of reporting outcomes of surgical activity. Lezzoni
described the occurrence of "death creep" - reprising "code creep", which has been
reported to occur within the Medicare database if hospitals know that their discharge
abstracts will be used to evaluate mortality rates. "Death creep" describes the practice
whereby hospitals increase the coding of near-death conditions such as cardiac arrest
and respiratory failure for example which have the effect of confusing efforts to risk-
adjust mortality rates when making comparisons across hospitals.
While this phenomenon could potentially impact on our case study investigating how
higher volume centres achieve improved outcome following radical pelvic surgery, it
is unlikely to have been a major source of error in this thesis. First because medical
coders coding for complications of surgery in 2002 were unaware that the surgical
outcomes achieved by their individual hospitals were to be analysed, especially given
that few studies were utilising HES data at this time to report outcomes of surgery and
second, unlike their US counterparts, at least prior to the UK government initiating
the Patient Choice agenda, hospitals in the UK were not competing against each other
for work and as such revenue.
Another pitfall of administrative data to report and compare outcomes of surgery as
identified by Ayanian, concerns its lack of information concerning disease severity or
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stage of disease. The importance of this pitfall or limitation will of course depend on
the surgical procedure being studied. For example, Lewsey et al utilised
administrative data -linked hospital discharge and mortality data created by the
Information and Statistics Division of the NHS in Scotland, to analyse and compare
outcomes (I-year survival) of Percutaneous Transluminal Coronary Angioplasty
(PTCA) and Coronary Artery Bypass Graft (CABG) surgery. As this data source
lacked information about each patients' left ventricular function - the two most
critical factors for determining shot-term outcome of such procedures, questions have
been raised concerning the ability of such data to compare outcomes of the two
procedures. While cancer disease severity will not tend to influence short-term
outcome measures such as 30-day mortality, the inability to adjust for this factor will
certainly limit the use of lIES data to compare long-term outcomes that in turn reflect
the oncological outcomes achievable by different centres. This limitation is illustrated
within this thesis in the case study investigating the impact of delay on long-term
survival following radical cystectomy for bladder cancer. Furthermore, the lack of
data concerning severity of co-morbid disease within any administrative database
such as HES will affect attempts to risk-adjust mortality rates when comparing
outcomes achievable by different centres.
10.5 Recommendations and conditions required prior to the use of HES data
Below are a list of recommendations that are derived from the lessons learnt from the
review and case studies included within this thesis. These recommendations concern a
number of conditions that must be met for the HES database to be considered a valid
and so valuable source of information for the urologist.
11When incidence is to be calculated using the HES database, there must be no or
minimal ambiguity regarding the diagnostic or procedural coding for a particular
disease or a particular surgical intervention. If a condition or disease was not listed in
the tenth revision of the International Classification of Diseases coding system (ICD-
10), or the Offices of Populations Censuses and Surveys operative procedure coding
system (OPCS-4), it is not possible to calculate disease incidence or surgical practice.
All case studies within this thesis investigated surgical diseases and procedures that
were coded for with minimal ambiguity. For example, hypspadias is a common
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procedure that is coded with a single specific single OPCS-4 code while the diagnosis
of hypospadias itself is again coded for with a single ICD-l 0 diagnosis code. When
identifying other diagnoses or operative procedures, a number of codes can be used,
however, all operative and diagnostic codes should not be identified in advance.
Instead all diagnosis and operative codes listed within lIES admission should be
reviewed to identify specific coding practice employed by hospital coders. This
recommendation is supported by case studies reporting complications of circumcision
and radical cystectomy. Both case studies dramatically increased the number of
complications recorded within HES records by reviewing coding practice rather than
identifying diagnostic and operative codes in advance. Adherence to this
recommendation, the investigative urologist may reliably define a diagnosis or a
treatment/intervention that can be "operationalised" using a number of available HES
codes.
2/ If incidence of a condition is to be based on treatment identified from the HES
database, all or certainly the majority of patients must undergo treatment for that
condition. Furthermore, all or certainly the majority of patients with a particular
diagnosis must be hospitalised. Finally, if hospitalisation is to occur, all or the
majority of patients must be hospitalised within an NHS hospital. These
recommendations are supported by the case studies concerning the incidence of
hypospadias and the incidence of acute urinary retention. If the majority of boys with
hypospadias did not undergo surgery for their congenital anomaly, incidence
estimates based on treatment would be incorrectly low. If the majority of men with
acute urinary retention as a result of BPH progression had not been admitted to
hospital, it may not have been possible to evaluate the impact of change in the
management of BPH. Furthermore, if a high proportion of both boys undergoing
surgery for hypospadias, or men experiencing acute urinary retention were treated
outside the NHS, incidence estimates would again have been incorrectly low.
3/ When the HES database is to be used as a source of data to report incidence of a
particular condition prior to the introduction of HESid numbers, indiscriminate use of
Finished Consultant Episodes (FeE's) should be avoided due issues of double-
counting which lead to over-estimation of disease incidence. Instead, researchers
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should use a combination of date of birth, postcode, discharge destination, as well as
episode order in order to identify patient level data.
41 When the HES database is to be utilised as a source of information concerning
clinical appropriateness of treatment, the prevalence of that condition must be known.
This recommendation is supported by our case study concerning clinical
appropriateness of circumcision. Without a well-documented incidence of phimosis
being known, the HES database could not have been used to identify that too many
boys undergo unnecessary surgery.
51 The HES database would appear ideally suited to monitoring trends over time in
incidence and practice of surgery as well as changing trends in outcome of surgery.
However, for trends to be interpretable, there must be no changes in coding practice
over time. For example, in the case study concerning circumcision, boys noted to have
undergone ritual circumcision increased over the study period (these boys were
excluded from our analysis, the number of boys being excluded for this reason were
seen to increase over time). This may have been because boys were increasingly
undergoing ritual circumcision or because coders were more likely to use this code. A
change in the structure of the HES database may also influence trends. For example,
after 2002, the number of diagnosis and procedure fields increased to 14 and 12, from
7 and 4 respectively. This increase allows coders to code for more diagnoses and
operative procedures that could in-turn suggest a rising incidence of disease. Care
should therefore be taken when interpreting trends in incidence using HES data
around this time although analyses of case studies in this thesis have not suggested a
sudden increase or decrease in disease incidence over this particular time.
61The HES database should not be used as a source of data in isolation to report long-
term oncological outcomes of surgery. This recommendation is supported by the case
study investigating the impact of delay on outcome of radical cystectomy as HES data
did not identify that patients experiencing prolonged delay for treatment had an
inferior outcome, a finding at odds with the majority of data published on this issue.
Linkage with pathological data sources may on the other hand aid the use of the HES
database to report and investigate such outcomes.
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7/ HES data may be used to investigate the determinants of short-term surgical
outcome. This recommendation is supported by the case study investigating how high
volume hospitals achieve improved outcome. This case study used HES data to
identify that high volume hospitals achieve improved outcome following radical
pelvic cancer surgery - a finding compatible with the majority of data published on
this topic.
8/ To maximise the value of HES to report on the processes and outcomes of surgery,
outcome measures other than hospital mortality should be evaluated. This
recommendation is supported by the review that identified other indices of quality
available within HES. These include - the percentage of FeE's with a coded
complication - identified by searches of HES records to identify diagnostic and
operative coding adverse events, the percentage of FeE's with a prolonged length of
stay, mean length ofspeU and the percentage of FeE's in which patients undergo
more than one operative procedure.
10.6 Clinical Questions suited to liES data
HES data is suited to asking questions concerning common conditions that are easily
defined and diagnosed without ambiguity which can subsequently be easily coded for,
such as hypospadias. Treatment for such conditions/diseases should again be easily
defmed and coded for, again alike hypospadias. On the other hand,
conditions/diseases for which multiple different treatments are available are best
avoided as defining treatment will be complicated. Questions concerning incidence of
disease are suited to liES data due to its comprehensive nature given that the majority
of people in England receive medical treatment within NHS hospitals.
The HES database does also lend itself to answering questions regarding the clinical
appropriateness of treatment as in the case study of circumcision and phimosis, again
given its comprehensive nature, providing the prevalence of the medical condition
that is being treated in known.
The HES database may also be useful in answering questions concerning the real-life
impact of change in the management of clinical diseases. While the randomised
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controlled trial is the gold standard research methodology and has been used on many
occasions to identify that one treatment may be better than another, HES data may be
used to evaluate the real-life impact of adopting treatments advocated by such trials.
This is demonstrated by the case study on the impact of a shift away from surgery for
men with BPH on the incidence of acute urinary retention. Of course, the outcome
measure of disease progression would have to require hospital admission.
HES data may be used to answer questions concerning outcome of surgery providing
the outcome of interest requires hospital admission and again is coded for e.g. post-
operative mortality. Identifying the determinants of outcome such as erectile
dysfunction following radical prostatectomy for prostate cancer for example is not
suited to the HES data as first the outcome does not require hospital admission for
treatment and second, it not easily coded for within the database.
HES data does not suit questions concerning specific cancer-related outcomes as
demonstrated by the case study concerning impact of delay of radical cystectomy for
patients with bladder cancer but on the other hand is suited to asking administrative
questions such as is delay in surgery occurring? Answering such questions can help
improve cancer services as it can lead to the targeting of services and the
improvement in healthcare delivery.
Indeed, HES data is particularly suited to answering questions concerning structure of
healthcare and the improvement of healthcare provision chiefly because investigation
of outcome on a hospital level can be performed. For example, HES was able to
identify that improving the management of complications following radical pelvic
surgery may enable lower volume centres to improve their outcomes. HES on the
other hand does not lend itself to the identification of the determinants of outcome for
individual surgeons.
Finally, the review suggests liES data is ideally suited to investigating Healthcare
Needs Assessment, a topic for which the lIES database has been utilised most often to
date. The main attribute the HES database has for this purpose is its national coverage
together with its high ascertainment.
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10.7 Future Directions
Future research concerning the possible uses of HES data to answer clinically
pertinent questions is essential as the liES database represents a rich, available and
cost-effective medical research resource.
With specific respect to the lIES database, future research is needed to better
understand the completeness, reliability and timeliness of HES data, on which the
value of HES data to epidemiology rests. Further studies are needed on the accuracy
and validity of liES data.
Such validation studies may be either performed by directly comparing HES data
records with medical notes or alternatively, liES data can be compared with pre-
existing large national audits that have been commissioned either by the UK
government or by the individual medical colleges. An example would be the National
Prospective Tonsillectomy Audit (NPTA). This audit was commissioned by the
British Association of Otolaryngology specifically to investigate the determinants of
post-tonsillectomy haemorrhage. Direct comparison could be performed between
HES data and NPTA data. Not only would such comparison studies evaluate the
accuracy of liES data, they would also evaluate to what extent the HES database
could be subsequently used for 'continual monitoring of surgical outcomes' as
opposed to periodically repeating these national audits which are known to be both
highly expensive and labour-intensive.
The Clinical Effectiveness Unit is in an ideal position to undertake such research as it
has developed extensive expertise in the processing and analysis of liES data while it
also conducts many of the national audits such as the NPTA on behalf of the
individual speciality associations.
Further work is also ongoing at the Department of Health to develop a Spells Universe
(expected to be made available by autumn 2007). As alluded to on multiple occasions
through out this thesis, it is essential to recognise that episodes of care (FCE's) do not
represent patient level data and as such should be processed in such a way that
individual patient level data be generated. Although each spell still does not equate to
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patient level data (when a single patient is readmitted, a second spell will be
generated), the use of a Spells Universe would certainly make HES data processing
and analysis easier for the medical researcher.
In addition, the Department of Health has recently started collecting data within the
HES database concerning outpatient consultations. Information gleaned from these
data have yet to be the topic of a research publication. However, the collection of such
data would enhance the usefulness of the HES database to answer clinically
significant questions. A number of conditions, such as urinary incontinence for
example, although potentially treatable by surgery, may also be treated, at least
initially, by alternative treatment strategies. Identifying patients in the outpatient
setting would enable not only the incidence of the condition to be estimated, but also
enable the natural history of the condition to be established and monitored.
Further work is also required to link the HES database with additional databases. This
is again vital work as linkage, if accurate, will only increase the usefulness and power
of the HES database. Currently work is underway linking the HES database with
regional cancer registries as well as national radiotherapy databases (Bristol).
Finally, with the publication of the Darzi report in 2008, increasing emphasis will be
placed on improving the quality of care provided by the NHS. Data concerning all
three tenets of quality - patient safety, patient experience and effectiveness of care,
will increasingly be required to be made available within the public domain. HES data
is likely to be used increasingly for such purposes. Future work using HES data is
likely to focus on the identification of liES derived "quality indicators" that can be
used to monitor the quality of surgical care within the UK.
12.7 Concluding comments
Growing emphasis has been placed by on clinical governance and assessment of
clinicians outcomes, especially those of surgeons, the importance of which is
recognised by government, the general public and the medical profession alike.
Despite this, there is a lack of data available on patient outcomes after surgical care in
the UK. As a result the Clinical Effectiveness Unit of the Royal College of Surgeons
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of England has sought to evaluate alternative data sources that could be used to study
the "epidemiology of the quality of surgical care". Part of this body of work is
contained within this thesis. The overall objective of this thesis was to evaluate if the
HES database could be used as an alternative data source to answer questions of
clinical relevance to the urological surgeon.
This thesis has utilised a number of case studies together with a review of the
published literature to identify the strengths as well as weaknesses of the HES
database for such a purpose. While some of these strengths and weaknesses are
specific to the particular case studies included within this thesis, others are relevant to
general use of lIES data as a whole. Such analysis has enabled the development and
formation of a number of key recommendations that need to be met before the
urologist can use the liES database as a valid and valuable source of information from
which clinical questions can be asked.
HES data does hold considerable promise for the clinical researcher as an untapped
source of data. However, alike all data sources, HES data is only as good as the
question asked of it. This would appear the key point. The HES database will only be
useful provided appropriate questions are asked in light of its strengths and
weaknesses.
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Appendices
Appendix 1
HES Extract Pack Application form for circumcision data
(Please either type or write in black ink, as this form will be photocopied)
Data years (please tick):
1989/90 1990/91 1991/92 1992/93 1993/94 1994/95
1995/96 1996/97 1997/98 1998/99 1999/00 2000/01
2001102 2002/03 2003/04
Filter details (see 2.3.1 to 2.4.1)
Epistat=3
OPER_I-4=N303
To identify these episodes and all subsequent episodes over a period of 1 year
following initial surgery. Individual patients will need to be identified using a
unique anonymous patient identifier based on DOB, SEX and HOMEADD.
Fields to be extracted (please tick):
Please note that the fields below are of the General Table, for Augmented Care,
Maternity and Psychiatric A fields. Please refer to the Data Dictionary and write down
the selected fields in Other Details on page 17.
Data Dictionary: http://tapccta.gov.ukJdoh/hes
ADMIDATE DIAG 6 HOMEADD
(Date of Admission) (Diagnosis) (postcode of patient)
ADMIMETII DIAG 7 HOTEL
(Method of Admission) (Diagnosis) (cost per day)
AMDICAT DISDATE HRGLATE
(Admission Category group) (Date of discharge) (desc. of healthcare resource)
ADMISORC DISDEST HRGORIG
200
200
(Source of Admission)
201
(Destination of discharge) (healthcare resource group)
ADMISTAT
(psychiatric patient status)
DISMETH
(Method of discharge)
AIDSIND
(aids flag)
DOB
(Date of birth)
BEDYEAR
(Bed days within year)
ELECDATE
(Date of decision to admit) (local patient identifier)
LOPATID
CARERS I
(carer support indicator)
ELECDUR
(Waiting time)
CATEGORY
(psychiatric patient status)
ENDAGE
(Age at the end of episode) (marital status)
MARSTAT
INTMANIG
(Intended management)
LAGLAT
(legal category)
MAINSPEF
(main speciality)
CAUSE
(External cause of injury)
EPIDUR NEOCARE
(Episode duration) (neonatal level of care)
CLASSPAT
(Patient classification)
EPIEND NEODUR
(Date episode ended) (babies age in days)
CURRWARD + RESLADST EPlKEY NEWNHSNO
(Current Electoral ward) (System record identifier) (NHS number)
DETNCAT
(Detention category)
EPIORDER
(Episode order)
DHATREA T\HA
(District of treatment)
EPISTART
(Date episode started)
DHACOMP\HA
(DHA comparison)
EPITYPE
(Type of episode) (contains information about patients operation)
OPER 2
NUMACP
(No. of augmented care periods)
OPER 1
(contains information about patients operation)
DIAG 1
(Diagnosis)
GPPRAC OPER 3
(Code ofG.P. practice) (contains inrormation about patients operation)
DIAG 2
(Diagnosis)
GPPRACHA OPER 4
(Health authority ofG.P. practice) (contains information about patients operation)
DIAG 3
(Diagnosis)
GPPRACRO OP DTE 1
(Regional office ofG.P. practice)-(Date ofcperation)
DIAG 4
(Diagnosis)
GROSS A
(Clinical grossing)
DIAG 5 GROSS B
OP DTE 2
- (Date or operation)
OP_DTE_3
201
202
(Diagnosis) (Combined coverage & clinical grossing) (Date of operation)
OP DIE 4
(Date of operation) -
202
203
Appendix 2
Business Objects online HES Interrogation System Query for Hypospadias data
Universe:
1997/1998 (subsequent universes thereafter unti1200412005)
Objects:
ALL DIAGNOSES
ALL OPERATIVE PROCEDURES
EPISODE DURATION
SEX
DATE OF BIRTH
ADMISSION DATE
DATE OF DISCHARGE
EPISODE START DATE
EPISODE END DATE
AGE AT END OF EPISODE
EPISODE ORDER
MAIN SPECIALITY
BABIES AGE IN DAYS
ALL DATES OF OPERATION
HESID NUMBER
PATIENT AGE
Condition Objects:
ALL DIAGNOSES BETWEEN "Q54" AND "Q55"
AND
FINISHED CONSULTANT EPISODES (FCE's)
Definitions:
Universe - a logical grouping of classes. It corresponds to an individual HES
datayear.
Object - elements in the Business Objects universe that correspond to a
selection of data within the HES database. Objects within the HES database
correspond to the fields of the HES database e.g. ADMIMETH. However
within the framework of Business objects, HES objects are given descriptive
names e.g. admission method=ADMIMETH.
203
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Appendix 3
Business Objects online HES Interrogation System Query for BPH-related
surgery data
Universe:
1990/1991 (subsequent universes thereafter until200212003)
Objects:
ALL DIAGNOSES
ALL OPERATIVE PROCEDURES
EPISODE DURATION
SEX
DATE OF BIRTH
ADMISSION DATE
DATE OF DISCHARGE
EPISODE START DATE
EPISODE END DATE
AGE AT END OF EPISODE
EPISODE ORDER
ALL DATES OF OPERATION
HESID NUMBER
PATIENT AGE
Condition Objects:
ALL OPERATIONS BETWEEN "M65" AND "M66"
OR
ALL OPERATIONS BETWEEN ,m AND ""
AND
FINISHED CONSULTANT EPISODES (FCE's)
HES data obtained from this Business Objects query was subsequently linked to the
HES data gained from the Business Objects query identifying men experiencing
urinary retention (appendix 4) to enable "outcome of BPH-related surgery", to be
reported on.
204
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Appendix 4
Business Objects online HES Interrogation System Query for urinary retention data
Universe:
1997/1998 (subsequent universes thereafter unti1200312004)
Objects:
ALL DIAGNOSES
EPISODE DURATION
SEX
DATE OF BIRTH
ADMISSION DATE
DATE OF DISCHARGE
EPISODE START DATE
EPISODE END DATE
AGE AT END OF EPISODE
EPISODE ORDER
ALL DATES OF OPERATION
HESID NUMBER
PATIENT AGE
Condition Objects:
ALL DIAGNOSES BETWEEN "R33" AND "R34"
AND
FINISHED CONSULTANT EPISODES (FCE's)
205
Appendix 5
HES Extract Pack Application form for Radical Urological Pelvic surgery data
(Please either type or write in black ink, as this form will be photocopied)
Data years (please tick):
1989/90 1990/91 1991/92 1992/93 1993/94 1994/95
1995/96 1996/97 1997/98 1998/99 1999/00 2000/01
2001102
Filter details (see 2.3.1 to 2.4.1)
Epistat=3
OPER_I-4=M02 AND DIAG_I-7=(C64 OR C65)
OPER_I-4=M34 AND DIAG_I-7=C67
OPER 1-4=M61 AND DIAG 1-7=C61_ _
OPER_I-4=M03 AND DIAG_I-7=(C64 ORC65)
To identify these episodes and all subsequent episodes over a period of
2 years following the initial surgery and all episodes over a period of 2 years
prior to admission for initial surgery. Individual patients will need to be
identified using a unique anonymous patient identifier based on DOB, SEX
and HOMEADD.
Fields to be extracted (please tick):
206
Please note that the fields below are of the General Table, for Augmented Care,
Maternity and Psychiatric A fields. Please refer to the Data Dictionary and write down
the selected fields in Other Details on page 17.
Data Dictionary: h!tO:lltap.ccta.gov.ukldoh/hes
ADMIDATE
(Date of Admission)
DIAG 6
(Diagnosis)
HOMEADD
(postcode of patient)
ADMIMETH
(Method of Admission)
DIAG 7
(Diagnosis)
HOTEL
(cost per day)
AMDICAT
(Admission Category group)
DISDATE HRGLATE
(Date of discharge) (desc. of health care resource)
ADMISORC
(Source of Admission)
DISDEST HRGORIG
(Destination of discharge) (healthcare resource group)
206
ADMISTAT
(psychiatric patient status)
DISMETH
(Method of discharge)
AIDSIND
(aids flag)
DOB
(Date of birth)
207
INTMANIG
(Intended management)
LAGLAT
(legal category)
BEDYEAR
(Bed days within year)
ELECDATE LOPATID
(Date of decision to adinit) (local patient identifier)
CARERS I
(carer support indicator)
ELECDUR
(Waiting time)
CATEGORY
(psychiatric patient status)
ENDAGE
(Age at the end of episode) (marital status)
MARSTAT
MAINSPEF
(main speciality)
CAUSE
(External cause of injury)
EPIDUR NEOCARE
(Episode duration) (neonatal level of care)
CLASSPAT
(Patient classification)
EPIEND NEODUR
(Date episode ended) (babies age in days)
CURR WARD + RESLADST EPlKEY
(System record identifier) (NHS number)
NEWNHSNO
(Current Electoral ward)
DETNCAT
(Detention category)
EPIORDER
(Episode order)
DBA TREA T\lIA
(District of treatment)
EPISTART
(Date episode started)
DBACOMP\llA
(DHA comparison)
EPITYPE
(Type of episode) (contains information about patients operation)
OPER 2
NUMACP
(No. of augmented care periods)
OPER 1
(eontams information about patients operation)
DIAG 1
(Diagnosis)
GPPRAC OPER 3
(Code of G.P. practice) (contains inwrrnation about patients operation)
DIAG 2
(Diagnosis)
GPPRACHA
(Health authority ofG.P. practice) (contains information about patients operation)
OPER 4
DIAG 3
(Diagnosis)
GPPRACRO OP DTE 1
(Regional office of G.P. practice)-(Date ofoperation)
DIAG 4
(Diagnosis)
GROSS A
(Clinical grossing)
DIAG 5 GROSS B
OP DTE 2
_ (Date oToperation)
OP_DTE_3
207
208
(Diagnosis) (Combined coverage & clinical grossing) (Date of operation)
OP DTE 4
(Date of operation) -
208
Appendix 6
Review literature search strategies
Database Search strategies (Medline)
Database Terms
1 Hospital episode statistics.mp.
2 exp Hospital record$/
3 hospital admiss$ adj25NHS.mp
4 hospital admiss$ adj25 record$.mp
5 hospital adj25 episode$.mp
6 routine adj25 statistic$.mp
7 Discharge statistic$.mp.
8 Hospital statistic$.mp.
9 Routine data.mp.
10 Link$ adj25 record$.mp.
11 «Death record$ or death certif$) adj25 hospital admiss$).mp
12 (medical record$ adj25 references database).mp
13 or/l-12
16,651 references
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